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DNA looping plays an important role in gene regulation by increasing the lo-
cal concentration of a transcriptional activator or repressor at its primary binding
site. Several in vitro and in vivo studies on DNA looping showed that the stability
of protein-mediated DNA loops depends on the flexibility of both the looping pro-
tein and the DNA that contains the binding sites. We designed two types of short
and rigid DNA looping proteins, based on a coiled-coil motif, in order to probe
DNA flexibility on the thermodynamics of protein-mediated DNA loop formation.
In vitro characterization of the putatively tetrameric DNA binding protein lzee by
electrophoretic mobility shift assays (EMSA) did not show evidence of a sandwich
complex, which is a necessary precursor to DNA looping. A quantitative in vivo
looping assay, adapted from the reporter gene assay developed by Becker, Kahn,
and Maher (2005), showed relatively weak enhancement of repression on GCN4
operators spaced >300 bp apart by lzee and the dimeric looping proteins LZD73,
LZD80 and LZD87. However, lzee and LZD87 expression triggers cell toxicity or
highly decreased reporter protein expression on reporter strains containing GCN4
sites <240 bp apart. We proposed recombination events to explain the unexpected
behavior in this distance range. Results from in vitro Plasmid Conformation Cap-
ture (PCC) revealed a very weak increase in crosslinking efficiency on 450- and
900-bp DNA loops. The apparent failure in capturing DNA loops by in vivo and in
vitro PCC was attributed to the LZD proteins not being able to crosslink to DNA.
Lastly, we introduced two kinds of modifications to our DNA binding proteins. The
first modification sought to improve the linker sequence in lzee in order to select
for better tetrameric looping proteins. The other modification introduced lysine
residues at the DNA binding domains in the dimeric GCN4 looping protein LZD87
to enhance their ability to crosslink DNA. The in vivo repression assay failed to
select for lzee mutants that are better repressors than lzee, while the crosslinking
assays on the LZD single mutants did not show clear evidence that the new pro-
teins can crosslink DNA. Taking all of these results together, we have concluded
that the inability of the LZD proteins to stabilize DNA loops in vivo support the
model that DNA plays a more passive role in the thermodynamics of DNA looping.
However, the unique ability of lzee to trigger recombination in our repression assays
can be utilized to design assays that detect recombination as a consequence of DNA
looping, although further studies are required to understand this behavior. The
molecular tools presented in this work would serve not only in providing a deeper
understanding the thermodynamics of DNA looping, but could also be used as a
starting point to develop better systems for modulating gene expression.
EVALUATING IN VITRO AND IN VIVO
LOOPING EFFICIENCIES OF ARTIFICIAL
DNA-BINDING PROTEINS
by
Sarah Mae Cruzada Sucayan
Dissertation submitted to the Faculty of the Graduate School of the
University of Maryland, College Park in partial fulfillment




Associate Professor Jason D. Kahn, Chair/Advisor
Professor David Fushman
Associate Professor Douglas A. Julin
Associate Professor Stephen M. Mount
Professor William E. Bentley, Dean’s Representative
c© Copyright by
Sarah Mae C. Sucayan
2014
Dedication
Para ini sa akon ginikanan, mga kauturan, kag sa akon mga kahinablusan.
Labi sa tanan, para man ini sa akon hinigugma, sa iya nga walay kahimoan nga
pagsakdag sang akon mga handum.
ii
Acknowledgments
My time in graduate school has been long and arduous, but it has been a
life-changing experience for me. For that, I am forever grateful to the following
people..
To Dr. Jason D. Kahn, my thesis advisor and mentor.. for welcoming me
into his lab, for letting me take the reins to my project, and for providing me with
the guidance when I needed it. Thank you for giving me the opportunity to grow
professionally, and for reminding me to always "scan the entire forest and not get
hung up on the individual leaves."
The members of my Ph. D. Committee.. for their invaluable criticisms and
advice as they guide me through the process of pursuing a doctorate degree.
All the members of the Kahn Lab.. for you helpful comments and suggestions
during lab presentations. I am especially thankful for Aaron, Kathy, and Dan – lab
members who started graduate school with me.. for being more than just colleagues,
you have been instrumental for me to finally adapt to the rigors and challenges of
graduate school.
My past and present housemates and roommates, who have hailed from all
walks of life.. for teaching me to keep an open mind on everything. For most of
you, you have been more than just people who I live with. I am very thankful for
your friendship.
Friends from back home and all over the world who I have kept in touch,
and friends who have introduced me to activities and experiences that I have never
iii
thought possible.. for making my life more meaningful. It’s been quite an adventure
so far. Thank you for all of the wonderful memories.
My parents and my siblings.. for their unwavering love and support in all of
my endeavours, even if means we have to be physically apart for a very long time.
They have always been my #1 cheering squad.
Finally, to Marti, my beloved.. for being the most stable and calming presence
that I can always rely on. I thank God to have met you at just the right time, and




List of Tables viii
List of Figures ix
List of Abbreviations xii
1 Introduction 1
1.1 On DNA looping and gene regulation . . . . . . . . . . . . . . . . . . 1
1.2 Thermodynamic models on DNA looping . . . . . . . . . . . . . . . . 2
1.3 Approach: Removing the protein flexibility allows us to probe DNA
flexibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2 Initial expression and in vitro characterization of the LZT and LZD proteins 13
2.1 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.2 Rationale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3.1 Subcloning into pFastBac1 and pGEX6P1 plasmids . . . . . . 17
2.3.2 Protein expression using baculoviruses . . . . . . . . . . . . . 18
2.3.3 Protein expression in BL21 E. coli cells . . . . . . . . . . . . . 20
2.3.4 Protein expression in BL21-AI E. coli cells . . . . . . . . . . . 20
2.3.5 Protein isolation, purification and workup . . . . . . . . . . . 21
2.3.6 Purification of His-tagged fusion proteins from inclusion bodies 23
2.3.7 Electrophoretic Mobility Shift Assay (EMSA) . . . . . . . . . 24
2.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.4.1 Protein expression and purification . . . . . . . . . . . . . . . 25
2.4.2 EMSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3 Probing the in vivo looping efficiencies of LZT and LZD proteins 34
3.1 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.2 Rationale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.3.1 Promoter-operator constructs . . . . . . . . . . . . . . . . . . 40
3.3.1.1 Single operator controls . . . . . . . . . . . . . . . . 41
3.3.1.2 85- and 85.5-bp looping constructs . . . . . . . . . . 44
v
3.3.1.3 138.5- to 237.5-bp looping constructs with proximal
wild-type GCN4 site . . . . . . . . . . . . . . . . . . 44
3.3.1.4 300- to 1150-bp looping constructs with distal INV2
site . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.3.2 Expression plasmids . . . . . . . . . . . . . . . . . . . . . . . 47
3.3.3 Reporter protein assays . . . . . . . . . . . . . . . . . . . . . . 48
3.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.4.1 Baseline expression in reporter strains . . . . . . . . . . . . . 50
3.4.2 Testing operator strength with 4har and lzee proteins . . . . . 50
3.4.3 Testing operator strength with LZD proteins . . . . . . . . . . 58
3.4.4 Colorimetric screen on tac-pGEX transformants using Mac-
Conkey and tetrazolium media . . . . . . . . . . . . . . . . . . 63
3.4.5 Colorimetric screen on lacUV5-pGEX transformants . . . . . . 65
3.4.6 Cross-streaking experiments between indicator media . . . . . 72
3.4.7 Repression assays on 85- to 650-bp looping strains . . . . . . . 76
3.4.8 Proposed model for baseline repression triggered by pGEX
expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
3.4.9 Reporter assays on lacUV5-pGEXb recombinants . . . . . . . 85
3.4.10 Reporter assays on pBAD recombinants . . . . . . . . . . . . 89
3.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4 Catching DNA-protein loops using Plasmid Conformation Capture 94
4.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.2 Rationale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.3.1 In vivo PCC . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.3.2 In vitro PCC . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.3.3 Quantitative PCR (qPCR) . . . . . . . . . . . . . . . . . . . . 101
4.3.4 qPCR data analysis . . . . . . . . . . . . . . . . . . . . . . . . 102
4.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.4.1 In vivo PCC control experiments . . . . . . . . . . . . . . . . 103
4.4.2 In vitro PCC control experiments . . . . . . . . . . . . . . . . 108
4.4.3 Quantification of in vitro PCC ligation products . . . . . . . . 111
4.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
5 Improving protein design 120
5.1 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.2 Rationale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.3.1 Generating the LZT protein library . . . . . . . . . . . . . . . 124
5.3.2 Generating the LZD87 lysine mutants . . . . . . . . . . . . . . 126
5.3.3 In vivo crosslinking assays on LZD87 single mutants . . . . . . 128
5.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5.4.1 Screening the LZT library for better repressors . . . . . . . . . 129
5.4.2 In vivo crosslinking results . . . . . . . . . . . . . . . . . . . . 131
vi
5.4.3 In vitro crosslinking results . . . . . . . . . . . . . . . . . . . 131
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
6 Conclusions and Future Directions 139
6.1 Characterization experiments on the LZD proteins . . . . . . . . . . . 140
6.2 Modifications on the LZT protein library . . . . . . . . . . . . . . . . 141
6.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Appendix 1 Growth Media and Selection Plates for Microbiology Work 143
1.1 General Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
1.2 Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
1.3 Growth Media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
1.4 Agar Plates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Appendix 2 Relevant DNA and Protein Sequences 146
2.1 Expression plasmids . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
2.2 Mutagenesis primer sequences for generating 300- to 1150-bp looping
constructs with distal INV2 site . . . . . . . . . . . . . . . . . . . . . 157
2.3 Promoter-operator constructs . . . . . . . . . . . . . . . . . . . . . . 158
2.4 Translated protein sequences . . . . . . . . . . . . . . . . . . . . . . . 165




3.1 Reporter protein behavior in looping strains . . . . . . . . . . . . . . 55
3.2 Reporter protein behavior in “Op only” non-looping strains . . . . . . 57
3.3 Reporter protein behavior in “Od only” non-looping strains . . . . . . 57
3.4 Reporter protein behavior of lzee and LZD proteins in looping strains 61
3.5 Reporter protein behavior of lzee annd LZD proteins BL876 strains . 62
3.6 Repression ratios (± IPTG) on reporter strains containing proximal
CREB site . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.7 Repression ratios (± IPTG) on reporter strains containing proximal
wild-type GCN4 site . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.8 Reporter protein behavior in FW102/IC-450 looping strains trans-
formed with pGEXb plasmids . . . . . . . . . . . . . . . . . . . . . . 90
3.9 Reporter protein behavior in FW102/IC-450 looping strains trans-
formed with pBAD plasmids . . . . . . . . . . . . . . . . . . . . . . . 92
4.1 Comparison of DNA yields in in vitro PCC templates . . . . . . . . . 116
4.2 Cycle threshold values from all in vitro PCC qPCR products . . . . . 117
viii
List of Figures
1.1 Negative regulation of the lac operon using LacI protein . . . . . . . 3
1.2 Thermodynamic model for DNA cyclization . . . . . . . . . . . . . . 5
1.3 Cooperative repression via DNA looping . . . . . . . . . . . . . . . . 7
1.4 LZT protein design . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.5 LZD protein design . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.6 Graphical renderings of LZD73 (green), LZD80 (blue) and LZD87
(magenta) bound to 20-bp DNA containing CREB or INV2 site . . . 12
2.1 Baculovirus life cycle in insect cells . . . . . . . . . . . . . . . . . . . 15
2.2 Baculoviral expression of 4har protein in Sf9 cells . . . . . . . . . . . 26
2.3 Protein expression and purification of GST-lzee in BL21 cells . . . . . 27
2.4 SDS-PAGE of FPLC-purified GST fusion proteins stored at different
temperatures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.5 EMSA on GST-4har and GST-lzee with 26-mer CREB DNA . . . . . 30
2.6 EMSA on GST-4har and cleaved off GST-lzee with 26-mer CREB DNA 32
3.1 In vivo repression assay . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2 Promoter-operator regions of the reporter (FW102) strains used for
the control experiments . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.3 Cloning strategy for generating proxWT-1 and proxCREB-1 . . . . . 42
3.4 Cloning strategy for generating distWT . . . . . . . . . . . . . . . . . 43
3.5 Cloning strategy for generating distCREB . . . . . . . . . . . . . . . 43
3.6 Cloning strategy for generating looping constructs . . . . . . . . . . . 45
3.7 Cloning strategy for generating looping constructs . . . . . . . . . . . 46
3.8 β-galactosidase activity in untransformed reporter strains . . . . . . . 51
3.9 Comparing β-galactosidase activities in looping strains transformed
with 4har and lzee . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.10 Comparing β-galactosidase activities in “Op only” non-looping strains
transformed with 4har and lzee . . . . . . . . . . . . . . . . . . . . . 54
3.11 Comparing β-galactosidase activity in “Od only” non-looping strains
transformed with 4har and lzee . . . . . . . . . . . . . . . . . . . . . 56
3.12 Comparing β-galactosidase activity in looping strains transformed
with lzee and LZDs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.13 β-galactosidase activity in BL876 strains transformed with lzee and
LZDs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
ix
3.14 β-galactosidase activity of BL876 reporter strain, transformed with
tac-lzee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.15 Western blot of clarified lysates from lacUV5-pGEX transformants in
BL21 E. coli cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.16 Comparing β-galactosidase amounts on FW102/CC-85 transformants
selected from different indicator plates . . . . . . . . . . . . . . . . . 68
3.17 Comparing β-galactosidase amounts on FW102/proxCREB-1 trans-
formants selected from different indicator plates . . . . . . . . . . . . 69
3.18 Comparing β-galactosidase amounts on FW102/proxWT-1 transfor-
mants selected from different indicator plates . . . . . . . . . . . . . . 70
3.19 Comparing β-galactosidase amounts on FW102/CW-237.5 transfor-
mants selected from different indicator plates . . . . . . . . . . . . . . 71
3.20 Colorimetric screen on lacUV5-pGEX transformants using tetrazolium
and Xgal plates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.21 β-galactosidase levels in FW102/CW-138.5 reporter strains trans-
formed with lacUV5-LZDs . . . . . . . . . . . . . . . . . . . . . . . . 79
3.22 Proposed recombination event I (lacI – lacZ cassette) in reporter
strains transformed with pGEX plasmids . . . . . . . . . . . . . . . . 82
3.23 Proposed recombination event II (Plac – lacZ cassette) in reporter
strains transformed with pGEX plasmids . . . . . . . . . . . . . . . . 83
3.24 Culture PCR results I on FW102/IC-450 reporter strains transformed
with lacUV5-pGEXb recombinants . . . . . . . . . . . . . . . . . . . 87
3.25 Culture PCR results II on FW102/IC-450 reporter strains trans-
formed with lacUV5-pGEXb recombinants . . . . . . . . . . . . . . . 88
3.26 β-galactosidase levels from FW102/IC-450 reporter strains transformed
with lacUV5-pGEXb (empty vector, lzeeV2, LZD73, LZD80, LZD87) 89
3.27 Western blot of crude lysates from lacUV5-pGEXb transformants in
FW102/IC-450 reporter strains . . . . . . . . . . . . . . . . . . . . . 90
3.28 β-galactosidase levels from FW102/IC-450 reporter strains transformed
with pBAD (empty vector, lzeeV2, LZD73, LZD80, LZD87) . . . . . . 91
4.1 Plasmid Chromosome Capture . . . . . . . . . . . . . . . . . . . . . . 95
4.2 DNA templates and PCR primers used in PCC . . . . . . . . . . . . 97
4.3 In vivo PCC control experiments for proxCREB-2 ± LZD80 or LZD87104
4.4 In vivo PCC control experiments for IC-300 ± LZD80 or LZD87 . . . 105
4.5 Template dilutions of proxCREB-2 ± LZD80 or LZD87 + IPTG . . . 107
4.6 Quantification of in vivo PCC A1+B2 PCR products in proxCREB-2
± LZD80 or LZD87 + IPTG . . . . . . . . . . . . . . . . . . . . . . . 108
4.7 Quantification of in vivo PCC A1+B2 PCR products in IC-300 ±
LZD80 or LZD87 + IPTG . . . . . . . . . . . . . . . . . . . . . . . . 109
4.8 In vitro PCC control experiments for IC-450 ± LZD73 or LZD80 with
internal control primers . . . . . . . . . . . . . . . . . . . . . . . . . . 111
4.9 In vitro PCC control experiments for IC-450 ± LZD73 or LZD80 . . 112
4.10 In vitro PCC for detecting 300-, 450- and 900-bp interaction between
GCN4 sites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
x
4.11 Concentration curves for in vitro PCC . . . . . . . . . . . . . . . . . 115
4.12 Crosslinking efficiencies among in vitro PCC templates . . . . . . . . 118
5.1 Strategy for designing the LZT protein library . . . . . . . . . . . . . 122
5.2 Two views of the LZD87 mutants . . . . . . . . . . . . . . . . . . . . 123
5.3 Screening the LZT library for better repressors . . . . . . . . . . . . . 130
5.4 Protein expression on LZD87 single mutants . . . . . . . . . . . . . . 132
5.5 Plasmid yields from batch purification of crosslinked protein-DNA
complexes, initial supernatants . . . . . . . . . . . . . . . . . . . . . . 133
5.6 Plasmid yields from batch purification of crosslinked protein-DNA
complexes, initial eluates . . . . . . . . . . . . . . . . . . . . . . . . . 134
5.7 Comparing various methods of removing formaldehyde in crosslinked
DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
5.8 ApoI digestion products of formaldehyde-crosslinked IC-450 ± LZD87
mutants after batch purification, initial supernatants . . . . . . . . . 137
5.9 ApoI digestion products of UV-crosslinked IC-450 ± LZD87 mutants
after batch purification . . . . . . . . . . . . . . . . . . . . . . . . . . 138
xi
List of Abbreviations
3C chromosome conformation capture
4HB four helix bundle (tetramerization domain)
6x His 6x Histidine (affinity tag)
aa amino acid
amp ampicillin




cAMP cyclic adenosine monophosphate
CAP catabolite activator protein
ChIP chromatin immunoprecipitation
CREB cAMP response element-binding protein
CV column volume





EMSA electrophoretic mobility shift assay
FPLC fast protein liquid chromatography
gen gentamicin






lacI lactose repressor (protein)
lacY lactose permease (protein)
lacZ β-galactosidase (protein)
LB Luria-Bertani
LZD leucine zipper dual-binding (protein)
LZIP leucine zipper (dimerization domain)
LZT leucine zipper tetrameric (protein)
MCS multiple cloning site
MES 2-(N-morpholino)ethanesulfonic acid
ONPG o-nitrophenyl-β-galactosidase
PAA proline-alanine-alanine (GCN4 protein dimer)
xii
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PCC plasmid conformation capture
PCR polymerase chain reaction
PNK polynucleotide kinase
RNA ribonucleic acid




TBE tris, borate, and EDTA (buffer)
TBS tris-buffered saline







IDT Integrated DNA Technologies
NEB New England Biolabs
xiii
Chapter 1: Introduction
1.1 On DNA looping and gene regulation
Gene regulation is an essential process for the growth, development, and evo-
lution of many organisms. A variety of genes would be expressed at different times,
places, and in different combinations during the lifetime of an organism. In Es-
cherichia coli, not all genes in its chromosome are expressed at the same time.
Rather, signals from the cell’s environment dictate which of these genes get tran-
scribed. For more complex organisms, the intricate regulation of gene expression
in different cells would result to different products of these genes, i.e. enzymes and
structural proteins, that determine the cell architecture and behavior in the different
parts of the organism.
There are two general steps in gene expression that are common in all or-
ganisms. First, the gene is transcribed into messenger RNA (mRNA), and second,
the mRNA gets translated into protein. More complex organisms have developed
additional steps in controlling gene expression. However, the most common way to
regulate gene expression, which is the least taxing to the cell, is to control the tran-
scription initiation (Matthews, 1992). Given the limited amounts of transcriptional
machinery in a cell at any given time, organisms have developed a wide array of tran-
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scription factors. These are DNA binding proteins whose sole purpose is to direct,
or block, RNA polymerase into transcribing certain genes based on a combination
of signals received from the cell’s environment.
One common mechanism for transcriptional activators to recruit RNA poly-
merase to the promoter region of the gene to be transcribed, or for repressors to
block RNA polymerase more efficiently, is by DNA looping. By being tethered at one
end to a secondary binding site, the local concentration of an activator or repressor
to its primary binding site is increased tremendously. In the case of transcriptional
activation of glnA (glutamine synthetase) during nitrogen starvation, the activator
NtrC, bound at strong sites located at 110 and 140 bp upstream of the transcription
start site for glnA, has to bind to the σ54 subunit of the RNA polymerase so the
latter can be converted to an open complex, thereby activating transcription of the
gene (Sasse-Dwight & Gralla, 1988; Echols, 1990; Weiss, Batut, Klose, Keener, &
Kustu, 1991). In the arabinose operon, which contains divergent promoters pBAD
and pC, positive and negative regulation of the araBAD genes is controlled by the
AraC protein. In the absence of arabinose, AraC interacts with both the O2 and
I2 operators, forming a 210-bp DNA loop that effectively blocks RNA polymerase
access to the pBAD and pC promoters. In the presence of arabinose, AraC binds in-
stead to the adjacent I1 and I2 sites, releasing the loop and activating the expression
of araBAD genes (Matthews, 1992; Schleif, 2000). In the lactose operon, auxillary
operators both upstream and downstream of the primary operator ensure high ef-
fective concentration of the lactose repressor protein, LacI, to the primary operator
for efficient repression of the lacZYA genes in the absence of lactose (Mossing &
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Record, 1986; Krämer et al., 1987; Oehler, Eismann, Krämer, & Müller-Hill, 1990).
The DNA loop bridged by LacI is one of the simplest looping systems and has been
the paradigm for several studies on looping (see Figure 1.1).
1.2 Thermodynamic models on DNA looping
DNA looping, as a regulatory mechanism for gene expression, requires bending
and contorting the DNA. Thus, it is essential to consider the mechanical properties
of this biological polymer in order to study DNA looping. The Worm-Like Chain
(WLC) model has been used to describe semi-flexible polymers (Kratky & Porod,
1949), and has been successfully applied to DNA bending behavior. In this model,
the energy it takes to bend DNA is dependent on the angles between planes of
adjacent base pairs in the double helix and the number of base pairs. The winding
of the DNA strands along the axis dyad, forming the double helix, as well as the
base pair stacking interactions, confer torsional stiffness and bending rigidity to the
dsDNA. This led to the definition of the intrinsic inflexibility of DNA called the
persistence length. The physical implications of the WLC model on DNA looping
are (1) DNA behaves as a rigid rod at contour lengths shorter than its persistence
length, thus requiring considerable energy to bend and form the DNA loop; and (2)
at contour lengths greater than the persistence length, DNA behaves like a random
coil, in which entropy dominates over bending energy in loop formation.
T4 ligase-mediated DNA cyclization experiments has shown that the ring clo-


























Figure 1.1: Negative regulation of the lac operon using LacI protein, from Oehler et
al. (1990). (1) Presence of auxillary operators O2 and O3 enhances the repression
of the lacZYA genes in the absence of lactose. (2) By tethering LacI (shown as four
yellow circles) to either O2 or O3, the local concentration of LacI to the primary
operator is increased by looping the intervening DNA.
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equilibrium concentration of the ligatable ends in the vicinity of one another (Shore,
Langowski, & Baldwin, 1981; Shimada & Yamakawa, 1984; Zhang & Crothers, 2003)
(see Figure 1.2). Mossing and Record (1986) first demonstrated parallels between
cooperative repression in the presence of an operator at various distances upstream
of a promoter-constitutive operator control region, and length dependent circulariza-
tion of DNA fragments using T4 ligase. The observed effects of DNA twist, shape
and stiffness from these experiments initiated the development of a quantitative
model that would explain the regulatory action of distant DNA sites. According
to this model, the effective local concentration, known as the j -factor, of looping
components bound to different sites in the DNA sequence is controlled by the length
of the intervening DNA and its inherent bending and torsional stiffness. Measure-
ment of the looping efficiency as a function of DNA length showed that the effective
concentration increases as the distance between looping partners increases, reaching
a maximum value at around 400 bp, then gradually decreases as the distance in-
creases further. Furthermore, periodic fluctuations in the j -factor are superimposed
on the overall curve, where the period of the oscillations is equivalent to one helical
repeat. This is due to the specific spatial relationship of the looping partners upon
binding. This model had been consistent in interpreting early experimental results
on looping efficiency.
Kramer and co-workers used electron microscopy, non-denaturing polyacry-
lamide electrophoresis and DNAse I footprinting experiments to show that the sta-
bility of the LacI-DNA loops in vitro depends on the distance between the operators,
the phasing of the two lac operators and the concentrations of repressor and DNA
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Figure 1.2: Themodynamic model for DNA cyclization, from Zhang and Crothers
(2003). Calculations done by Zhang and Crothers (2003) (ZC) and Shimada and
Yamakawa (1984) (SY) on homogeneous DNA were compared. Discrepancies in the
calculated values of j -factors aside, this model illustrates the physical forces involved
in the formation of circular DNA based on DNA length. At short DNA lengths, DNA
flexibility plays a major role in forming circular DNA, whereas at longer lengths,
random motion of the ligatable ends determines cyclization. Oscillations in the j -
factors correspond to one helical repeat, which are due to varying orientations of
the ligatable ends to one another.
(Krämer et al., 1987). Bellomy and colleagues developed a DNA looping assay, using
plasmid constructs containing a wild-type lac operator located at various distances
upstream of an operator-constitutive lac control element, to determine the looping
efficiency in vivo (Bellomy, Mossing, & Record, 1988). Maher and colleagues de-
veloped a similar repression assay that probes properties of lac repression loops in
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vivo, using single-copy reporter constructs containing varied spacings of the lac op-
erators (Becker et al., 2005). Figure 1.3 shows the correlation between cooperative
repression and the lac operator spacings. However, derived looping parameters from
the in vivo studies suggest that in vivo formation of DNA loops seems to be less
sensitive to the physical properties of DNA.
Figure 1.3: Cooperative repression via DNA looping, from Peters et al. (2011). (A)
Single-copy reporter constructs used to measure repression of lacZ by occupancy of
O2, as a function of increased local concentration of lacI due to collisions with lacI
tethered at the Osym operator. (B) Experimental data fitted to a thermodynamic
model for repression ratio (top) and DNA looping-dependent reporter activity, E’
(bottom), from wild-type (WT) and nucleoid heat unstable HU-deficient (∆HU)
E. coli cells. The oscillations in all data fits demonstrate lacZ repression by DNA
looping.
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There are at least three possible explanations regarding the discrepancy in the
looping efficiency between the in vitro and in vivo experiments. In the case of the
NtrC-Eσ54 interaction, the activator is a hexamer, and so at least six possible loops
can occur upon binding to DNA (Lilja, Jenssen, & Kahn, 2004). Studies probing
the various loop conformations mediated by LacI suggest that the flexibility of the
looping protein has a significant contribution to the apparent DNA flexibility (Vanzi,
Broggio, Sacconi, & Pavone, 2006; Rutkauskas, Zhan, Matthews, Pavone, & Vanzi,
2009; Haeusler et al., 2012; Goodson, Wang, Haeusler, Kahn, & English, 2013).
The bacterial assay developed by Maher and colleagues verified how architectural
proteins like bacterial HU and mammalian HMGB1 affected the apparent flexibility
of DNA in vivo. Moreover, phasing of the operators affects the looping efficiency,
although a striking observation was noted in that inter-operator distances lower than
the persistence length have little or no apparent effect on looping, even on systems
lacking the HU protein (Becker et al., 2005; Becker, Kahn, & Maher, 2007). Taken
all of these possibilities together, one can conclude that the inherent inflexibility of
DNA, as described by classical elastic models and demonstrated in in vitro studies,
is overcome in in vivo loop formation by interactions with non-specific DNA bending
proteins, as well as the flexibility of the looping protein. DNA flexibility, in this case,
plays a passive role in the formation of DNA loops.
However, spontaneous in vitro cyclization of 89-105 bp DNA fragments gave
way to alternative models for DNA bending at DNA lengths shorter than its in vitro
persistence length (Cloutier & Widom, 2004, 2005). One model proposed that local-
ized melted regions within the dsDNA account for the enhanced circularization of
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very short DNA fragments. Another model suggested that formation of local kinks
in the intervening DNA also accounts for DNA hyperflexibility in the formation of
DNA minicircles (Wiggins, Phillips, & Nelson, 2005). Both of these models indicate
that DNA flexibility has a more significant role in stabilizing small in vivo loops.
This view has been openly challenged by different research groups. Du, Smith,
Shiffeldrim, Vologodskaia, and Vologodskii (2005) demonstrated that incorporation
of kinks in the intervening DNA produced the enhanced cyclization efficiencies in
100-bp DNA minicircles, but failed to find a model that accounted for the periodic
fluctuations in the j -factor values. Gowetski, Kodis, and Kahn (2013) designed and
characterized small and relatively inflexible looping peptides to directly probe in-
herent DNA flexibility in DNA loop formation. Ring closure experiments on DNA
fragments bound at both ends of the looping protein revealed the minimum sepa-
ration of DNA binding sites to be much longer than the in vitro DNA persistence
length. Extending these experiments on DNA fragments with varying binding site
separations showed periodic fluctuations in topoisomer distributions that are con-
sistent with the classic model for DNA bending.
These two competing theories that explain the contribution of inherent DNA
flexibility in in vivo loop formation is far from being resolved. Thus, we set out to
design molecular tools with the intent of determining whether protein flexibility or
DNA flexibility drives the formation and stability of DNA loops in vivo.
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1.3 Approach: Removing the protein flexibility allows us to probe DNA
flexibility
Most of the highly efficient looping proteins in nature are relatively large with
flexible regions that allow them to have different conformations. Thus, we needed to
design a new set of looping proteins that are small and relatively rigid. The looping
protein has to be relatively small and inflexible such that characterization of the
looping parameters would be attributed to the flexibility of the intervening DNA.
Among the different protein secondary structures that can be relatively inflexible,
an alpha-helical coiled-coil motif seems most promising.
Figures 1.4 and 1.5 show the schematic design for two types of short and
relatively rigid proteins. The first design (LZT proteins) fuses together the dimeric
DNA-binding and leucine zipper regions (LZIP) of the yeast transcription factor
GCN4, and the C-terminal tetramerization domain (4HB) of the lactose repressor
protein. The other design (LZD proteins) places the DNA-binding domains of GCN4
on both the N-terminal and C-terminal ends of the leucine zipper motif.
Four variants were designed for the LZT peptides by varying the sequences
of the linker region between the LZIP and the lacI four helix bundles. Two of
these variants (4har and 4hee) have linker sequences from the extension of the 4HB
domain. The other two variants (lzar and lzee) have linker sequences from the
extension of the LZIP region. The hope is that one of these variants can fold into a
stable tetramer upon binding to DNA. Initial cloning attempts of these genes into
10




















Figure 1.4: LZT protein design. top: schematic design for the LZT proteins, in-
dicating the DNA binding domain (dark blue rods), dimerization domain (light
blue rods), the linker sequence (black lines), and the tetramerization domain (yel-
low rods). middle: components of the LZT protein monomer, cloned with the
N-terminal affinity tag. The linker sequences between LZIP and lacI 4HB were de-
termined by extending the 4HB domain (in 4har and 4hee), or extending the LZIP
region (in lzar and lzee). bottom: amino acid sequences of the four variants of the
LZT proteins, cloned as 6x His fusion proteins.
pGEX2T plasmid resulted in several mutations in the gene inserts. The genes were
eventually fixed and were successfully cloned into pRSETA.
On the other hand, three variants were cloned for the LZD peptides, by ex-
tending the LZIP sequence by one or two heptad repeats. As illustrated in Figure
1.6, changing the linker sequence length rotates the orientation of one of the binding
sites in a left-handed twist, giving rise to different crossover angles between DNA
binding sites.
Two of the LZD peptides (LZD73 and LZD87) have been previously demon-






Figure 1.5: LZD protein design, from Gowetski et al. (2013). top: schematic design
for the LZD proteins, indicating the DNA binding domains (dark blue rods) and
dimerization domain (opaque and translucent light blue rods). middle: components
of the LZD protein monomer, cloned with the N-terminal affinity tag. The linker
sequence between LZIP and C-terminal DBD was determined in Hollenbeck et al.
(2001). bottom: amino acid sequences of the three variants of the LZD proteins,
cloned as 6x His fusion proteins.
look on the topoisomer distributions in ring closure experiments revealed similar
peak locations for the different topoisomers for both peptides, suggesting similar
torsional flexibilities for peptides that were designed to have different crossover an-
gles of the DNA binding sites. By utilizing molecular tools that probe in vivo DNA
looping by these peptides, we might be able to differentiate the in vivo looping






Figure 1.6: Graphical renderings of LZD73 (green), LZD80 (blue) and LZD87 (ma-
genta) bound to 20-bp DNA containing CREB or INV2 site. The image illustrates
the left-handed twisting of the coiled-coil domain. As the linker sequence is ex-
tended, the orientation of the binding sites rotates in a left-handed direction. Com-
posite images were generated using PyMOL, with PDB file 2DGC as template.
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Chapter 2: Initial expression and in vitro characterization of the LZT
and LZD proteins
2.1 Objectives
Initial attempts to clone the LZT proteins in E. coli resulted in various gene se-
quence deletions, which indicated that baseline expression levels of these proteins are
toxic to the bacterial host. The mutated gene sequences were eventually fixed using
PCR and cloned into T7 promoter-controlled vectors. However, subsequent protein
expression studies showed that three of the proteins (4har, 4hee and lzar) form insol-
uble aggregates. This makes protein characterization by in vitro experiments rather
cumbersome although not impossible. Thus, we present two alternative protein ex-
pression strategies to produce soluble recombinant proteins. The first strategy is to
express the putative proteins in insect cells using recombinant baculoviruses. The
second is to attach a GST affinity tag to the recombinant proteins, and express them
in bacterial cells. Furthermore, we present initial characterization results for two of
the LZT proteins in their ability to loop DNA in vitro. The main goals addressed
in this chapter are to (1) express and isolate soluble LZT proteins, and (2) to test
their ability to loop DNA in vitro.
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2.2 Rationale
Our first strategy in producing soluble artificial DNA-binding proteins is to
express them in eukaryotes. Compartmentalization of different cellular processes
in eukaryotes would prevent our DNA binding proteins from interacting with the
chromosomal DNA. Among the various eukaryotic expression systems available, we
decided to use recombinant baculoviruses to generate our artificial proteins. The
relative ease in generating recombinant baculoviral vectors, along with the eukaryotic
post-translational processes of the host make this system ideal in producing our
proteins.
Baculoviruses are rod-shaped viruses that primarily infect insect larvae. Two
of the most common viruses used in recombinant gene expression are Autographa
californica multiple nuclear polyhedrosis virus (AcMNPV) and Bombyx mori nuclear
polyhedrosis virus (BmNPV). The life cycle of the wild-type baculovirus is shown
in Figure 2.1.
In recombinant gene expression using baculoviruses, the lytic cycle is utilized
to generate high-titer viral stock solutions to be used for protein expression studies.
To generate the desired protein, the recombinant gene is placed downstream of the
polyhedrin promoter so that the gene product is expressed instead of the polyhedrin
protein. Furthermore, the polyhedrin gene product in the wild-type baculovirus
makes up around 50% of the total viral protein. Thus we would expect to have
reasonable yield of the recombinant protein.





















Figure 2.1: Baculovirus life cycle in insect cells from Murphy et al. (2004). Viral
infection of the insect larva generates two types of progeny, which are developed
independently throughout the life cycle. During the lytic cycle (shown in red ar-
rows), the host cell produces non-occluded or budded viruses. The budded virus is
coated with a lipid bilayer membrane acquired from the host cell membrane. This
promotes horizontal transmission of the virus to other types of cells in the larva. On
the other hand, occluded viruses are generated during the occluded cycle (shown
in green arrows). The mature virions are packaged together inside an envelope ac-
quired from the nuclear membrane of the host, forming the occluded virus. Several
occluded viruses are then embedded within a polyhedrin crystal matrix. When the
larva dies, the polyhedra are released into the environment where they can then be
ingested by another insect host, promoting the vertical transmission of the virus.
prokaryotic metabolic enzymes whose known purpose is to remove xenobiotics and
products of oxidative stress by conjugating them with the reduced form of glu-
tathione (GSH) (Hayes, Flanagan, & Jowsey, 2005). In recombinant gene tech-
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nology, Schistosoma japonicum GSTs are cloned into the recombinant protein as
an N-terminal affinity tag (Smith & Johnson, 1988). This strategy has a two-fold
advantage: (1) its strong affinity to glutathione makes it relatively easy to isolate
and purify the protein of interest from bacterial lysates, and (2) dimerization of the
affinity tag (Parker, Lo Bello, & Federici, 1990; Ji, Zhang, Armstrong, & Gilliland,
1992; Maru, Afar, Witte, & Shibuya, 1996) would aid in the solubilization of some
recombinant proteins deemed toxic to the host cells, as well as trigger correct folding
of the LZIP motif.
Finally, we used Electrophoretic Mobility Shift Assay (EMSA) to see whether
our artificial proteins can actually loop DNA. EMSA, also called gel shift assay, is
based on the premise that DNA bound to a protein will migrate slower in a poly-
acrylamide gel, when an electric field is applied to it. To illustrate the ability to
loop DNA, a DNA-looping protein should first have the ability to bind two separate
DNA strands, forming a structure called “sandwich complex.” Binding reaction con-
ditions are optimized such that the formation of a protein-DNA sandwich complex
is highly dependent on the correct stoichiometry between the protein and its DNA
binding site.
2.3 Materials and Methods
Reagents used for microbiology work were purchased from Fisher Scientific,
Sigma, and USB Corporation. The oligonucleotides used for cloning were synthe-
sized by Integrated DNA Technologies (IDT). All molecular biology reagents and
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enzymes were purchased from New England Biolabs (NEB). The pFastBac1 plasmid
(Invitrogen) is a kind gift from the Bentley lab, while pGEX6P1 was purchased from
Amersham Biosciences. PCR was done on either Eppendorf Mastercycler or MJ Re-
search PTC-200 thermal cycler. All protein purifications were done on the ÅKTA
FPLC instrument (Amersham Biosciences), attached with either a 1-mL prepacked
HisTrap HP (GE Healthcare) column previously charged with 0.2 M cobalt acetate,
or a 1-mL prepacked GSTrap FF (GE Healthcare) column.
Native PAGE gels for EMSA were run on a Hoefer SE600 Dual Cooled vertical
electrophoresis unit. Phosphorimages were taken using the Storm 860 Phosphorim-
ager, and processed using ImageJ software.
2.3.1 Subcloning into pFastBac1 and pGEX6P1 plasmids
The DNA sequences for the tetrameric DNA binding proteins, which were
previously cloned into pRSETA (see Appendix 2.1, pages 146 and 153 for gene
sequences of pRSETA and LZT gene inserts), were amplified by PCR using the fol-
lowing primers: 5’-TATAGGGAGCTCACAACGGTTTCC-3’ and 5’-TGCTAGT
TATTGCTCAGCGGTGG-3’. The resulting PCR product was digested with either
SacI and HindIII, or with BamHI and EcoRI, and purified using non-denaturing
PAGE. In parallel, pFastBac1 was digested with SacI and HindIII, while pGEX6P1
was digested with BamHI and EcoRI. The digestion products of the parent plasmids
were treated with phosphatase to prevent religation. The recombinant plasmids were
subsequently assembled by ligating together the digestion products of the gene insert
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to the parent plasmids.
The ligation products were then transformed into E. coli XL1-Blue electro-
competent cells for recombinant plasmid propagation using standard electroporation
protocols. Transformants were plated onto LB agar plates containing 100 µg/mL
ampicillin. Colonies were then selected for liquid culture growth in LB amp media.
Plasmid preps were done using QIAprep Spin miniprep kit, according to manufac-
turer’s instructions. Correct clones were identified by BanI (for pFastBac1 clones),
or PvuII (for pGEX6P1 clones) digestion, and by DNA sequencing.
2.3.2 Protein expression using baculoviruses
To generate the baculoviruses expressing our DNA binding proteins, the re-
combinant pFastBac1 plasmids (see Appendix 2.1, page 147) were transformed into
DH10Bac E. coli cells according to manufacturer’s transformation protocols, and
plated onto LB agar plates containing 50 µg/mL kanamycin, 7 µg/mL gentamicin,
10 µg/mL tetracycline, 100 µg/mL Bluo-gal and 40 µg/mL IPTG. White colonies
were selected for liquid culture growth in LB kan gen tet media, and the baculovirus
shuttle vector (bacmid) DNA was harvested using standard DNA prep protocols.
In brief, cells were resuspended in Solution I (15 mM Tris-HCl pH 8, 10 mM EDTA,
100 µg/mL RNase A), and lysed in Solution II (0.2 N NaOH, 1% SDS). Host pro-
teins and chromosomal DNA were precipitated out using 3M KOAc pH 5.5, and the
supernatant was treated with isopropanol and 70% ethanol to isolate the bacmid
DNA. Finally, the bacmid DNA was resuspended in TE (10 mM Tris-HCl pH 8, 1
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mM EDTA) buffer. Recombinant bacmids were then analyzed by PCR using M13
Forward (-41) [5’-CGCCAGGGTTTTCCCAGTCACGAC-3’] and M13 Reverse (-
27) [5’-CAGGAAACAGCTATGAC-3’] primers.
The recombinant bacmids were subsequently transfected into Sf9 insect cells
to generate P1 and P2 baculoviral stock solutions. The protocol for generating P1
stock solutions was as follows: Sf9 cells were allowed to settle at the bottom of a 6-
well culture plate (9 x 105 cells per well, containing 2 mL Sf900-II SFM + 50 µg/mL
streptomycin) at 27 ◦C prior to baculoviral transfection. To prepare the baculovirus,
1 µg of purified bacmid was coated with Cellfectin R© reagent before mixing into the
prepared cell hosts. Transfection was done at 27 ◦C for 5 hours, then the cells were
supplemented with growth media (Sf900-II SFM + 50 µg/mL streptomycin), and
incubated at 27 ◦C for 72 hours. The P2 baculoviral stock solutions were prepared
by inoculating 2 x 106 cells with P1 stock at 0.1 pfu/cell and incubated at 27 ◦C for
four days. The number of infected cells was determined by a viral titer, and the P2
viral stock (cells and growth media) was analyzed by SDS-PAGE and Western blot
to determine whether the expressed protein is being secreted out of the cell hosts.
For large-scale expression of the tetrameric DNA binding proteins, at least 30
mL of Sf9 cells were transfected with the P2 viral stock at MOI = 1. The transfected
cells were incubated at 27 ◦C for 72 hours with aeration before cell harvest. The
cells were resuspended in Lysis Buffer (25 mM KOAc pH 5.5, 500 mM NaCl, 20 mM
imidazole), and lysed by repeated freeze-thaw cycles and several passes through a
25G needle. The lysate was cleared by centrifugation (10000 x g, 4 ◦C, 15 minutes;
supposedly at 15000 x g, 4 ◦C, 1 hour) and filtered through a 0.2-µm syringe filter
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prior to purification by affinity chromatography.
2.3.3 Protein expression in BL21 E. coli cells
Recombinant pGEX6P1 plasmids (see Appendix 2.1, pages 150 and 153) were
transformed into BL21 electrocompetent cells, according to standard electroporation
protocols, and plated onto LB agar plates containing 20 mM glucose and 100 µg/mL
ampicillin. Colonies were selected for liquid culture growth in 10 mL 2x YT + 100
µg/mL ampicillin, incubated at 37 ◦C with ample aeration for at least 12 hours.
The liquid cultures were scaled up to 2 L 2x YTA for 3 hours at 37 ◦C, and protein
expression was induced for 20 hours at 37 ◦C with 0.1 mM IPTG. The cells were
then harvested by centrifugation (7700 x g, 4 ◦C, 10 minutes), resuspended in PBS
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3), and
lysed by three passes through the French press (10000-12000 psi). The soluble and
insoluble lysates from each pass were analyzed by SDS-PAGE to determine optimal
lysis conditions. After lysis, Triton X-100 was added to 1% final concentration and
the lysate was cleared by centrifugation (>10000 x g, 4 ◦C, 20 minutes) and filtered
through a 0.2-µm syringe filter prior to purification by affinity chromatography.
2.3.4 Protein expression in BL21-AI E. coli cells
Recombinant pRSETA plasmids were transformed into BL21-AI electrocom-
petent cells, according to standard electroporation protocols, and plated onto LB
agar plates containing 100 µg/mL ampicillin. Colonies were selected for liquid cul-
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ture growth in 10 mL LB + 20 mM glucose and 100 µg/mL amp and incubated for
at least 12 hours at 37 ◦C. The starter cultures were then used to inoculate 500 mL
LB amp, and incubated at 37 ◦C with aeration until the OD600 reached 0.4 – 0.6
(1 – 3 hours). Protein expression was induced with 0.02% arabinose at 37 ◦C for
18 hours with aeration. The cells were harvested by centrifugation, resuspended in
Equilibration Buffer (10 mM MES-NaOH pH 6, 500 mM NaCl, 20 mM imidazole),
and lysed by three passes through the French press. The crude lysate was cleared
by centrifugation (14000 x g, 4 ◦C, 1 hour) and filtered through a 0.2-µm syringe
filter prior to purification by affinity chromatography.
2.3.5 Protein isolation, purification and workup
Two buffer systems were developed in the course of optimizing pH and salt
conditions for isolating the DNA binding proteins containing the His affinity tag.
The following buffers were used for the isolation of the His-tagged proteins harvested
from Sf9 cells:
• Equilibration – 25 mM KOAc pH 5.5, 500 mM NaCl, 20 mM imidazole
• Elution – 25 mM KOAc pH 5.5, 500 mM NaCl, 500 mM imidazole
Isolation of the His-tagged proteins harvested from BL21-AI cells was done using
the following buffers:
• Equilibration – 10 mM MES-NaOH pH 6, 500 mM NaCl, 20 mM imidazole
• Elution – 10 mM MES-NaOH pH 6, 500 mM NaCl, 600 mM imidazole
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Lastly, the buffers used for isolating GST-tagged proteins are the following:
• Equilibration – 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4, pH 7.3 (PBS)
• Elution – 100 mM Tris-HCl pH 8, 50 mM reduced glutathione
After sample loading, a 5-CV wash with Equilibration buffer was passed through
the column. The protein was then eluted out of the column in 1-mL aliquots either
by an imidazole gradient (20 – 400 mM or 20 – 600 mM), or step elution using 50
mM reduced glutathione through 25 or 50 CVs. The eluates were analyzed by SDS-
PAGE, in 18% (32:1) or 16% (40:1) polyacrylamide gels, using a Tris-glycine-SDS
or Tris-tricine-SDS buffering system ran at 25 W for 50-60 minutes, to check for
purity. The presence of tricine in the running buffer allows for better separation
of low MW proteins (Schägger & von Jagow, 1987). Eluates containing pure His-
tagged protein were concentrated and buffer-exchanged with Storage Buffer (20 mM
HEPES-NaOH pH 7, 150 mM NaCl, 10% glycerol) using Amicon YM-10 membrane
filters, and stored at -80 ◦C.
The affinity tags from GST-tagged proteins were cleaved off using the following
protocol: the pooled samples from the FPLC run were first buffer exchanged with
PreScission Cleavage Buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA,
1 mM DTT) through a 5-mL prepacked HiTrap Desalting Column (GE Healthcare).
Eluents containing the protein were pooled and treated with PreScission protease at
4 ◦C for 4 hours. Finally, the cleaved GST tag and PreScission protease, which is also
GST-tagged, were isolated from the mixture by FPLC through a 1-mL prepacked
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GSTrap FF column, as the untagged protein is collected in the flowthrough.
2.3.6 Purification of His-tagged fusion proteins from inclusion bodies
The insoluble pellet after the French press cell lysis step was resuspended in
Solubilization Buffer (10 mM MES-NaOH pH 6, 500 mM NaCl, 6 M Gua-HCl,
5 mM imidazole), and incubated at 4 ◦C for at least 30 minutes with occasional
mixing until a homogeneous mixture is obtained. The mixture is then cleared by
centrifugation (14000 x g, 4 ◦C, 1 hour), and the clarified lysate was loaded manually
(1 drop/sec) into the 1-mL prepacked HisTrap HP column charged with 0.2 M cobalt
acetate. The column was then washed manually with 10 CV of Solubilization Buffer
(1 drop/sec) and attached into the FPLC instrument.
The buffers used for refolding and isolating the His-tagged proteins were as
follows:
• Denaturing – 10 mM MES pH 6, 500 mM NaCl, 8 M urea, 5 mM imidazole
• Equilibration – 10 mM MES pH 6, 500 mM NaCl, 20 mM imidazole
• Elution – 10 mM MES pH 6, 500 mM NaCl, 600 mM imidazole
A 10 CV wash with Denaturing Buffer was done to remove the guanidine
from the column, then the protein is refolded in-column by a linear gradient of
decreasing urea concentration (6 – 0 M). The protein was then eluted out using
an imidazole gradient (20 – 600 mM). The eluates were analyzed by SDS-Tricine
PAGE, and fractions containing the His-tagged protein were pooled, concentrated
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and buffer-exchanged with Storage Buffer using Amicon YM-10 membrane filters.
The concentrated samples were then stored at -80 ◦C.
2.3.7 Electrophoretic Mobility Shift Assay (EMSA)
First, a 26-mer ssDNA containing the palindromic GCN4 site CREB was end-
labeled with γ-32P ATP in a 15-µL reaction mixture that contains the following: 5
µM CREB DNA (5’-CAGTGGAGATGACGTCATCTCGTGCC-3’), 1x T4 PNK
Buffer, 100 µmol γ-32P ATP, 10 U T4 PNK. The reaction was done at 37 ◦C for 1
hour. Afterwards, the reaction was diluted to 75 µL with STE (10 mM Tris-HCl
pH 7.5, 1 mM EDTA, 100 mM NaCl), and unincorporated label was removed by
passing the sample through a P-30 MicroBioSpin column (Bio-Rad). The comple-
mentary strand was then annealed to the labeled DNA, and the dsDNA mixture
was incubated in a heat block preheated to 100 ◦C that is gradually cooled to ∼ 40
◦C. The labeling efficiency was then measured for a 100-fold dilution of the dsDNA
by scintillation counting.
The following components of the binding reaction (10-µL total volume) were
mixed together in a buffer formulation containing 20 mM Tris-HCl pH 7.5, 60 mM
KCl, 5 mM MgCl2, 10 mg/mL BSA, 1 mM DTT, 1 % glycerol, 4 % sucrose, 0.0025%
bromophenol blue: 25 nM labeled CREB DNA, 0.5 µg poly(dI-dC), 1 µL purified
protein. Protein dilutions, when needed, were done in Protein Dilution Buffer (20
mM Tris-HCl pH 7.5, 150 mM KCl, 1 mM DTT, 10 mg/mL BSA, 5 % glycerol, 0.1 %
Triton X-100). The binding reaction mixture was incubated at ambient temperature
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for 30 minutes, and then subsequently analyzed using native PAGE.
The following gel formulation was cast for the EMSA: 10 % (75:1) polyacry-
lamide gel in 1x Native PAGE Buffer (25 mM Tris-Cl, 192 mM glycine pH 8.3)
supplemented with 5 % glycerol. The gel was maintained at <16 ◦C while running
at 400 V for 1 hour. The resulting gel was then dried on a filter paper, and exposed
to the phosphor screen (Molecular Dynamics) for at least 8 hours prior to image
visualization and processing.
2.4 Results and Discussion
2.4.1 Protein expression and purification
Initial protein expression in Sf9 insect cells gave good yields from all four LZT
proteins. Figure 2.2 shows the results from 4har.
Next, we scaled up the protein expression for 4har to 750 mL culture, and
proceeded to isolate the His-tagged protein by FPLC. The chromatogram showed
a significant peak at fractions B4 to B6, and a wide and shallow peak at fractions
B7 to B10, which corresponds to elution with ∼ 80-150 mM imidazole. However,
SDS-PAGE and Western blot analyses failed to detect the His-tagged 4har.
Baculoviral expression of our recombinant proteins is expensive and time con-
suming, in terms of growing the host cell line to the desired cell density prior to cell
transfection. Thus, we decided to do another attempt at expressing our proteins in
bacteria.
Of the four LZT proteins, we were successful in subcloning 4har and lzee into
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(+) (-) (+) (-)
Coomassie Blue staining Western blot
Figure 2.2: Baculoviral expression of 4har protein in Sf9 cells. Left panel: SDS-
Tricine PAGE on 20 % (32.3:1) polyacrylamide gel, stained with Coomassie Blue.
Various amounts of crude lysate (lanes 1-4) illustrates the appearance of a protein
band that matches the approximate size for FPLC-purified His-tagged lzee (+).
Right panel: Western blot of increasing amounts of crude lysate verifies the presence
of the Histidine-tagged 4har (lanes 1-4) which matches the approximate size for
FPLC-purified His-tagged lzee (+). A smear on the untransfected cells (-) and high
MW bands on the lysates on the Western blot are due to non-specific binding of the
antibody. The protein of interest is boxed in red.
pGEX6P1. Initial protein expression of these proteins in BL21 cells showed a distinct
band at around the 35 kDa protein ladder mark from the recombinant plasmids,
which is roughly the size of the GST-LZT fusion proteins (∼36 kDa). As a control,
protein expression from the empty vector generated a dark band that corresponds to
the size of the GST tag (∼26 kDa) Furthermore, there was no significant difference in
the amount of expressed proteins between 0.1 and 1 mM IPTG. Thus, we proceeded
to large-scale expression using 0.1 mM IPTG and purification for both proteins.
SDS-PAGE analysis of the clarified lysates and the cell pellets for lzee from
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each French press pass showed that it takes at least two passes to get decent yields
of the GST-tagged protein from the soluble material. Moreover, the chromatogram
from the FPLC purification of the final clarified lysate L3 revealed a distinct peak
at fractions A2-A4, which was verified by SDS-PAGE to be the GST-tagged fusion
protein (see Figure 2.3). Similar results were also seen in the purification of GST-
4har fusion protein. Now that we have isolated GST-tagged 4har and lzee, we can
then proceed to in vitro characterization.
Figure 2.3: Protein expression and purification of GST-lzee in BL21 cells. It takes
at least two passes through the French press to get good lysis quality, as evidenced
by the increasing intensity of a protein band that lines up with the FPLC-purified
GST-tagged lzee in fractions A2-A4. WC: whole cells, 20 hours post-induction with
0.1 mM IPTG at 37 ◦C. L1, L2, L3: clarified lysates from each pass through the
French press. P1, P2, P3: cell pellets from each French press passage. A2, A3, A4:
FPLC fractions purified from clarified lysate L3, containing GST-tagged lzee. All
sample aliquots were taken from the same protein prep.
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2.4.2 EMSA
To form DNA loops, a DNA binding protein has to bind to a single DNA
strand at two different regions. However, the length of the intervening DNA and the
orientation of the binding sites affect the stability of the resulting loop, and would
complicate analysis of our characterization studies. Thus, we devised a simple assay
that would illustrate the first requirement for DNA looping: show that our proteins
can actually bind two independent DNA strands. Short oligonucleotides containing
the GCN4 binding site CREB were mixed together with purified proteins. The
resulting complexes were subsequently analyzed by native PAGE. The migration of
a DNA-protein complex should differ from that of free DNA. Different complexes
would have distinct mobilities in a polyacrylamide gel. Thus, if a protein molecule
can bind to two DNA strands, forming a sandwich complex, it will have a distinct
shifted band that will only show up when the stoichiometries between the protein
and the DNA are optimized.
SDS-PAGE analysis of the the GST-tagged fusion proteins to be used in the
gel shift assay revealed that all of the protein preps are starting to degrade into
two bands (see Figure 2.4). The degradation seem to occur more rapidly when the
protein samples are left at ambient temperature overnight (GST-lzee #1), as seen
by the protein bands at ∼26 kDa (GST affinity tag) and ∼10 kDa (untagged LZT
protein). Storage at 4 ◦C (GST-lzee #2 and GST-4har #1) and -20 ◦C (GST-lzee
#3 and GST-4har #2) showed partial degradation of the ∼36 kDa band (GST-
tagged fusion proteins) into two smaller protein bands. Thus, long term storage of
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LZT protein preps are done at -80 ◦C, while the working solutions are temporarily



















































Figure 2.4: SDS-PAGE of FPLC-purified GST fusion proteins stored at different
temperatures. Protein preps were exposed at ambient temperature (GST-lzee #1),
4 ◦C (GST-lzee #2 and GST-4har #1), and -20 ◦C (GST-lzee #3 and GST-4har #2)
for at least 10 hours prior to analysis. Prolonged exposure to higher temperatures
triggers proteolysis at the linker region between the GST tag and the protein insert.
We thought that the proteolysis would result to a partially degraded protein
that can still bind to its DNA substrate. Thus, we proceeded to analyze all of our
GST-fusion protein preps by EMSA.
Figure 2.5 shows the gel shift assay of the GST-tagged proteins with the 26 bp
DNA oligomer containing the CREB binding site. Results showed that the two GST-
lzee protein preps gave different shifted complexes at pH 7.5. GST-lzee #1 prep,
which was previously exposed to ambient temperature, gave a single population
of DNA-protein complexes, while GST-lzee #2 prep, stored at 4 ◦C, showed three
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shifted bands. Furthermore, all of the populations increased linearly with a linear
increase in the protein concentration. On the other hand, GST-4har showed four
complexes with the topmost band having the highest intensity. Similar results were
























































Figure 2.5: EMSA on GST-4har and GST-lzee with 26-mer CREB DNA, at different
pH conditions. The GST affinity tags are shown as red circles. 32P-labeled DNA
in each binding reaction is 25 nM. Different shifted bands are due to the different
combinations of protein dimers bound to the DNA. Any bands that are stuck on the
wells are most likely from insoluble protein-DNA aggregates. There is no significant
difference in the number of shifted bands between different pH conditions.
The GCN4 LZIP protein has been previously shown to bind with high affin-
ity to the palindromic CREB site (Hill, Hope, Macke, & Struhl, 1986; König &
Richmond, 1993). Given that the LZT protein preps used in the gel shift assay
are essentially the extended version of GCN4 LZIP, we thought that the simplest
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and most stable complex that can enter the polyacrylamide gel matrix is that of a
protein dimer bound to one DNA fragment. Thus, we initially assigned the single
shifted band from GST-lzee #1 to be that of the untagged lzee dimer:DNA com-
plex. Partially degraded protein preps would then bind to DNA with different dimer
combinations, giving way to three possible shifted bands. It is possible that some or
all of the shifted bands are actually sandwich complexes. In order to further verify
our initial assignment of the shifted bands, we cleaved off the GST tag from lzee
(see Section 2.3.5, page 22 for procedure) and repeated the assay at pH 7.5.
As shown in Figure 2.6, saturating amounts of GST-4har resulted to a well
shift, indicating that 4har forms aggregates along with the DNA. We speculate that
the C-terminal end of the protein dimer, which does not bind DNA, forms networks
with other similar complexes. On the other hand, gel shift assay results on the
untagged lzee showed a single shifted band. In order to make sense of the binding
behavior, we also did the assay using PAA peptide. PAA is a GCN4 derivative
that has been previously shown to bind to CREB site as a dimer (Strauss-Soukup &
Maher, 1997). Gel shift assay results on PAA binding to a DNA fragment containing
a single CREB site showed two shifted bands of different intensities. The major band
is most likely due to the PAA dimer:DNA complex. The more retarded band can
be attributed to two protein dimers bound to a single DNA fragment, in which the
second dimer is bound nonspecifically to the DNA. Since the untagged lzee preps
showed similar band shifting, we conclude that the lzee protein can only bind to a




































Figure 2.6: EMSA on GST-4har and cleaved off GST-lzee with 26-mer CREB DNA.
The GST affinity tags are shown as red circles. 32P-labeled DNA in each binding
reaction is 25 nM. PAA is a GCN4 peptide derivative that is used as a positive control
for protein dimer binding to CREB DNA. Different shifted bands in the (partially
degraded) GST-lzee are due to the different combinations of protein dimers bound
to the DNA. The affinity tag was cleaved off using PreScission protease (lzee mix),
and the untagged protein was subsequently isolated by FPLC (lzee #1). In-column
cleavage of the GST tag was also done, which led to a significant loss of the untagged
protein yield (lzee #2). The similarity in band shifting behavior seen in PAA and
untagged lzee indicate that lzee can not bind to two DNA fragments and form a
sandwich complex. The additional band shift (in red box) upon GST-lzee binding
is most likely a result of non-specific binding at higher protein concentrations.
2.5 Conclusions
Based on the results presented, we have achieved a few goals. First, we have
successfully expressed and purified two of the LZT proteins, 4har and lzee, by fusing
them to a GST affinity tag, and producing them in E. coli cells. Second, we have
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shown that 4har forms aggregates with itself along with the DNA it is bound to.
Lastly, we have illustrated that lzee can only bind to DNA as a dimer. It is important
to note that the initial characterizations presented so far are done in vitro. The fact
that initial cloning attempts of these proteins had deleterious effects in the host
cells led us to the possibility that these proteins may be able to form tetramers,
as originally designed, and stabilize in vivo DNA loops. Thus, we have adapted a
few more experiments that would study the possible looping abilities of the LZT
proteins in vivo.
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Chapter 3: Probing the in vivo looping efficiencies of LZT and LZD
proteins
3.1 Objectives
In vitro characterization of the putatively tetrameric protein lzee using EMSA
showed no evidence of a protein-DNA sandwich complex, which is a necessary pre-
cursor for forming DNA loops. On the other hand, the LZD proteins had been
previously shown to loop DNA in vitro (Gowetski et al., 2013). In this chapter,
we adapted a quantitative assay to probe the looping ability of lzee, and the LZD
proteins, in vivo. This assay incorporates the elements of the lac operon assembled
together to generate a repression assay dependent on DNA looping. Furthermore,
we tested various indicator media as a qualitative means to screen for transformants
with downregulated reporter protein activity, to complement the quantitative re-
pression assay. The main goals for this set of experiments are to (1) determine the
smallest stable loops that can be mediated by our artificial DNA-binding proteins in
vivo, (2) show how the length and orientation of the binding sites in the three LZD
proteins affect the degree of reporter protein repression, which in turn characterize
in vivo DNA flexibility, and (3) to combine the use of both the colorimetric screen
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and the quantitative in vivo repression assay as a toolkit to design more efficient
DNA looping proteins.
3.2 Rationale
The repression-based genetic assay relies on the concept of repression by “co-
operativity at a distance” (Peters et al., 2011). In this assay, the F’ episome in
specialized E. coli cells was modified to place the lacZYA genes under the control
of the lacUV5 promoter (Whipple, 1998). As illustrated in Figure 3.1, a primary
operator site, to which a DNA-binding protein can bind, is located downstream of
the -10 region of the lacUV5 promoter, in the vicinity of the +1 start site for the
transcription of lacZYA. When the DNA binding protein is expressed, it binds to the
primary operator in the F’ episome, which represses the expression of the lacZYA
genes. If the DNA binding protein contains two DNA-binding domains, a second
operator located upstream of the -35 region of the lacUV5 promoter will enhance
reporter gene repression via protein delivery by looping of the intervening DNA.
To generate these specialized reporter strains, we modified several plasmid-
based reporter constructs used in a previous study by Maher and colleagues (Becker
et al., 2005), which were then introduced into the F’ episome by homologous re-
combination. These constructs contain cis elements derived from the lac operon –
the gene sequence that codes for the 250 amino acids at the C-terminal end of the
lactose repressor (lacI), a distal operator Od located at varying distances upstream














Figure 3.1: In vivo repression assay, adapted from Becker et al. (2005). Reporter
strains were prepared, containing cis elements from the lac operon (1) in single copy
via homologous recombination to the F’ episome. In the recombinant F’ episome,
the O2 operator was inactivated by mutagenesis, while the O3 and O1 sites were
replaced with binding sites for the looping protein of interest at the distal (Od)
and proximal (Op) positions, respectively. In order to detect looping-dependent
repression of the the lacZYA genes, the following criteria must be met: Reporter
gene expression should not be affected by looping protein binding to reporter strains
that do not contain binding sites (2), or Od only binding sites (3); There should be
weak repression upon looping protein expression in reporter strains containing a
low-affinity Op only (4); In the presence of a high-affinity Od (5), lacZYA repression
would be more enhanced due to the tethering of the looping protein at the distal site,
which increases the looping protein’s local concentration to the primary proximal
site.
codons 8-212 of the β-galactosidase (lacZ ) gene. In addition, the kanamycin resis-
tance gene is cloned in between lacI and the operator-promoter regions. Our looping
constructs contained the high-affinity palindromic GCN4 operator ATF/CREB (5’-
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ATGACGTCAT-3’) (Hill et al., 1986) or the inverted INV2 site (5’-GTCATATGAC-
3’), recognized by a C-terminal reverseGCN4 protein (Hollenbeck et al., 2001), at
various distances in the distal site, with either the ATF/CREB or the wild-type
GCN4 operator (5’-ATGACTCTT-3’) placed in the proximal position (Hill et al.,
1986). In addition, ATF/CREB and wild-type GCN4 sites are each cloned at the
upstream and downstream positions separately, as non-looping constructs that can
serve as negative and positive controls for lacZYA repression, respectively. The com-
bination of operators has to be optimized such that the decrease in reporter protein
levels would be more sensitive to the increased local concentration of the looping
protein to the primary operator via DNA looping than to random binding of the
looping protein to its primary site. Figure 3.2 lists the various promoter-operator
regions used in the initial characterization for binding and looping of our putative
looping proteins.
The in vivo assay also requires regulated amounts of the DNA-binding protein
such that the amounts of the putative protein are high enough to affect reporter pro-
tein levels, but not detrimental to the host cell’s growth. However, most expression
plasmids are designed for large-scale expression and purification of the protein of
interest, which is subsequently used for in vitro studies. Using these expression plas-
mids as-is would saturate the system with the protein being studied, which would
mask the effect of DNA looping on reporter protein repression. Two strategies were
used to adjust protein expression. First, the tac promoters controlling lzee and
LZD expression in pGEX6P1 were changed into lacUV5 or wild-type lac promot-




































                      3'-TACTGCAGTA-5'
wild-type (low-affinity): 5'-ATGACTCTT-3'
                          3'-TACTGAGAA-5'
Od Op
Figure 3.2: Promoter-operator regions of the reporter (FW102) strains used for the
optimizing operators. GCN4 binding sites CREB (red boxes) or wild-type GCN4
(pink boxes) were cloned into the distal (Od) and proximal (Op) positions. LacI
and kanamycin resistance genes are located upstream of Od, while lacZYA genes are
located downstream of Op.
in the proposed reporter assay. The other strategy was to subclone the genes for
the putative looping proteins into pBAD, which allows for tighter regulation of the
recombinant protein expression by the arabinose promoter.
Reporter protein activity was monitored qualitatively using available indicator
media, and quantitatively in liquid cultures using a colorimetric assay based on
the cleavage reaction of o-nitrophenyl-β-galactoside (ONPG). We have tested three
types of indicator media – LB plates with the chromogenic substrate 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal), MacConkey agar, and tetrazolium
agar. X-gal is a lactose analog, that acts as a substrate but not as an inducer
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for β-galactosidase. Enzyme-catalyzed hydrolysis of X-gal yields galactose and a
substituted indole, which dimerizes and is oxidized to form the highly insoluble
blue dye indigo. Cells that have a fully functional β-galactosidase (Lac+ strains)
produce blue colonies in media containing X-gal, while those that produce very low
levels or mutated β-galactosidase yield white or light blue colonies (Lac- strains).
MacConkey and tetrazolium agar, combined with a sugar source such as lactose,
are rich media that are used to detect the degree of metabolism of the sugar source.
MacConkey lactose media was initially formulated to selectively grow Gram-negative
bacteria and detect lactose fermenters (MacConkey, 1908). It is a rich medium that
contains bile salts and crystal violet to prevent growth of Gram-positive bacteria,
and neutral red, which acts as a pH indicator. Lac+ strains metabolize lactose and
release acid into the immediate environment, thus colonies rendered are stained red
and usually surrounded with a hazy red precipitate of bile salts, whereas weakly
Lac+ strains produce white or pale pink colonies. Tetrazolium agar contains the
redox indicator triphenyl tetrazolium chloride (TTC), which detects metabolically
active cells. Cells that grow in this medium can reduce TTC into a red insoluble
compound triphenylformazan (TPF). When lactose is added into the medium, Lac+
strains can utilize the added sugar and generate acid into the immediate environment
due to fermentation. Excess acid prevents the formation of the formazan dye, hence
colonies of lactose fermenters remain white, while weakly Lac+ or Lac- colonies are
pink or dark red respectively (Shuman & Silhavy, 2003).
ONPG is another analog of lactose which can act as a substrate for β-
galactosidase, but not as an inducer for lacZYA expression. Hydrolysis of ONPG
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produces galactose and o-nitrophenol, and the latter can be quantified by absorbance
at 420 nm. The rate of product formation is proportional to the amount of the re-
porter protein expressed in the host cells, which is the definition of a Miller unit.
3.3 Materials and Methods
The plasmids pJ1645, pJ1654, and pJ1655 used to make the promoter-operator
constructs were a kind gift from L. James Maher III. The pBAD/Myc-HisA plasmid
(Invitrogen) was provided by the Cropp lab. E. coli XL1-Blue and XL10-Gold cells
used to propagate the plasmids were purchased from Stratagene. MacConkey Lac-
tose medium and Antibiotic Medium 2 were purchased from Difco Laboratories while
2,3,5-triphenyl-2H-tetrazolium chloride (TTC) and o-nitrophenyl-β-D-galactoside
(ONPG) were purchased from USB Corporation. Instructions for preparing the LB
liquid media and all selection plates are given in Appendix 1. Glucose (1%), lactose
(1%), IPTG (0.1 mM), Bluo-gal (100 µg/mL) or X-gal (0.5 mM), and the antibiotics
kanamycin (50 µg/mL), chloramphenicol (50 µg/mL), ampicillin (100 µg/mL), and
streptomycin (100 µg/mL) were added as indicated. Absorbance readings were done
on a Cary 300 UV-vis Spectrophotometer.
3.3.1 Promoter-operator constructs
The first set of plasmid-based constructs containing one or two operators were
generated using the non-looping (pJ1645 and pJ1654) and looping (pJ1655) plas-
mids, respectively as templates for PCR. The template plasmids contained the κB
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operators. The distance between the GCN4 binding sites in the resulting looping
constructs is 85 bp for two CREB sites, or 85.5 bp for one CREB site and one
wild-type GCN4 site.
3.3.1.1 Single operator controls
The plasmids proxWT-1 and proxCREB-1were constructed by mutating the
proximal operator, Op, of pJ1645 into either the GCN4 wild-type (5’-ATGACTCTT-
3’), or ATF/CREB (5’-ATGACGTCAT-3’) operator using the QuikChange II XL
Mutagenesis Kit (Stratagene), as shown in Figure 3.3. The resulting linear ampli-
fication products were digested with DpnI to remove parental DNA, then trans-
formed into XL10-Gold or XL1-Blue cells, and grown on LB agar plates containing
kanamycin and chloramphenicol. Transformants containing the mutated Op sites
gave a 151-bp PCR product using primers (a) Od-fp2.1 (5’-GGCGTATCACGAG
GCCCTTTCGTCTTCAAGAATTC-3’) and Op-rp2a (5’-GTGCGGCCGCGGTT
GTGGGAATGACGT-3’) to verify the proximal CREB site, or (b) Od-fp2.1 and
Op-rp2b (5’-GTGCGGCCGCGGTTGTGGGAAAGAGT-3’) to verify the proximal
wild-type GCN4 site. The sequences of the correct transformants were then deter-
mined by DNA sequencing using seqFP-OdOp (5’-GGCCCGGAGGGTGGCGGG
CAGG-3’) as the sequencing primer.
Figure 3.4 shows the cloning strategy for plasmid distWTby introducing the
wild-type GCN4 operator into Od of pJ1654 using PCR with phosphorylated primers.
The 5’ ends of the resulting amplification product were ligated together to form the
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g site at p
forward primer (fp2)
r imer (rp2)
AA AATGACTCTT A A
    wt AAGAGTCAT A
AA ATGACGTCAT A A
ATGACGTCAT A
Figure 3.3: Cloning strategy for generating proxWT-1 and proxCREB-1, using site-
directed mutagenesis. Complementary mutagenic primers containing the desired
mutations are used for linear amplification of the plasmid template. The amplifica-
tion product is a circular product with two single nicks on opposite strands, which
is then transformed into the host cell for plasmid propagation.
circular plasmid. This ligation product was subsequently transformed into XL10-
Gold or XL1-Blue cells and grown in LB agar plates containing kanamycin and
chloramphenicol. Transformants were screened for the presence of the correct distal
operator by BsrGI digestion and verified by DNA sequencing with Op-rp1.1 (5’-T
CATAGCTGTTTCCTGTGTGCGGCCGCG-3’). Cloning of the new operators at
Od introduced a single BsrGI site between the new operator and the SacI recog-
nition site. This cloning maneuver enables easy switching of Od while keeping the
linker sequence between operators intact, or extending the linker sequence without
affecting the Od sequence.
The preparation of plasmid distCREB is illustrated in Figure 3.5. In brief,
the ATF/CREB operator was cloned into the distal site by ligating the EcoRI-SacI
double digests of pJ1654 to the EcoRI-SacI double digest of the complementary
mutagenic oligonucleotides that were annealed in the reaction buffer prior to enzy-
matic digestion. The crude ligation mixture was transformed into XL1-Blue cells
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AA A AAGAGTCAT A A AA
Figure 3.4: Cloning strategy for generating distWT, using phosphorylated primers.
Mutations are introduced on one of the primers, which are then used for amplifying
the plasmid template. The resulting product is circularized and transformed into
the host cell for plasmid propagation
and grown in LB agar plates with kanamycin and chloramphenicol. Transformants
were screened by BsrGI digestion and verified by DNA sequencing using seqRP-
OdOp (5’-GGATTGACCGTAATGGGATAGG-3’) as the sequencing primer.














Figure 3.5: Cloning strategy for generating distCREB, using a simple cut-and-paste
method. Complementary oligonucleotides containing the CREB site are annealed to-
gether, and digested with EcoRI and SacI. The oligonucleotide insert is then cloned
into the EcoRI – SacI digestion product of the parent plasmid, and transformed
into the host cell for plasmid propagation.
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3.3.1.2 85- and 85.5-bp looping constructs
Looping constructs CC-85 and CW-85.5 were prepared in two steps, as shown
in Figure 3.6. First, the ATF/CREB site was cloned into the distal site of pJ1655
using the same method in the previous paragraph. The correct transformant,
CREB/pJ1655, was then used as the starting template in the next step. The
GCN4 site was introduced in the distal site of promoter/operator region of the
CREB/pJ1655 plasmid by amplifying with mutagenic primers (i) CREBfp1a and
CREBrp2, or (ii) CREBfp1a and wt-rp2, generating a 141-bp PCR product con-
taining (i) two ATF/CREB sites, or (ii) a distal ATF/CREB site and a proximal
wild-type GCN4 site. The PCR products were then digested with EcoRI and NotI
and cloned into the EcoRI-NotI double digest of pJ1655. The crude ligation mix-
tures were subsequently transformed into XL1-Blue cells and grown in LB agar
plates containing kanamycin and chloramphenicol. Transformants containing the
desired operators were then sequenced using Od-fp2.1 and Op-rp1.1 as the sequenc-
ing primers.
3.3.1.3 138.5- to 237.5-bp looping constructs with proximal wild-type
GCN4 site
The second set of promoter-operator constructs were prepared from CW-85.5.
The separation between the GCN4 sites was increased to 138.5, 187.5 or 237.5 bp.
Figure 3.7 illustrates how the linker sequences were generated. PCR amplification
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CREB site at Od 
forward primer (CREBfp1a)
reverse primer (rp2)
i)  CREBfp1a 5’-CCTTTCGTCTTCAAGAATTCAAATGACGTCATGTACAATT-3’
    CREBrp2 5'-CTGTGTGCGGCCGCGGTTGTGGGAATGACGTCATTGGTCGACACATTA-3'
ii) CREBfp1a 5’-CCTTTCGTCTTCAAGAATTCAAATGACGTCATGTACAATT-3’
    wt-rp2 5'-CTGTGTGCGGCCGCGGTTGTGGGAAAGAGTCATTTGGTCGACACATTA-3'




Figure 3.6: Cloning strategy for generating looping constructs, 85- or 85.5-bp dis-
tance between operators. The CREB site is cloned into the plasmid as described
in Figure 3.5. Then, the second operator is introduced into the downstream site
by PCR. The resulting PCR product is digested with EcoRI and NotI, and ligated
into the EcoRI – NotI digest of the parent plasmid. The ligation product is then
transformed into the host cell for plasmid propagation.
from the pRSETA plasmid using the primer pairs (a) SMSlinkFP + SMSlinkRP1,
(b) SMSlinkFP + SMSlinkRP2, and (c) SMSlinkFP + SMSlinkRP3, generated a
85-, 139-, and 187-bp PCR product, respectively. Both the parent plasmid (CW-
85.5) and aforementioned PCR products were digested with SacI and BamHI, with
the parent plasmid dephosphorylated. The resulting digestion products are then
ligated together, transformed into XL1-Blue cells, and grown on LB plates contain-
ing kanamycin and chloramphenicol. Correct transformants gave a 203-, 252-, and
302-bp PCR product using primers Od-fp1a.1 (5’-CGTATCACGAGGCCCTTTC
GTCTTCAAGAATTCAAATGAC-3’) and Op-rp2b. The plasmid minipreps were
then sequenced using seqFP-OdOp as the sequencing primer. The sequence-verified
plasmids were identified as MP56-14a, MP56-15c and MP56-16a, which we later
renamed to CW-138.5, CW-187.5, and CW-237.5, respectively.
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CREB at distal site
wild-type GCN4 at proximal site
Figure 3.7: Cloning strategy for generating looping constructs, 138.5- to 237.5-bp
distance between operators. The locations of the reverse primers are not drawn to
scale.
3.3.1.4 300- to 1150-bp looping constructs with distal INV2 site
The last set of promoter-operator constructs were prepared using proxCREB-
1 as parent plasmid. A 1120-bp linker sequence, which was PCR-amplified from
lambda phage using the primers lambdaFP-EcoRI and lambdaRP-SacI and digested
with EcoRI and SacI, was cloned into the EcoRI-SacI region in proxCREB-1. Cor-
rect clones were verified by colony PCR using seqFP-OdOp and Op-rp2a primers,
which gave a 1382-bp product. We have named this plasmid proxCREB-2. Then,
a second symmetrical GCN4 binding site, INV2 (5’-GTCATATGAC-3’) was cloned
at various upstream positions (300, 450, 650, 900, and 1150 bp away from CREB)
by mutagenesis PCR similar to the preparation of distWT plasmid (see Figure 3.4).
The correct clones were verified by BsrGI or SpeI digestion, and sequenced us-
ing seqFP-OdOp as sequencing primer. We have named the correct transformants
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IC-300, IC-450, IC-650, IC-900 and IC-1150. Finally, the IW series of plasmids (IW-
300.5, IW-450.5, IW-650.5, IW-900.5 and IW-1150.5) were generated by switching
out the CREB operators in the IC plasmid series with the wild-type GCN4 binding
sites. Primer sequences for the linker sequences and the mutagenesis primers for
cloning in INV2 sites are listed in Appendix 2.2.
All promoter-operator constructs were then sent to the Maher lab for recom-
bination experiments, generating our specialized E. coli reporter strains. The full
sequences of the promoter-operator constructs are included in Appendix 2.3.
3.3.2 Expression plasmids
The following phosphorylated primers were used to mutate the tac promoter in
the pGEX6P1 plasmids to (a) lacUV5 and (b) lacWT : (a) mutFP-lacUV5 (5’-TT
TACACTTTATGCTTCCGGCTCGTATAATGTGTGGAATTGTGAGCGG-3’)
and mutRP-pGEX (5’-CAGCTCATTTCAGAATATTTGCCAGAACCGTTATG
ATGTCGGCGC-3’), (b) mutFP2-pGEX (5’-GTGTGGAATTGTGAGCGGATAA
CAATTTCACACAGGAAACAGTATTCATGTCCCCTATAC-3’) and mutRP2-
lacWT (3’-GGCTGTAGTATTGCCAAGACCGTTTATAAGACTTTACTCGAC
AAATGTGAAATACGAAGGCCGAGCATACAA-5’). The PCR products were
ligated, transformed into XL-1 Blue cells and grown in LB plates containing ampi-
cillin. Transformants were screened for the presence of the mutated promoter by
PvuII digestion, and verified by DNA sequencing with seqFP2-pGEX (5’-CGTTC
TGGATAATGTTTTTTGCGCC-3’).
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To subclone the DNA-binding proteins in pBAD/Myc-HisA, the gene inserts
in the recombinant pGEX6P1 plasmids were amplified by PCR using the following
primer pairs: (a) pGEXfp2 (5’-CCAAAATCGGGTACCGAAGTTCTGTTCC-3’)
and pGEXrp (5’-CGATGCGGCCGCTCGAGTC-3’), and (b) pGEXfp3 (5’-ACA
GGAAACAGGTACCATGTCCCCTATACTAGGTTATTGG-3’) and pGEXrp.
Primer pair (a) amplified the gene inserts without the affinity tag, while the pair
(b) amplified the genes with the N-terminal GST tag. The resulting PCR prod-
ucts were then digested with KpnI and EcoRI, purified by native PAGE, and sub-
sequently subcloned into the KpnI-EcoRI digestion product of pBAD/Myc-HisA
plasmid. Recombinant plasmids were then identified using PCR and verified by
DNA sequencing.
The sequences of the expression plasmids used in this study are included in
Appendix 2.1.
3.3.3 Reporter protein assays
The expression plasmids (recombinant pGEX6P1 or pBAD/Myc-HisA) were
transformed into electrocompetent reporter strains using standard electroporation
protocols, and grown on selection plates containing ampicillin, kanamycin, and strep-
tomycin. The following selection plates were used in the course of characterizing
the putative DNA binding proteins: (1) LB, (2) LB X-gal or Bluo-gal ± IPTG, (3)
MacConkey lactose ± IPTG, (4) tetrazolium glucose, and (5) tetrazolium lactose.
Individual colonies were selected for starter culture growth overnight (∼16 hours)
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at 37 ◦C in LB supplemented with amp, kan and strep. The starter cultures were
then diluted 50-fold with fresh growth media varying concentrations of IPTG (0 – 1
mM) or arabinose (0 – 0.2%) and incubated at 37 ◦C with agitation for two hours or
until A600 ∼0.3 – 0.7. For samples with high β-galactosidase levels, 100-µL aliquots
of the resulting cultures were mixed with 900 µL Z-buffer (60 mM Na2HPO4, 40
mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM β-mercaptoethanol). Cell cul-
tures with low β-galactosidase levels were pelleted out from 1-mL aliquots, and
resuspended in 1 mL Z-buffer. The cells were then lysed by pulse-vortexing for 10
seconds with 50 µL chloroform and 25 µL 0.1% SDS. The lysed cells were equi-
librated at 30 ◦C for 5 minutes, then the substrate for the assay (200 µL of 4
mg/mL o-nitrophenyl-β-galactoside in Z-buffer) was added and the mixtures were
incubated for 10 – 15 minutes at 30 ◦C. The reactions were subsequently quenched
by adding 500 µL of 1 M Na2CO3 and reaction times were recorded. Absorbance
readings at 420 nm and 550 nm were then measured from 1-mL aliquots of the re-
action mixtures, and at 600 nm from 1-mL aliquots of the working cultures. Raw
enzyme units (E) were then calculated using the formula: 1000 x [A420 - 1.75 x
A550]/[reaction time (in minutes) x culture volume (in mL) x A600] (Miller, 1972).
The repression ratios for all looping and non-looping constructs were calculated as
RR = E-IPTG/E+IPTG, where E+IPTG is the raw enzyme units for transformants in-
duced at a specific IPTG concentration and E-IPTG is the corresponding raw enzyme
units for uninduced transformants. Two replicates per transformant in a selection
plate were analyzed.
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3.4 Results and Discussion
3.4.1 Baseline expression in reporter strains
Baseline levels of the β-galactosidase in all of the reporter strains studied were
first determined qualitatively and quantitatively. The reporter strains were plated
onto LB plates containing antibiotics and Bluo-gal. All reporter strains that have
intact lacUV5 promoter in the F’ episome would fully express the reporter protein,
and hydrolyze Bluo-gal to stain colonies blue. All of the reporter strains in this study
yielded blue colonies, indicating that the recombination procedures were successful.
Plating the same strains onto LB Bluo-gal plates containing IPTG also produced
blue colonies, which would indicate that baseline amounts of β-galactosidase in
untransformed reporter strains are not affected by IPTG. Reporter protein activities
on liquid cultures of transformants from both selection plates have verified this
observation (see Figure 3.8).
3.4.2 Testing operator strength with 4har and lzee proteins
Next, the reporter strains FW102/CC-85 and FW102/CW-85.5 were trans-
formed with recombinant pGEX6P1 (4har and lzee), in which expression of the gene
inserts is controlled by the tac promoter. We want to test whether over-expression
of the tetrameric DNA-binding proteins would elicit a change of phenotype in the
reporter strains. The resulting transformants produced blue colonies in both Bluo-
gal and Bluo-gal + IPTG plates. Blue colonies were then selected from Bluo-gal
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Figure 3.8: β-galactosidase activity in untransformed reporter strains. The values
reported are average numbers from four replicates, in which two were selected from
LB Bluo-gal plates and the other two from LB Bluo-gal IPTG plates. Results show
that the reporter protein activities are not affected by IPTG
plates and analyzed for reporter protein activity (see Figure 3.9). Quantitative
reporter protein assay results showed no significant repression in the FW102/CW-
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85.5 reporter strain upon dose-dependent expression of either 4har or lzee protein.
This correlates well with the phenotype generated from the Bluo-gal IPTG plate.
On the other hand, FW102/CC-85 showed at least 50% repression in the presence
of 4har, and 83% repression from lzee expression, although the measured values
were no less than 242 (for 4har) or 44 (for lzee) β-gal units. However, a change
in color from blue to white only occurs from loss of reporter protein activity, cor-
responding to <20 β-gal units (Whipple, 1998). Thus, the observed phenotypes
for FW102/CC-85 transformants in the X-gal + IPTG plates still match with the
measured β-galactosidase activities.
Blue colonies were also observed in both Bluo-gal and Bluo-gal IPTG
plates after transforming the reporter strains containing proximal operators only
(FW102/proxCREB-1 and FW102/proxWT-1) with 4har and lzee. Quantitative
reporter activities also show similar trends as their corresponding looping strains
(see Figure 3.10). However, in both cases, there is no significant difference in the
repression levels due to the presence of the upstream GCN4 site. This suggests that
the repression level of β-gal exhibited by looping strains is not due to DNA looping.
On the other hand, transformation of reporter strains containing GCN4 sites
in the distal position (FW102/distCREB and FW102/distWT) with 4har or lzee
expression plasmids generated a lawn of white colonies in selection plates contain-
ing Bluo-gal ± IPTG. It turned out that saturation of the selection plates with
distal non-looping transformants could give false negative results , as restreaking
white colonies onto fresh selection plates yielded individual blue colonies on both


























































Figure 3.9: Comparing β-galactosidase activities in looping strains transformed with
4har and lzee, highlighting the difference in the operator strengths at the proximal
site. Both proteins bind more strongly to the palindromic CREB site (5’-ATGACG
TCAT-3’) in FW102/CC-85 than the pseudopalindromic wild-type GCN4 site (5’-
ATGACTCTT-3’) in FW102/CW-85.5. The numbers reported are average values
from two replicates selected from LB Bluo-gal plates.
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Figure 3.10: Comparing β-galactosidase activities in “Op only” non-looping strains
transformed with 4har and lzee, highlighting the difference in the operator strengths
at the proximal site. Both proteins bind more strongly to the CREB site than the
wild-type GCN4 site. The values reported are average numbers from two replicates
selected from LB Bluo-gal plates.
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dependent repression in any of these transformants upon IPTG induction, as illus-
trated in Figure 3.11.
The first set of results of the β-galactosidase assay, illustrated in Figures 3.9
– 3.11 are summarized in Tables 3.1 – 3.2. Several points can be derived from the
data. First, in the absence of the protein expression plasmid, cell strains did not
show significant dose-dependent repression of lacZYA upon induction with IPTG
(RR values do not deviate much from 1.0). This is to be expected, as the promoter-
operator constructs were designed such that the primary and auxiliary operators in
the wild-type lac operon have been removed, and replaced with the GCN4 binding
sites. Thus, the reporter protein in the F’ episome can only be inhibited by our
putative DNA-binding proteins.
Table 3.1: Reporter protein behavior in looping strains, with GCN4 sites 85 or 85.5
bp apart
Looping Expression β-gal Units β-gal Units Repression Ratio,
Strain Plasmid (0 mM IPTG) (1 mM IPTG) RR
FW102/CC-85 — 1156 ± 526 1140 ± 454 1.0 ± 0.6
FW102/CC-85 tac-4har 659 ± 102 330 ± 51 2.0 ± 0.4
FW102/CC-85 tac-lzee 283 ± 23 44 ± 10 6 ± 2
FW102/CW-85.5 — 1028 ± 289 1163 ± 343 0.9 ± 0.4
FW102/CW-85.5 tac-4har 689 ± 413 579 ± 117 1.2 ± 0.8
FW102/CW-85.5 tac-lzee 913 ± 1 617 ± 36 1.48 ± 0.09
Second, there was no significant change in reporter gene levels for strains
containing strong or weak operators in the distal (upstream) position, upon 4har or
lzee expression. This suggests that a protein bound to the distal site has no effect
on promoter strength, and any non-specific loops formed from the tethering of the
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Figure 3.11: Comparing β-galactosidase activity in “Od only” non-looping strains
transformed with 4har and lzee, highlighting the effect of the distal site on repres-
sion. Repression levels are not affected by the presence of an upstream GCN4 site,
signifying that any nonspecific loops formed upstream of the promoter do not repress
the reporter protein. The values reported are average numbers from two replicates
selected from LB Bluo-gal plates.
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Table 3.2: Reporter protein behavior in “Op only” non-looping strains. Only one
tac-lzee:FW102/proxCREB-1 transformant gave positive reporter activity at 1 mM
IPTG.
Proximal Expression β-gal Units β-gal Units Repression Ratio,
Operator Plasmid (0 mM IPTG) (1 mM IPTG) RR
CREB — 454 ± 164 447 ± 127 1.0 ± 0.5
CREB tac-4har 365 ± 24 192 ± 28 1.9 ± 0.3
CREB tac-lzee 154 ± 14 10 15
Wild-type — 613 ± 161 527 ± 35 1.2 ± 0.3
Wild-type tac-4har 625 ± 84 447 ± 112 1.4 ± 0.4
Wild-type tac-lzee 693 ± 30 564 ± 289 1.2 ± 0.6
Table 3.3: Reporter protein behavior in “Od only” non-looping strains. Only one tac-
4har/Wild-type (GCN4) transformant was successfully analyzed for this experiment
Distal Expression β-gal Units β-gal Units Repression Ratio,
Operator Plasmid (0 mM IPTG) (1 mM IPTG) RR
CREB — 1150 ± 426 1281 ± 389 0.9 ± 0.4
CREB tac-4har 1108 ± 88 996 ± 88 1.1 ± 0.1
CREB tac-lzee 1323 ± 12 1288 ± 110 1.03 ± 0.09
Wild-type — 1284 ± 540 1070 ± 349 1.2 ± 0.6
Wild-type tac-4har 1295 1158 1.1
Wild-type tac-lzee 1094 ± 15 1004 ± 28 1.09 ± 0.03
protein upstream of the promoter would not repress the reporter gene (Becker et
al., 2005).
Third, there is significant repression at non-inducing conditions from lzee
transformed into reporter strains containing CREB at the proximal site. On the
other hand, the same expression plasmid does not have a similar effect on reporter
strains containing the downstream wild-type GCN4 site. The baseline repression is
most likely due to leaky expression of lzee, which has stronger affinity to the CREB
site.
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To summarize our findings so far, our initial reporter gene assay results indicate
that lzee is a fairly good repressor but not an efficient looping protein on operators
spaced 85.5 base pairs apart. The distance between the operators in the looping
strains is ∼28.9 – 29.1 nm. Given that 4har and lzee are both ∼18.75 nm, as
measured using PyMOL on the composite protein image generated from PDB files
2DGC (Keller, König, & Richmond, 1995) and 1TLF (Friedman, Fischmann, &
Steitz, 1995), the intervening distance between the operators is too short to produce
a stable DNA loop with the LZT proteins. Therefore, longer looping strains were
made to address this issue. Moreover, having longer looping strains would enable us
to further optimize the proximal operator such that it might significantly enhance
repression upon looping protein expression if the strong distal operator is far enough
upstream to form a stable loop.
3.4.3 Testing operator strength with LZD proteins
The three LZD variants (LZD73, LZD80, and LZD87), along with lzee and the
empty vector as positive and negative controls for repression, respectively, were then
transformed into FW102/CC-85 and FW102/CW-85.5 strains, and plated onto LB
X-gal plates. All transformants yielded blue colonies. Streaking the blue colonies
onto X-gal plates containing IPTG resulted in blue colonies with occasional white
ones (∼1%). Initial protein expression and purification experiments done on the
LZD proteins showed that leaky transcription of these proteins proved to be toxic to
the host cells. One way to circumvent this was to narrow down the range of IPTG
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concentrations for the in vivo repression assay from 0 – 0.01 mM in an attempt
to minimize, if not prevent, cell toxicity of the LZD proteins. Furthermore, blue
colonies growing on Xgal plates were selected for the reporter protein assays, as the
(rare) white ones are most likely aberrant transformants.
Miller assay results on lzee and the LZD proteins transformed into three re-
porter strains are shown in Figure 3.12 and Table 3.4. Similar trends to those
from 4har and lzee can also be seen from the data. First, there is no significant
repression of β-galactosidase on any of the transformants that contain the wild-type
GCN4 site at the proximal position (FW102/CW-85.5). On the other hand, trans-
formants containing the proximal CREB site showed some repression upon inducing
protein expression from the recombinant plasmids, but not from the empty vector
(tac-pGEX6P1).
Among the expression plasmids analyzed, lzee and LZD87 transformed into
reporter strains containing a proximal CREB site have relatively low levels of β-
galactosidase at non-inducing conditions which decreased slightly in a dose-dependent
manner upon protein expression. The rest of the FW102/CC-85 transformants have
higher reporter protein activities, and exhibit dose-dependent β-gal repression in the
range of IPTG used. Similar observations hold for all of the FW102/CW-85.5 trans-
formants.
Finally, the recombinant pGEX plasmids were transformed into the BL876
reporter strain. The F’ episome of BL876 does not contain any GCN4 sites in the
promoter-operator region, thus reporter protein activity from this strain should not




























































Figure 3.12: Comparing β-galactosidase activity in looping strains transformed with
lzee and LZDs, showing the significantly lower β-galactosidase levels from lzee and
LZD87 transformants containing the proximal CREB site. The values reported are
average numbers from two replicates selected from LB X-gal plates
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Table 3.4: Reporter protein behavior of lzee annd LZD proteins in looping strains.
Results show weak repression of the lacZ protein from FW102/CC-85 strains upon
induction of the recombinant proteins, but not the empty vector (tac-pGEX). On the
other hand, there is no difference in lacZ protein expression from FW102/CW-85.5
strains upon recombinant protein expression.
Reporter Expression β-gal Units β-gal Units Repression Ratio,
Strain Plasmid (0 mM IPTG) (10 µM IPTG) RR
FW102/CC-85 tac-pGEX 557 ± 1 639 ± 81 0.9 ± 0.1
FW102/CC-85 tac-lzee 227.3 ± 0.1 131 ± 43 1.7 ± 0.6
FW102/CC-85 tac-LZD73 1226 ± 103 829 ± 40 1.5 ± 0.1
FW102/CC-85 tac-LZD80 1132 ± 13 768 ± 34 1.47 ± 0.07
FW102/CC-85 tac-LZD87 408 ± 122 252 ± 88 1.6 ± 0.7
FW102/CW-85.5 tac-pGEX 837 ± 267 684 ± 130 1.2 ± 0.5
FW102/CW-85.5 tac-lzee 1275 ± 112 1179 ± 6 1.08 ± 0.10
FW102/CW-85.5 tac-LZD73 963 ± 156 853 ± 250 1.1 ± 0.4
FW102/CW-85.5 tac-LZD80 971 ± 259 853 ± 292 1.1 ± 0.5
FW102/CW-85.5 tac-LZD87 1012 ± 332 831 ± 407 1.2 ± 0.7
Figure 3.13 and Table 3.5 has shown some dose-dependent repression of the reporter
protein in all of the transformants analyzed. Further reporter protein assays on
BL876 strains transformed with lzee at 0 – 10 mM IPTG shows that β-galactoside
repression indeed occurs in a dose-dependent manner (see Figure 3.14). There are
two possible reasons for this observation. One would be due to leaky transcription
from the tac promoter. Previous in vitro gel shift assays have shown that at excess
amounts of protein, lzee starts to bind non-specifically to DNA. Another possibility
is due to transcriptional load. Upon IPTG induction, there is a reduced number
of RNA polymerase transcribing the reporter gene because some of the former are
being used to transcribe the genes from the multi-copy plasmids (Glick, 1995).
Given the narrower range of IPTG concentrations required to do the reporter
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Figure 3.13: β-galactosidase activity in BL876 strains transformed with lzee and
LZDs, showing dose-dependent repression from a reporter strain that do not contain
any GCN4 sites. The values reported are average numbers from two replicates
selected from LB X-gal plates
Table 3.5: Reporter protein behavior of lzee annd LZD proteins in BL876 strains,
showing dose-dependent repression from a reporter strain that do not contain any
GCN4 sites.
Reporter Expression β-gal Units β-gal Units Repression Ratio,
Strain Plasmid (0 mM IPTG) (10 µM IPTG) RR
BL876 tac-pGEX 652 ± 109 377 ± 307 2 ± 1
BL876 tac-lzee 885 ± 75 509 ± 122 1.7 ± 0.4
BL876 tac-LZD73 627 ± 14 502 ± 157 1.2 ± 0.4
BL876 tac-LZD87 495 ± 142 350 ± 142 1.4 ± 0.7
assays without killing the host cells, it is reasonable to say that the LZD pro-
teins are likely better repressors than lzee. The toxicity is most likely coming from
non-specific binding of LZD proteins at multiple sites in the bacterial chromosome,
inhibiting cell growth. This can be circumvented by cloning these proteins into
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Figure 3.14: β-galactosidase activity of BL876 reporter strain, transformed with
tac-lzee. Overexpression of lzee (using 10 mM IPTG) showed significant repression
of the reporter protein.
an expression plasmid that minimizes, if not prevents, leaky transcription under
non-inducing conditions.
3.4.4 Colorimetric screen on tac-pGEX transformants using MacConkey
and tetrazolium media
The colorimetric screen results with Bluo-gal (or X-gal) indicate that white/
blue screening is not sensitive enough to distinguish repression by strong vs. weak
binding at the primary operator. Thus, we used two other indicator media to char-
acterize the behavior of our DNA-binding proteins. First, the non-looping reporter
strains were inoculated into liquid cultures and plated onto both MacConkey lactose
and tetrazolium lactose plates. XL10-Gold was used as the control for a lac- strain.
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By design, XL10-Gold contains an incomplete fragment of lacZ (lacZ∆M15) in its F’
episome. The alpha fragment has to be provided in trans, usually from a multicopy
plasmid, in order to generate a fully functional β-galactosidase.
All non-looping strains grew red colonies on MacConkey media, and white
colonies on tetrazolium lactose (TZ lac) media, indicating that these strains are
lac+. On the other hand, XL10-Gold, which are lac-, yielded white colonies on Mac-
Conkey plates, and red ones on TZ lac plates. Interestingly, when the strains were
plated onto the indicator plates without antibiotics, the reporter strains retained the
same colors, whereas XL10-Gold switched colors (from white to red in MacConkey,
and from red to white in TZ lac). Producing antibiotic resistance is taxing to the
host cell, as it uses up a significant portion of the host cell’s resources [Bentley et
al., 1990]. When E. coli cells containing customized F’ episomes are grown without
antibiotics, normal E. coli cells, which contain a wild-type lac operon in their chro-
mosomes, would eventually outgrow the ones with antibiotic resistance. Thus, in
losing the F’ episome, there is loss of lac- strains and gradual growth of lac+ strains.
Transformation of the tac-pGEX6P1 recombinants into the nonlooping re-
porter strains generated pink to red colonies on MacConkey plates, and pale pink
colonies on TZ lac plates. However, looping strains transformed with lzee or any of
the LZD expression plasmids either (1) did not grow colonies on MacConkey and
tetrazolium plates, as in the case of lzee and LZD87, or (2) surviving colonies have
roughly 50% chance of surviving the liquid culture growth. In a control experiment,
the same reporter strains were transformed with the LZD87-pRSETA plasmid. Ex-
pression of the gene inserts in pRSETA is regulated by the T7 promoter. Our
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reporter strains do not produce T7 polymerase, thus there would not be any leaky
transcription from the expression plasmid in the resulting transformants. Indeed,
all LZD87-pRSETA transformants grew a lawn of white colonies on TZ lac plates,
and light blue colonies on X-gal plates. This illustrates that over-expression of the
DNA-binding proteins from pGEX tends to be detrimental to the host cells, which
makes it quite difficult to characterize them using our in vivo genetic assays.
The pGEX6P1 plasmids that we are using as expression plasmids in our initial
β-galactosidase assays are designed to produce high levels of recombinant protein us-
ing the minimum amount of inducer. While this may work for large-scale production
of recombinant protein for in vitro experiments, this is not applicable for our in vivo
assays, where recombinant protein levels have to be fine-tuned at below-saturating
conditions. Therefore, another expression plasmid have to be used that would pro-
duce much lower quantities of our putative proteins that are more appropriate to in
vivo repression assays.
3.4.5 Colorimetric screen on lacUV5-pGEX transformants
At this point, neither indicator media can elicit different phenotypes in dis-
tinguishing strong vs. weak repression without killing the host cells. However,
tetrazolium-containing media is useful for detecting reporter strains with reduced
lac activity, since strongly Lac+ strains produce white colonies while weakly Lac+
or Lac- transformants produce pink or red colonies (Shuman & Silhavy, 2003). In
addition, the indicator media recipe is easily adjustable to prepare inducible and
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non-inducible plates by simply changing the sugar supplement. On the other hand,
Xgal-containing media are still useful to detect transformants with defective pro-
moters, as these transformants would form white colonies. Hence, we would be using
Xgal and tetrazolium in our indicator media for our qualitative colorimetric screens.
In order to address the toxicity issue, the tac promoters in the expression
plasmids were mutated to the lacUV5 or wild-type lac promoters. Recombinant
protein expression from the lacUV5 -controlled plasmids were then verified in BL21
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Figure 3.15: Western blot of clarified lysates from lacUV5-pGEX transformants
(empty vector, lzeeV2, LZD73, LZD80, LZD87) in BL21 E. coli cells, 2 hours post-
induction with 1 mM IPTG.
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The lacUV5-pGEX recombinants (empty vector, lzeeV2 and LZD87) were
transformed into FW102/CC-85 and plated onto X-gal and TZ lac plates. Lzee.v2
has the same protein sequence as lzee, but contains a few silent mutations, the ra-
tionale of which is explained in Chapter 5. All transformants grew colonies on both
indicator plates, signifying that leaky transcription of proteins from the lacUV5 pro-
moter is not detrimental to host cell growth. The resulting blue colonies from X-gal
plates, and white (empty vector) or light pink (lzee.v2 and LZD87) colonies from TZ
lac plates were then analyzed for reporter protein activity. Results are shown in Fig-
ure 3.16. Both lzee.v2 and LZD87 transformants selected from X-gal plates showed
a dose-dependent repression of β-galactosidase upon IPTG induction. Surprisingly,
transformants selected from TZ lac plates showed significantly lower amounts of
the reporter protein in our assays, even in non-inducing conditions. Transformants
containing the empty vector selected from both plates showed comparable reporter
activity, and do not seem to be affected upon IPTG induction.
The experiment was repeated on non-looping strains (FW102/proxCREB-1
and FW102/proxWT-1) and a longer looping strain (FW102/CW-237.5) to see if
this observation only occurs when growing transformants containing the GCN4 bind-
ing protein on TZ lac media (see Figures 3.17 – 3.19). Reporter activity assays
showed that there is a correlation between growing transformants on TZ lac and
lowered amounts of β-galactosidase. The same observation is also seen when the
reporter strains are transformed with the empty lacUV5-pGEX expression plasmid.
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(LB Xgal plates)





















































Figure 3.16: Comparing β-galactosidase amounts on FW102/CC-85 transformants
selected from different indicator plates. Lzee.v2 and LZD87 transformants selected
from Xgal plates showed dose-dependent repression of the reporter protein (top
graph), while the same transformants selected from TZ lac plates exhibited very


















































Figure 3.17: Comparing β-galactosidase amounts on FW102/proxCREB-1 transfor-
mants selected from different indicator plates. Transformants selected from Xgal
plates showed no dose-dependent repression of the reporter protein (top graph),
while the those selected from TZ lac plates exhibited significantly lower amounts of























































Figure 3.18: Comparing β-galactosidase amounts on FW102/proxWT-1 transfor-
mants selected from different indicator plates. Transformants selected from Xgal
plates showed no dose-dependent repression of the reporter protein (top graph),
while the those selected from tetrazolium-lactose plates exhibited significantly lower


























































Figure 3.19: Comparing β-galactosidase amounts on FW102/CW-237.5 transfor-
mants selected from different indicator plates. Transformants selected from Xgal
plates showed no dose-dependent repression of the reporter protein (top graph),
while the those selected from TZ-lac plates exhibited significantly lower amounts of
the reporter protein that increase slightly upon IPTG induction (bottom graph).
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3.4.6 Cross-streaking experiments between indicator media
A series of cross-streaking experiments between X-gal and tetrazolium was
subsequently done to find out (1) if the low levels of lacZ in the transformants
from tetrazolium-lactose plates are triggered by the presence of the inducer in the
plates, and (2) if this repression persists when the cells are moved to a new growth
media that do not contain the inducer. It is possible that the low expression of
the reporter protein could be due to the loss of the F’ episome in the host cells.
If this were indeed the case, we want to be able to pick out transformants that
have intact F’ episomes prior to doing the reporter protein assays. The looping
strains FW102/CC-85, FW102/CW-85.5 and FW102/CW-237.5 were transformed
with lacUV5-pGEX6P1 plasmids (empty vector, lzeeV2 and LZD87) and plated onto
TZ glu, TZ lac, LB X-gal and LB X-gal IPTG indicator plates. Figure 3.20 displays
the transformation results on four different indicator plates.
Most of the transformants yielded pink colonies on the tetrazolium plates, and
similar amounts of blue and white colonies on X-gal ± IPTG plates. Transformants
containing the empty vector grew comparable numbers of colonies on both tetra-
zolium and X-gal ± IPTG plates. Lzee.v2 transformants grown on X-gal plates
generally have more colonies compared to the ones on X-gal IPTG plates. However,
the same transformants did not grow colonies on TZ lac plates, but yielded a lot
of pink colonies on TZ glu plates. The only exception was the FW102/CW-237.5
transformant, where there was no colony growth in TZ glu plates. LZD87 trans-
formants have significantly fewer colonies on TZ glu plates compared to those with
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Figure 3.20: Colorimetric screens on lacUV5-pGEX transformants using tetrazolium
and Xgal plates. Each square that corresponds to an expression plasmid:reporter
strain transformant, contains the four selection plates. top row: TZ glu (left), TZ
lac (right); bottom row: LB Xgal (left), LB Xgal IPTG (right). Plates marked with
X indicate no colony growth. LZD87:FW102/CW-85.5 transformants grew sparse
red colonies on both tetrazolium plates
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the empty vector or lzee.v2. LZD87 transformed into FW102/CW-85.5 cells grew
very few red colonies on tetrazolium-containing plates. The number of colonies are
comparable upon IPTG induction (i.e. LB ± IPTG), but decreased significantly in
the presence of lactose (tetrazolium ± lactose). Moreover, FW102/CW-237.5 cells
transformed with LZD87 also did not grow colonies on tetrazolium-lactose plates.
The following set of cross-plating experiments were then done using the colonies
from these plates.
Initial plating results show that lzee.v2 becomes toxic to any reporter strain
when grown in media containing lactose. To find out if the toxicity is triggered
when the protein expression is induced on a selection plate, lzee.v2 transformants
from Xgal plates were streaked onto TZ lac plates, and transformants from TZ
glu plates were streaked onto Xgal IPTG plates. Results showed either no colony
growth (FW102/CC-85 transformants) or red colonies on TZ lac plates, and distinct
white colonies on Xgal IPTG plates. This shows that plating lzee.v2 transformants
onto selection plates containing an inducer either renders toxicity to the host cells,
or generates transformants with altered characteristics. Thus, subsequent repres-
sion assays on lzee.v2 were done on transformants grown on non-inducible selection
plates.
Dark and light blue colonies from X-gal plates were streaked onto fresh TZ
glu and TZ lac plates. All of the dark blue colonies resulted in pink colonies on TZ
glu plates, and the light blue ones to red colonies. Most of the dark blue colonies
from X-gal plates turned to pink colonies on TZ lac plates, and the light blue ones
became red colonies.
75
Pink colonies from TZ glu plates were streaked onto fresh X-gal IPTG plates.
FW102/CW-237.5 transformants selected containing the empty vector, and lzee.v2
grew blue colonies on the new selection plates. All of the LZD87 transformants left
blue streaks with mostly white colonies.
Finally, blue and light blue colonies from X-gal IPTG plates were streaked
onto TZ glu plates. Transformants containing the empty vector produced pink
colonies from blue ones selected, and red colonies from light blue ones. On the
other hand, all transformants containing the recombinant pGEX plasmid (lzee.v2,
LZD87) generated red colonies, regardless of the color of the selected colony from
X-gal IPTG.
A few points can be deduced from the results presented. First, colony color on
uninduced indicator plates can be used to qualitatively assess the behavior of the
selected transformant in the reporter protein assays. Cross-plating results from LB
Xgal to TZ glu plates should just reiterate the phenotype from LB Xgal since TZ
glu should be similar as LB Xgal. Hence, light blue to white colonies would yield red
colonies, indicative of a lac- phenotype. We would then expect these transformants
to show lower amounts of the reporter protein at non-inducing conditions.
Second, cross-plating from uninduced indicator plates to indicator plates con-
taining IPTG or lactose did not show a clear change of phenotype, i.e. blue colonies
from X-gal plates generating red colonies in TZ-lac plates. However, expression of
lzee transformants by lactose induction, either renders toxicity to the host cell, or
generates survivors with altered phenotypes.
Finally, cross-plating of transformants from selection plates containing the
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inducer to indicator plates that do not contain the inducer shows that any transfor-
mants with altered characteristics have maintained that phenotype upon removal
of the inducer. This introduces the possibility of reporter protein repression by our
DNA binding proteins occurring via a different mechanism.
3.4.7 Repression assays on 85- to 650-bp looping strains
In order to minimize transcriptional load, one approach was to mutate the
tac promoters in all our recombinant plasmids into either lacUV5 or wild-type lac
promoters. In addition, longer looping strains were constructed to compare looping
efficiencies in vivo over a wider range of distances between GCN4 binding sites. The
recombinant expression plasmids were transformed into the various looping and
non-looping reporter strains to compare the extent of reporter protein repression
over the span of 85 – 650-bp distance between GCN4 sites. Table 3.6 summarizes
the repression ratios of the recombinant proteins in reporter strains containing the
CREB site in the downstream position.
Table 3.6: Repression ratios on reporter strains containing proximal CREB site. All
transformants analyzed were selected from LB plates. Results from BL876 transfor-
mants are included to provide baseline repression ratio values
Reporter no pGEX lzee.v2 LZD73 LZD80 LZD87
Strain plasmid
BL876 1.04 ± 0.06 1.21 ± 0.05 1.37 ± 0.01 1.26 ± 0.07 1.11 ± 0.06 1.15 ± 0.01
proxCREB-1 1.01 ± 0.06 1.22 ± 0.05 2.39 ± 0.02 1.44 ± 0.04 1.53 ± 0.04 2.29 ± 0.02
CC-85 0.99 ± 0.03 not done 2.45 ± 0.02 1.43 ± 0.04 1.74 ± 0.06 2.482 ± 0.003
proxCREB-2 1.1 ± 0.3 1.29 ± 0.04 2.05 ± 0.06 1.2 ± 0.1 1.58 ± 0.06 2.00 ± 0.09
IC-450 1.1 ± 0.1 1.3 ± 0.1 2.31 ± 0.02 1.34 ± 0.02 1.58 ± 0.06 2.24 ± 0.04
IC-650 1.2 ± 0.2 1.25 ± 0.05 1.78 ± 0.05 1.5 ± 0.1 1.59 ± 0.03 1.66 ± 0.07
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The first thing to note is the small error associated with most of the re-
pression ratios calculated, which shows similar behavior among transformants an-
alyzed at sub-saturating amounts of the DNA binding proteins. Next, lzee.v2 and
LZD87 transformants have relatively higher repression ratios compared to LZD73
and LZD80 transformants. This is most likely from the fact that the DNA-binding
domain in lzee has high affinity to the CREB site, and can also bind to one half of
the INV2 site. On the other hand, the DNA-binding domains in the LZD proteins
have different affinities to the CREB site. The N-terminal end has higher binding
affinity to the CREB site, while the C-terminal end binds more preferrably to the
INV2 site. However, we could not tell at this point which end of the protein is
actually bound to which site in our repression assays.
There are two possible explanations for the differences in the extent of repres-
sion among the proteins tested. One, the relative orientations of the DNA-binding
domains in LZD73 and LZD80 may not be optimal in stabilizing the DNA loops in
the lengths between GCN4 sites analyzed. Another possibility could be the solubility
issues for LZD73 and LZD80.
Comparison of the repression ratios between the looping and non-looping
strains shows that there is slight enhancement of repression at the 85-bp distance
(LZD80, LZD87), 450-bp distance (lzee.v2, LZD73, LZD87), and 650-bp distance
(LZD73). We can not determine whether this increased repression is due to looping
since there are not enough data to cover a distance range that spans one helical turn
of the DNA.
Table 3.7 summarizes the reporter protein activities of host cells containing
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the downstream wild-type GCN4 site and strong GCN4 sites from 138.5 to 450.5 bp
away from the primary binding site, in the presence of lzee.v2 or LZD proteins. A
comparison between the non-looping and the longer (300.5- and 450.5-bp) looping
strains shows that there is no evidence of enhanced repression at this distance. This
probably stems from the proximal site being too weak to keep the putative looping
proteins bound long enough to repress the reporter gene.
Table 3.7: Repression ratios on reporter strains containing proximal wild-type GCN4
site. FW102/proxWT-1 and FW102/CW-237.5 transformants (last two rows) were
selected from tetrazolium-lactose plates, the rest from LB plates. Results from
BL876 transformants are included to provide baseline repression ratio values. No
colonies – no colony growth in TZ-lac plates, Dead culture – selected colony from
TZ-lac plate failed to grow in liquid growth medium, a – one replicate showed very
low starting amounts of lacZ, b – both replicates showed very low starting amounts
of lacZ.
Reporter no pGEX lzee.v2 LZD73 LZD80 LZD87
Strain plasmid
BL876 1.04 ± 0.06 1.21 ± 0.05 1.37 ± 0.01 1.26 ± 0.07 1.11 ± 0.06 1.15 ± 0.01
CW-138.5 1.1 ± 0.2 1 ± 2a 1 ± 2a 0.2 ± 3b 0.1 ± 1b 0.2 ± 0.7b
CW-187.5 1.1 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 1 ± 1a 1.1 ± 0.2 0.1 ± 100b
proxWT-2 1.06 ± 0.04 1.21 ± 0.03 1.06 ± 0.03 1.19 ± 0.05 1.23 ± 0.04 1.15 ± 0.05
IW-300.5 1.0 ± 0.1 1.16 ± 0.07 1.09 ± 0.09 1.20 ± 0.06 1.24 ± 0.05 1.22 ± 0.06
IW-450.5 1.01 ± 0.07 1.2 ± 0.1 1.0 ± 0.1 1.19 ± 0.02 1.17 ± 0.09 1.09 ± 0.02
proxWT-1 1.0 ± 0.2 not done dead culture 1.1 ± 0.1 1.1 ± 0.1 no colonies
CW-237.5 1.0 ± 0.1 not done dead culture 1.153 ± 0.007 1.1 ± 0.1 no colonies
However, things get pretty interesting in the 138.5- to 237.5-bp distance range.
Some of the transformants containing any of the pGEX expression plasmids exhibit
signs of permanent repression in our liquid culture assays. The behavior seems
to occur more frequently in (1) FW102/CW-138.5 transformants, where at least
one replicate from each expression plasmid showed very low levels of lacZ, and in
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(2) LZD73 and LZD87 transformants, where both of them gave aberrant average
reporter protein activities at the 138.5- and 187.5-bp looping strains. A closer
inspection on the reporter assay plots on LZDs:FW102/CW-138.5 transformants
show that the reporter protein is actually activated upon IPTG induction (see Figure
3.21). Moreover, plating the transformants onto indicator plates that contain an
inducer for the pGEX gene inserts prior to starter culture growth accelerates the
process to the point that it kills the host cells. This is the case seen in lzee.v2 and
LZD87 expression plasmids transformed into FW102/proxWT-1 and FW102/CW-
237.5 reporter strains.























Figure 3.21: β-galactosidase levels in FW102/CW-138.5 reporter strains trans-
formed with the lacUV5-LZDs, showing activation, instead of repression, of the
reporter protein
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3.4.8 Proposed model for baseline repression triggered by pGEX ex-
pression
The peculiar behavior seen in the shorter looping strains containing the pGEX
recombinants suggests the following questions:
1. What causes complete repression of the reporter protein in the presence of the
pGEX plasmids when plated on LB Xgal plates?
2. Why does this behavior occur less readily in reporter strains with longer sep-
aration between GCN4 sites?
To answer the first question, we have examined the sequences of the expression
plasmids, and the lacI – lacZ cassette region in the F’ episomes of all the reporter
strains. A closer inspection of the complete DNA sequences of the pGEX plasmids
revealed a wild-type lac promoter between the 3’ end of lacIq gene and upstream
of the tac (and lacUV5 ) promoter (see Appendix 2.1). This lac promoter has a lac
O1 operator and a short segment of the lacZ gene. This discovery has two possible
implications: (1) leaky expression from this promoter could contribute to levels of
the recombinant gene downstream of the main promoter, and (2) the lacZ gene
sequence downstream of the wild-type promoter has high sequence homology with
the lacZ sequence with the reporter gene in the F’ episome. The first implication
would explain the reduced lacZ levels observed in the reporter strains containing
the proximal CREB site transformed with either tac-lzee or tac-LZD87 (see Figures
3.9, 3.10, and 3.12). The second one would have two possible consequences, as
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summarized in Figures 3.22 and 3.23.
First, recombination at both lacI and lacZ regions introduces all three lac op-
erators into the F’ episome, and transfer the kanamycin resistance gene into pGEX.
The F’ episome would then lose the antibiotic resistance, and may be lost from the
host cells. Hence, blue-white screening with Xgal would render the transformants
white because there is no fully functional β-galactosidase protein that was provided
by the F’ episome. However, white-red screening with TZ-lac plates would have two
possible outcomes. First, lactose permease (lacY protein product) is required for
the host cells to metabolize lactose. With the F’ episome gone, the resulting trans-
formants can not utilize the added sugar and may not grow on lactose-containing
media. This is most likely the case with lzeeV2 and LZD87 transformants not grow-
ing on TZ-lac plates. Second, any surviving transformants, which may not need to
metabolize lactose, would most likely grow as pink to red colonies. This was the
observation shown by LZD87:FW102/CW-85.5 transformants (see Figure 3.20).
Second, recombination events occuring at both the secondary lac promoter
and lacZ regions also introduces two lac operators into the F’ episome, while main-
taining kanamycin resistance. The lactose repressor, overexpressed from the pGEX
plasmids, can bind to this operator, which can inhibit lacZYA expression in the F’
episome at non-inducing conditions. The resulting transformants would be blue on
Xgal plates, and grow white to pink colonies on TZ lac plates. This would most
likely explain the permanent repression or very low levels of reporter protein seen in

























F' episome can be lost from the
host cell due to loss of
antibiotic resistance 
Figure 3.22: Proposed recombination event I in reporter strains transformed with
pGEX plasmids. Double recombination events at the lacI and lacZ sequences intro-
duces three lac operators (red squares; the third operator is within lacZ) into the F’
episome, and transfers the kanamycin resistance gene into pGEX. The F’ episome
is kicked off the host cell, and the resulting transformants can not react with IPTG,
or metabolize lactose. The double arrows indicate varying distances between the

























bind here and repress
lacZYA expression
Figure 3.23: Proposed recombination event II in reporter strains transformed with
pGEX plasmids. Double recombination events at the secondary lac promoter and
lacZ sequences introduces two lac operators (red squares; the second operator is
within lacZ) into the F’ episome, while maintaining the kanamycin resistance gene.
The resulting transformants can utilize IPTG and lactose, but will exhibit perma-
nent repression in the liquid assays. The double arrows indicate varying distances
between the GCN4 sites. Blue squares – GCN4 site, Red squares – lac O1 and O3
operators
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Our colorimetric screen results have shown both events to be occurring ran-
domly, although there is no clear trend as to which one is favored. In order to
differentiate between the two, first thing to do is isolate the expression plasmids
from the host cells post-induction. If lacI – lacZ recombination has occured, one
telltale consequence would be a big difference in the expression plasmid size vs.
the unrecombined plasmid size. Another experiment that could be done is to re-
transform the plasmids into a different E. coli strain, and screen for ampicillin and
kanamycin resistant transformants. Lastly, one can verify for the presence of the
UV5 promoter – GCN4 operator sequence by PCR, or DNA sequencing.
We have routinely done colony and culture PCRs on the transformants we
analyze in our genetic assays to verify that we are not losing either the expression
plasmid nor the F’ episome. All of the transformants we have analyzed so far have
maintained both the plasmid and the F’ episome. However, the presence of the
correct PCR products from the colony or culture samples does not tell us where
these products are being amplified from, although the presence of extraneous PCR
products from transformants with altered phenotypes (i.e. white colonies from Xgal
plates, or red colonies from tetrazolium plates) would support our recombination
hypothesis. Analyzing the plasmids isolated from cultures post-pGEX expression,
instead of just the cultures themselves for multiple PCR products would show ir-
refutable proof in support for our proposed explanation.
If the Plac – lacZ recombination has happened, there would not be any differ-
ence in the plasmid sizes between the original and the modified plasmids. However,
one can amplify the promoter between lacI and lacZ regions in the expression plas-
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mids and determine the sequence. The proximal GCN4 site would be present in the
recombined plasmids.
It is not clear from the proposed recombination events why they occur more
frequently in shorter looping strains, or in the presence of the recombinant pGEX
plasmids, but not the empty vector. Moreover, the recombination events could not
fully explain why lzee.v2 transformants always end up dead when plated on TZ-lac
plates, although we have not verified yet whether the cell toxicity is dependent on the
presence of GCN4 sites in the reporter strains. One possibly farfetched idea would
be a formation of a lzee-lactose repressor hybrid protein that brings the homologous
regions from the F’ episome and the expression plasmid closer together to initiate
recombination. Based on what we have seen so far, there seems to be a link between
induction of our proteins and increased recombination activity.
3.4.9 Reporter assays on lacUV5-pGEXb recombinants
The proposed recombination events due to sequence homologies between the
F’ episome and the expression plasmids complicate the interpretation of data from
our looping assays. Thus, one way to minimize, if not prevent, recombination was
to remove the secondary lac promoter – lacZ fusion in the recombinant pGEX
plasmids. Recombination would most likely still happen at the lacI end, but this
should not affect the results of the in vivo looping assay.
FW102/IC-450 reporter strains were transformed with the new pGEX recom-
binants (empty vector, lzee.v2b, LZD73b, LZD80b and LZD87b), and plated onto
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TZ-glu and TZ-lac plates. All transformants grew mainly pink colonies on glucose-
containing plates. On the other hand, transformants grown on TZ-lac plates are
small light pink colonies, except for lzee.v2 transformants which did not grow at all.
There was no significant difference in the number of colonies between the two col-
orimetric plates, indicating that lactose induction of the GST tag (from the empty
vector) and LZDs is not detrimental to the host cell survival.
Next, we screened the different transformants for the presence of intact lacUV5
promoter-GCN4 operator with Od-fp2.1 and Op-rp1.1. Culture PCR results from
the rare red colonies selected from both plates, and white colonies from the unin-
duced plates showed the disappearance of the 1233-bp PCR product. In its stead
were multiple PCR products, illustrating that these transformants may have un-
dergone recombination, although we don’t know exactly how. On the other hand,
culture PCR results on pink colonies selected from both TZ-glu and TZ-lac plates
showed the same single PCR product, indicating no recombination had occured from
these transformants (see Figure 3.24). Thus, we proceeded on selecting pink colonies
from the tetrazolium-containing plates in our next round of reporter assays.
In a new experiment, PCR on the pink colonies with recomFP2-lacZ +
recomRP4-lacZ (which amplifies the suspected lacZ homologous region in the F’
episome) did not generate a PCR product. In parallel, the gene insert in the ex-
pression plasmids are intact, albeit in relatively low amounts, as seen by PCR with
seqFP2-pGEX + pGEXrp (see Figure 3.25).
It is possible that the recombination primers designed for amplifying the lacZ
region in the F’ episome are not optimal, so we proceeded to analyze the cultures
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Figure 3.24: Culture PCR results I on FW102/IC-450 reporter strains transformed
with lacUV5-pGEXb (empty vector, lzeeV2, LZD73, LZD80, LZD87), using Od-
fp2.1 + Op-rp1.1 (1233 bp PCR product) and pGEXfp2 + pGEXrp primers (80,
325, 332, 353 or 387 bp PCR product). White (W, W+), light pink (P, P+), and
red (R, R+) colonies were selected from tetrazolium-glucose and tetrazolium-lactose
(+) plates for overnight growth in LB amp kan strep. Purified plasmids are used
as controls for PCR. Extraneous PCR products (i.e. ∼ 250 bp and 310 bp) are due
to PCR artifacts from one of the primers. Results show that the promoter-operator
region in the F’ episome has not been recombined into the pGEX expression plasmid,
i.e. P and P+ samples give the same PCR products.
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Figure 3.25: Culture PCR results II on FW102/IC-450 reporter strains trans-
formed with lacUV5-pGEXb (empty vector, lzeeV2, LZD73, LZD80, LZD87), us-
ing recomFP2-lacZ + recomRP4-lacZ and seqFP2-pGEX + pGEXrp primers (870,
1115, 1122, 1143 or 1164 bp PCR products). Pink colonies were selected from TZ-
glu (lanes 1 and 2) and TZ-lac plates (lanes 3 and 4) for overnight growth in LB
amp kan strep. Purified plasmids are used as controls for PCR, shown on the left
of the 100-bp DNA ladder. No products were detected in any of the transformants
from recomFP2-lacZ + recomRP4-lacZ, which may indicate these primers to have
very low annealing efficiencies.
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selected from the uninduced plates for reporter protein activity. Results show there
is weak dose-dependent repression of the reporter protein upon IPTG induction (see
Figure 3.26 and Table 3.8). In addition, analysis of the same cultures revealed that
the new pGEX recombinants are expressing our proteins (see Figure 3.27), although
it is not clear whether the proteins are soluble.

























Figure 3.26: β-galactosidase levels from FW102/IC-450 reporter strains transformed
with lacUV5-pGEXb (empty vector, lzeeV2, LZD73, LZD80, LZD87).
3.4.10 Reporter assays on pBAD recombinants
Lastly, recombinant pBAD plasmids were used as expression plasmids to test
for DNA looping-dependent repression of β-galactosidase. Protein expression from
these plasmids is regulated by the arabinose promoter, which should not interfere
with the lacZYA expression. Furthermore, we have not seen any sequence homologies
between the pBAD plasmids and F’ episome.
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Table 3.8: Reporter protein behavior in FW102/IC-450 looping strains transformed
with pGEXb plasmids. There is no dose-dependent repression of the reporter protein
upon expression of the gene inserts in pGEXb.
Expression β-gal Units β-gal Units Repression Ratio,
Plasmid (0 mM IPTG) (1 mM IPTG) RR
— 943 ± 14 919 ± 18 1.03 ± 0.03
pGEX6P1b 809 ± 86 731 ± 16 1.1 ± 0.1
lzeeV2b 821 ± 35 563 ± 39 1.5 ± 0.1
LZD73b 799 ± 157 793 ± 95 1.0 ± 0.2
LZD80b 875 ± 95 854 ± 162 1.0 ± 0.2
LZD87b 793 ± 49 683 ± 133 1.2 ± 0.2









Figure 3.27: Western blot of crude lysates from lacUV5-pGEXb transformants
(empty vector, lzeeV2, LZD73, LZD80, LZD87) in FW102/IC-450 reporter strains,
2 hours post-induction with 1 mM IPTG.
FW102/IC-450 transformed with the recombinant pBAD plasmids generated
white to light pink colonies on TZ-glucose and TZ-lactose-arabinose plates. Trans-
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formants were selected from both plates and analyzed for reporter protein activity.
Results show that there is no significant repression of the β-galactosidase from any
of the pBAD recombinants tested (see Figure 3.28 and Table 3.9).


























Figure 3.28: β-galactosidase levels from FW102/IC-450 reporter strains transformed
with pBAD (empty vector, lzeeV2, LZD73, LZD80, LZD87).
A closer inspection of the genotypes of all our reporter strains showed a muta-
tion in the araD gene in the F’ episome, which prevents metabolism of arabinose by
the host cell, but no mutation or deletion in araEFGH genes, which enables arabi-
nose transport into the host cell (Whipple, 1998; Becker et al., 2005). Furthermore,
SDS-PAGE analysis of whole cell extracts obtained from cell cultures used in the
Miller assays did not show the presence of the putative proteins upon induction by
arabinose (results not shown). This might indicate the absence, or if present, an
inefficient one, of the arabinose transporter in the host cells.
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Table 3.9: Reporter protein behavior in FW102/IC-450 looping strains transformed
with pBAD plasmids. There is no dose-dependent repression of the reporter protein
upon expression of the gene inserts in pBAD.
Expression β-gal Units β-gal Units Repression Ratio,
Plasmid (0 % arabinose) (0.02 % arabinose) RR
— 1174 ± 129 1170 ± 116 1.0 ± 0.1
pBAD 1150 ± 115 1168 ± 85 1.0 ± 0.1
lzeeV2 1225 ± 192 1064 ± 181 1.2 ± 0.3
LZD73 1148 ± 155 1101 ± 202 1.0 ± 0.2
LZD80 1111 ± 51 1166 ± 130 1.0 ± 0.1
LZD87 117 ± 124 1086 ± 40 1.0 ± 0.1
3.5 Conclusions
The genetic assay originally developed by Whipple was designed to study
DNA-binding proteins from any source in bacterial cells (Whipple, 1998). Sev-
eral applications of this assay to probe DNA flexibility by the use of a DNA-looping
dependent repression has shown that non-specific DNA bending proteins, and the
flexibility of the DNA looping protein itself contribute to the stability of very small
DNA loops in vivo (Becker et al., 2005, 2007). In this chapter, we adapted the
same assay to determine the contribution of inherent DNA flexibility in in vivo loop
formation by using small and relatively rigid artificial DNA looping proteins that
have been previously shown to loop DNA in vitro (Gowetski et al., 2013). In course
of optimizing our genetic assays, we have observed either cell death, or permanent
repression in reporter strains that contain relatively short distances between GCN4
sites upon expression from the pGEX recombinants. We proposed possible recom-
bination events that have led to the loss of the F’ episome in these strains, and have
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seen some evidence to support this explanation.
On the other hand, we have observed relatively weak enhancement of repres-
sion on reporter strains with longer separation between GCN4 sites in the presence
of our proteins. It is not clear at this point whether this enhancement is due to
DNA looping. One future direction for this project is to do measurements on a
much shorter distance range, that spans one helical turn of the DNA, to illustrate
reporter protein repression that is dependent on DNA looping. By changing the rel-
ative orientations of the binding sites, we might expect to see periodic fluctuations
in the calculated repression ratios.
Given the unexpected effects observed in shorter distances between GCN4
operators, it is possible that LZD proteins may be stabilizing much shorter DNA
loops in vivo after all. However, its leaky expression in lacUV5-pGEX may trigger
the recombination events in the host cells as a response to deal with the toxic protein.
It would be interesting to note if there is a missing link between the expression of
the LZD proteins and host cell toxicity that is a consequence of DNA looping.
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Chapter 4: Catching DNA-protein loops using Plasmid Conformation
Capture
4.1 Overview
Generating specialized E. coli cells that house the modified operator-promoter
construct in single-copy for the reporter gene assay requires considerable time and ef-
fort. Moreover, it was a challenge selecting for transformants that survived overnight
growth in liquid culture, which is required to measure β-galactosidase levels, as
these looping proteins have been previously shown to be toxic to its cell host when
expressed in high amounts. Thus, another assay was developed to directly analyze
various operator distances for DNA loop formation with the LZD proteins. The chro-
mosome conformation capture (3C) method, developed by Dekker and colleagues,
was adapted for this system (Dekker, Rippe, Dekker, & Kleckner, 2002). While
the reporter gene assay looks at changes in reporter protein levels in the presence
of a DNA looping protein, a consequence of DNA looping, 3C offers a more direct
method of analyzing protein-mediated DNA loops in in vivo and in vitro conditions.
For this system, this method will be renamed plasmid conformation capture (PCC)
since the binding sites for the LZD proteins are cloned into a low-copy plasmid
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instead of the bacterial chromosome.
4.2 Rationale
In this assay, whole cells or solutions containing the artificial looping protein
and the DNA binding sites were fixed using formaldehyde, which enables formation
of cross-links between the protein and the DNA. The DNA in the covalently linked
protein-DNA complex is subsequently digested by a restriction enzyme, followed
by a ligation step at very low DNA concentrations that favors intramolecular liga-
tion of DNA fragments cross-linked to the same protein. The cross-links were then
removed and specific ligation products were quantified using polymerase chain reac-
tion. The amount of each ligation product is indicative of the nature and frequency
of interaction between DNA fragments (see Figure 4.1).
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Figure 4.1: Plasmid Chromosome Capture. (1) In this method, host cells expressing
the LZD proteins (red circle) and the plasmid DNA containing binding sites for the
protein is fixed with formaldehyde, making protein-protein and protein-DNA cross-
links. (2) The cross-linked complex is digested with a restriction enzyme (HinP1I)
and (3) ligated at very low concentrations. (4) The cross-links are subsequently
removed and (5) the new ligation junction is detected by PCR.
As outlined in Figure 4.1, a low-MW PCR product should only form upon
ligation of two DNA fragments. The amount of a specific ligation product depends
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on the local concentration and orientation of the DNA termini. If there is a direct
interaction between two DNA loci, the efficiency of ligation increases. A specific
interaction occurs if the following criteria are met: (1) bimolecular ligation product
yields from the same DNA fragments are low in the absence of the looping protein,
and (2) ligation product yields increase significantly upon crosslinking of the looping
protein to both DNA fragments. Thus, a protein-DNA complex can be detected if
there is a direct interaction between the looping protein and two DNA fragments
containing binding sites for the looping protein.
To generate DNA templates for PCC, the multiple cloning site in the transfer
plasmids containing the operator-promoter construct in the reporter assay is ex-
tended by inserting a 1100-bp DNA fragment derived from lambda DNA between
the EcoRI and SacI recognition sites. This allows the subsequent cloning of the INV2
(5’-GTCATATGAC-3’) operator, a strong binding site to the C-terminal DNA bind-
ing domain of the LZD proteins, at upstream positions ranging from 300 to 1150
base pairs from the proximal GCN4 site by site-directed mutagenesis (see Chapter
3.3.1.4). Next, a restriction enzyme is chosen for the digestion step that enables
high resolution and near coverage of the region of interest. In this system, very
short-range interactions are being mapped out compared to 3C methods. Thus, a
restriction enzyme that would generate at least 100-bp digestion fragments is picked.
HinP1I and CviQI are selected as possible candidates for this system. PCR primers
are then designed on the region of interest, based on the location of the restriction
enzyme cut sites. In addition, internal control primers located outside the region of
interest are designed for detecting intermolecular ligation, which is independent on
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LZD binding to its DNA site/s in the plasmid, and normalization primers that de-
termine template yields. A summary of DNA templates and PCR primers designed,
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Figure 4.2: DNA templates and PCR primers used in PCC. Position of GCN4 bind-
ing sites (CREB in red boxes, INV2 in green boxes) are not drawn to scale. Vertical
lines indicate HinP1I cut sites. PCR primers FPnorm and RPnorm determine DNA
template yield, while any combination of PCR primers FPctrl1, FPctrl2, RPctrl1,
and RPctrl2 detects intermolecular ligation. Sequences of all the primers shown in
this figure are listed in Appendix 2.5
.
Several factors must be taken into consideration in order to make a correct
analysis of results. First, template amounts have to be determined among all samples
such that the amount of a specific PCR product increases linearly with increasing
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amounts of template. Second, a control template should be generated such that it
contains equal amounts of all possible ligation products to account for differences
in primer efficiencies. Third, the level of background random interactions has to
be determined by testing several distances farther along the region of interest from
the DNA fragment containing the primary operator. A looping interaction would
be identified if there is a local peak in the interaction frequency between DNA frag-
ments containing the binding sites. Fourth, another set of control PCR primers
have to be designed in a different region of the plasmid to account for differences
in cell preparations and experiment conditions. These internal controls would de-
termine whether a specific interaction is correlated with biological activity such as
the expression of a DNA looping protein. Finally, in order to account for differences
in DNA yields, and interaction frequencies from various sample preparations, the
amount of PCR product from a specific ligation product is normalized to both the
PCR product that does not amplify across a ligation junction, and to a PCR prod-
uct from a bimolecular ligation event that is unaffected by the looping protein being
studied, respectively (Dekker, 2006).
In this study, we define the interaction frequency of a DNA ± protein sample
as the ratio of concentrations of a specific ligation product, e.g. using primers A1
and B2, to that of the internal control primers. Furthermore, the crosslinking effi-
ciency is defined as the ratio of interaction frequency between formaldehyde-treated
to uncrosslinked samples. To account for differences in sample preparation from
different experiment conditions, the interaction frequencies are normalized against
the DNA yield, which is quantified by PCR using FPnorm and RPnorm primers.
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4.3 Materials and Methods
Reagents and enzymes for molecular biology work were purchased from NEB,
while DNA oligonucleotides for PCR were purchased either from IDT or Sigma.
Quantitative PCR (qPCR) was done on a LightCycler R© 480 Real-time PCR In-
strument (Roche).
Promoter-operator constructs prepared as described in Chapter 3.3.1.4 were
used as the plasmid templates for PCC. The LZD expression plasmids used for in
vivo PCC are the recombinant lacUV5-pGEX plasmids.
4.3.1 In vivo PCC
We have adapted and modified the procedure developed by Dekker and col-
leagues (Miele, Gheldof, Tabuchi, Dostie, & Dekker, 2006) to work on E. coli sam-
ples. First, TOP10 E. coli cells were transformed with the plasmid DNA contain-
ing the GCN4 operators and the expression plasmid containing the LZD protein.
Correct transformants were identified using colony PCR that detects both the in-
tact operators (seqFP-OdOp + Op-rp2a) and the LZD gene sequence (pGEXfp3 +
pGEXrp), and then grown in LB media containing amp, kan, cam, and strep. The
seed cultures were then split up and diluted 50-fold into fresh growth media ± 1
mM IPTG and grown to mid-log phase. An aliquot of liquid culture from each setup
was then treated with 1% formaldehyde at room temperature for five minutes, and
quenched with 0.5 M glycine at 4 ◦C for 10 minutes. The cells were then harvested
after the cross-linking step. Cells from the remaining aliquots were harvested and
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used as the uncross-linked control samples. The cells were lysed at 37 ◦C for 30
minutes without agitation in Lysis Buffer (10 mM Tris-HCl pH 8.0, 20% sucrose,
50 mM NaCl, 10 mM EDTA, 10 mg/mL lysozyme), and the lysates could then be
stored at -80 ◦C upon addition of 1 mM PMSF, or 1X protease inhibitor cocktail.
An aliquot of the lysate was washed three times in the restriction enzyme
buffer and treated with 0.1% SDS for 10 minutes at 65 ◦C to remove any uncross-
linked proteins. Excess SDS was then sequestered with 1% Triton X-100 before
incubating the DNA in 1.2 U/µL restriction enzyme for at least 8 hours. The
restriction enzyme was then inactivated by incubating the digested samples with
1.5% SDS for 20 minutes at 65 ◦C. The digestion products were diluted 15-fold
with 1X T4 DNA Ligase Buffer supplemented with 1% Triton X-100, 1 mM ATP
and 100 µg/mL BSA, and then ligated for 2 hours at 16 ◦C with 1 U/µL T4 DNA
Ligase. Cross-links and all proteins were then removed by incubating the ligation
products with 50 µg Proteinase K at 65 ◦C for at least 12 hours. Finally, DNA was
isolated and worked up by phenol/chloroform extraction and ethanol precipitation,
and the DNA pellets resuspended in TE pH 8 buffer. Control DNA samples – (1)
intact plasmid, (2) digested DNA, and (3) randomly ligated DNA – were isolated
from each step of the method. Specific ligation products were then analyzed by PCR
and the resulting PCR products were visualized using agarose gel electrophoresis.
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4.3.2 In vitro PCC
Plasmid DNA containing GCN4 binding sites (500 pM) were incubated with
LZD protein (25 nM) at room temperature for at least 30 minutes. Afterwards, an
aliquot of this mixture was treated with 0.05% formaldehyde at 4 ◦C for 20 minutes,
and then quenched with 0.5 M glycine at 4 ◦C for 10 minutes. The protein-DNA
complexes were diluted 10-fold with the restriction enzyme buffer before incubating
in 1.2 U/µL restriction enzyme for at least 8 hours. The restriction enzyme was
then inactivated with 1.5% SDS at 65 ◦C for 20 minutes, then diluted the samples
15-fold with 1X T4 DNA Ligase Buffer supplemented with 1% Triton X-100, 1 mM
ATP and 100 µg/mL BSA, and ligated with 1-1.2 U/µL T4 DNA Ligase for two
hours at 16 ◦C. Cross-links and all other proteins were removed by incubating at 65
◦C for at least 12 hours with 50 µg Proteinase K. The ligation products were then
isolated and worked up by phenol/chloroform extraction and ethanol precipitation,
and the DNA pellets resuspended in TE pH 8.0 buffer. Control samples from both
uncross-linked and cross-linked samples were also isolated from each step of the
experiment. Finally, specific ligation products were analyzed by PCR.
4.3.3 Quantitative PCR (qPCR)
The qPCR master mix (20 µL per reaction) that contained the following was
prepared: 1X SYBR Green I Mix (proprietary mixture containing FastStart Taq
DNA Polymerase, reaction buffer, dNTP mix with dUTP replacing dTTP, SYBR
Green I dye and MgCl2), 250 nM each of the qPCR primers, and 1-5 µL DNA
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template.
The following program was set up on the thermal cycler:
• Initial Denaturation – 94 ◦C at 4.80 ◦C/s; hold for 2 minutes
• Amplification (35 cycles)
– 94 ◦C at 4.80 ◦C/s; hold for 15 seconds
– 60 ◦C at 2.50 ◦C/s; hold for 15 seconds
– 68 ◦C at 4.80 ◦C/s; hold for 30 seconds, single acquisition mode
• Melting Curve
– 95 ◦C at 4.80 ◦C/s; hold for 5 seconds
– 65 ◦C at 2.50 ◦C/s; hold for 1 minute
– 97 ◦C at 0.11 ◦C/s; continuous acquisition mode (five acquisitions per
◦C)
• Cooling – 40 ◦C at 2.50 ◦C/s; hold for 30 seconds
4.3.4 qPCR data analysis
First, a concentration curve was generated for each PCC plasmid template by
plotting the cycle threshold values, Ct, which were extrapolated from the qPCR re-
sults with FPnorm+RPnorm primers, against the logarithm of concentrations from
serial dilutions of undigested plasmid minipreps. The best fit line from this curve was
then used to calculate the concentrations of the PCC templates used in all qPCRs.
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The calculated concentrations of the PCC templates from qPCRs using A1+B2,
A1+C2 and A1+D2 primers were normalized against concentrations derived from
qPCRs using FPnorm+RPnorm or FPctrl1+FPctrl2 primers. Lastly, the crosslink-
ing efficiency is calculated as follows: [normalized PCR product]+ formaldehyde/[normalized
PCR product]- formaldehyde.
4.4 Results and Discussion
4.4.1 In vivo PCC control experiments
Optimization of existing 3C protocols to our system was done in vivo using
the plasmids proxCREB-2 and IC-300, the expression plasmids (lacUV5-pGEX6P1)
for LZD80 and LZD87, and HinP1I as the restriction enzyme. PCR was initially
done on undiluted templates from all cell preparations previously mentioned, to
check for the efficiencies of restriction enzyme digestion and religation under reaction
conditions in the capture experiment. Figures 4.3 and 4.4 showed that the 217-bp
PCR product from primers A1 and B2 only showed up in samples that were digested
and successfully ligated. The results indicate that the cross-linking stringency and
template concentration are low enough for a near-complete digestion of cross-linked
plasmid DNA. Moreover, cross-linking seems to increase the amount of ligation
product.
PCR was then done on serial dilutions of the proxCREB-2 templates (+ IPTG)
using primers A1 and B2 (see Figure 4.5) to optimize template concentrations to
the linear range. Results on ligation control DNA showed a significant decrease in
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Figure 4.3: In vivo PCC control experiments for proxCREB-2 ± LZD80 or LZD87.
Gel electrophoresis (1.5 % agarose in TBE) of PCR products obtained with primers
A1 and B2. 1 – PCC template, 2 – ligation control (cross-links were removed prior
to ligation step), 3 – digestion control, 4 – undigested template
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Figure 4.4: In vivo PCC control experiments for IC-300 ± LZD80 or LZD87. Gel
electrophoresis (1.5 % agarose in TBE) of PCR products obtained with primers A1
and B2. 1 – PCC template, 2 – ligation control (cross-links were removed prior to
ligation step), 3 – digestion control, 4 – undigested template
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the amount of PCR product, compared to the more gradual decrease of the PCR
product from the PCC template. The results show that intermolecular ligation
products are not detectable in the linear range of template concentration for PCR.
Next, we proceeded to quantifying the major PCR products by measuring band
intensities in a polyacrylamide gel stained with SYBR Gold (Life Technologies).
However, the stained gel revealed the presence of comparable amounts of higher
MW PCR products to the major PCR product in the PCC samples (see Figures 4.6
and 4.7). Apparently, the digestion efficiency was not nearly as complete as we have
previously thought. We attribute this to residual formaldehyde in the samples that
partially inactivated the restriction enzyme, which in turn, resulted to incomplete
digestion of our templates.
Based on the results presented so far, the assay seems to be working although
the biggest deterrent to continue with the quantification of specific ligation products
is the trace amounts of formaldehyde in the cross-linked samples, which affects the
amount of specific ligation products being quantified. We have done the experiment
using much higher amounts of restriction enzyme and ligase to improve digestion
and ligation efficiencies, but due to the sheer number of templates to be analyzed
and experiment conditions to consider, this assay can be quite expensive in the long
run. Thus, we need to review and modify the sample preparation method prior to
enzyme treatment of these samples.
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LZD80 LZD87 no protein
LZD80 LZD87 no protein
353 bp
Figure 4.5: Template dilutions of proxCREB-2 ± LZD80 or LZD87. Gel elec-
trophoresis of PCR products obtained with primers A1 and B2, using serial dilu-
tions of the DNA template (from left to right: 1600-fold, 800-fold, 400-fold, 200-fold,
100-fold, undiluted template). Results indicate that intermolecular ligation is un-
detectable at 100-fold dilution of the PCC template
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Figure 4.6: Quantification of in vivo PCC A1+B2 PCR products in proxCREB-2 ±
LZD80 or LZD87 + IPTG. Native PAGE of PCR products obtained with primers
A1 and B2. PCR was done in triplicate per template.
4.4.2 In vitro PCC control experiments
In order to simplify the analysis of our in vivo PCC results, we performed
the assay in vitro using plasmid DNA and purified protein. First, we started out
with a less stringent crosslinking condition (i.e. lower [CH2O] and temperature)
to give us enough crosslinked product but not adversely affect restriction enzyme
digestion and religation activities. PCR was done with internal control primers
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Figure 4.7: Quantification of in vivo PCC A1+B2 PCR products in IC-300 ± LZD80
or LZD87 + IPTG. Native PAGE of PCR products obtained with primers A1 and
B2. PCR was done in triplicate per template.
FPctrl1 and RPctrl2. Results are shown in Figure 4.8. The 156-bp product only
shows up in the PCC samples and the ligation controls, indicating that the HinP1I
sites at 428 and 581 have been cut and religated. The amount of this product
reflects the extent of intermolecular ligation. On the other hand, the amount of the
309-bp product reflects the amount of the PCR template in the intact plasmids, the
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extent of digestion in the digested samples, and the amount recovered from uncut
and incompletely digested plasmids upon ligation. For uncross-linked templates, the
relative amounts of both PCR products have not been significantly enhanced with
the addition of the LZD protein. This is to be expected since there are no GCN4
binding sites in that region. Formaldehyde treatment prior to digestion and ligation
resulted to a slight increase in the amount of the 309-bp PCR product in the PCC
templates, which is most likely coming from the amount of cross-linked samples that
could not be digested and were recovered upon the removal of the cross-links.
Next, we checked to see if there is a direct interaction between the GCN4
sites in the IC-450 template upon LZD crosslinking. PCR results using primers A1
and C2 showed the emergence of a 222-bp PCR product upon religation of HinP1I
fragments containing CREB or INV2 operators (see Figure 4.9). This PCR product
is more pronounced when the LZD protein is cross-linked to the DNA template
prior to digestion and ligation. On the other hand, the high-MW PCR products
present in PCC templates containing the LZD proteins could be due to incomplete
digestion of the template. This can be minimized by either doing the ligation at
an even lower concentration of DNA, or by doing the PCR using a lower amount of
DNA template.
From the results presented, it looks like the template concentrations have been
optimized to amounts where we can detect specific ligation products upon crosslink-









1 3 4 1 3 4 1 3 4
1 3 4 1 3 4 1 3 4
309 bp
309 bp
Figure 4.8: In vitro PCC control experiments for IC-450 ± LZD73 or LZD80. Gel
electrophoresis (1.5 % agarose in TBE) of PCR products obtained with internal
control primers FPctrl1 and RPctrl2. Results highlight the appearance of the 156-
bp PCR on templates that have been successfully digested and ligated. 1 – PCC
template, 2 – ligation control (cross-links were removed prior to ligation step), 3 –
digestion control, 4 – undigested template
4.4.3 Quantification of in vitro PCC ligation products
In a parallel experiment, we attempted to concentrate His-tagged LZD73-DNA
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Figure 4.9: In vitro PCC control experiments for IC-450 ± LZD73 or LZD80. Gel
electrophoresis (1.5 % agarose in TBE) of PCR products obtained with primers A1
and C2. 1 – PCC template, 2 – ligation control (cross-links were removed prior to
ligation step), 3 – digestion control, 4 – undigested template
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digestion step using batch purification with Ni Sepharose FF beads. This additional
step would have the advantage of isolating the cross-linked protein-DNA complex
prior to enzymatic treatments, and would be expected to give a better signal for
enhanced ligation on fragments containing the GCN4 sites without having to dilute
the samples to minimize extent of intermolecular ligation. Specific PCR products
from different plasmid DNA samples using various primer pairs were then detected
using ethidium bromide on a 1.5% agarose gel (see Figure 4.10). Ligation products
from fractions eluted with 500 mM imidazole (E1) cannot be detected with ethidium
bromide, whereas those from the original mixture (crude) and fractions collected
with 25 mM imidazole (S1) seem to have comparable amounts.
Quantitative PCR using FPnorm and RPnorm primers was then used to de-
termine differences in the template amounts among the different samples. To do
this, calibration curves were first constructed for each template using known con-
centrations of the intact plasmid templates. (see Figure 4.11).
We then used the concentration curves to determine the template yields in all
our PCC templates (see Table 4.1).
The results showed that there is a 1.5- to 2.5-fold difference in the DNA yields
between the crude and S1 samples, whereas that difference increases 100- to 400-
fold between crude and E1 samples. This could indicate that (1) formaldehyde may
not have cross-linked LZD to the plasmid successfully, (2) the crosslinking step had
somehow affected the binding affinity of the Histidine tag in the LZD protein to
the affinity beads, or (3) the DNA-protein complexes were not completely eluted




















Figure 4.10: In vitro PCC for detecting 300-, 450- and 900-bp interaction between
GCN4 sites using A1+B2, A1+C2, and A1+D2 primers, respectively. In a parallel
experiment, enrichments of the crosslinked and non-crosslinked LZD-DNA com-
plexes were done using batch purification on Ni Sepharose FF beads, which bind to
6x His tag fused to the LZD proteins. The dotted box highlights the presence of
a very small amount of PCR product using A1+D2 primers. D2 primer has been
redesigned.
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Figure 4.11: Concentration curves for in vitro PCC. Cycle threshold values, Ct,
were extrapolated from three qPCRs per template concentration used.
DNA yields among E1 samples in all of the plasmid DNA used; there is a 2-to 5-fold
increase in the template amounts when LZD is present, but an almost imperceptible
change in DNA yield in the presence of formaldehyde. Despite the very small yields,
we proceeded in quantifying ligation products that detect a 300-, 450-, and 900-
bp interaction between GCN4 binding sites, using the crude samples as our DNA
templates.
Table 4.2 summarizes the cycle threshold values extrapolated from an average
of three qPCR runs for each sample prep. The concentrations of the PCR prod-
ucts were then calculated using the concentration curves in Figure 4.11. In order
to account for differences in sample preparation and experiment conditions, the
concentrations were normalized to (1) the amount of intermolecular ligation prod-
uct (FPctrl1+FPctrl2 PCR product), or (2) the template yield (FPnorm+RPnorm
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Table 4.1: Comparison of DNA yields in in vitro PCC templates, from qPCR data
with FPnorm + RPnorm primers. Crude – PCC template, S1 – supernatant col-
lected after incubating the LZD73-DNA mixture in Ni Sepharose FF beads, E1 –
supernatant eluted with 500 mM imidazole
DNA LZD73 CH2O Ct [Template yield], pM
Crude S1 E1 Crude S1 E1
CREB - - 16.65 17.65 24.39 2.70 1.33 1.13E-02
CREB - + 16.75 17.85 24.76 2.51 1.16 8.73E-03
CREB + - 16.61 18.49 24.40 2.78 1.47 1.14E-02
CREB + + 16.58 17.89 23.72 2.84 1.12 1.82E-02
IC-300 - - 16.70 17.63 25.71 1.99 1.06 4.65E-03
IC-300 - + 17.16 17.83 25.38 1.45 0.93 5.84E-03
IC-300 + - 16.86 17.51 24.07 1.78 1.15 1.41E-02
IC-300 + + 16.85 17.54 23.60 1.80 1.13 1.92E-02
IC-450 - - 17.06 17.65 25.49 2.59 1.70 7.06E-03
IC-450 - + 16.63 17.78 24.84 3.50 1.56 1.11E-02
IC-450 + - 16.72 17.44 24.05 3.27 1.99 1.93E-02
IC-450 + + 16.90 17.43 23.79 2.90 2.00 2.31E-02
IC-900 - - 17.54 18.39 25.90 1.82 1.01 5.37E-03
IC-900 - + 17.16 17.94 25.73 2.37 1.38 6.05E-03
IC-900 + - 17.01 18.01 23.61 2.63 1.31 2.64E-02
IC-900 + + 17.13 17.90 23.98 2.42 1.41 2.04E-02
PCR product). Finally, the crosslinking efficiency for each normalized specific PCR
product is calculated from the ratio between crosslinked and uncrosslinked samples.
The resulting crosslinking efficiencies from the different plasmid samples were
overlaid, and plotted against the DNA length (see Figure 4.12). Since the effec-
tiveness of the PCC experiment relies on successful crosslinking of LZD to its DNA
binding sites, one would expect to see enhanced ligation between DNA fragments
containing GCN4 sites, and consequently, increased crosslinking efficiencies of these
fragments in the presence of the looping protein. However, the plots revealed two
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Table 4.2: Cycle threshold values from all in vitro PCC qPCR products. norm –
FPnorm+RPnorm primers, ctrl – FPctrl1+FPctrl2 primers
DNA LZD73 CH2O A1+B2 A1+C2 A1+D2 norm ctrl
CREB - - 29.91 32.17 34.86 16.65 28.02
CREB - + 28.55 31.22 34.78 16.75 27.34
CREB + - 28.70 30.51 37.25 16.61 27.16
CREB + + 28.80 30.10 35.43 16.58 27.11
IC-300 - - 28.96 32.02 37.05 16.70 28.19
IC-300 - + 28.75 31.98 36.35 17.16 28.09
IC-300 + - 28.78 31.16 35.98 16.86 27.67
IC-300 + + 28.69 30.41 36.98 16.85 27.54
IC-450 - - 30.05 32.69 37.27 17.06 29.12
IC-450 - + 29.03 31.87 36.94 16.63 28.01
IC-450 + - 29.61 31.62 37.28 16.72 28.13
IC-450 + + 29.33 30.22 36.64 16.90 27.67
IC-900 - - 30.31 32.39 36.03 17.54 29.14
IC-900 - + 29.87 32.28 35.94 17.16 28.69
IC-900 + - 29.79 31.63 36.69 17.01 28.48
IC-900 + + 29.24 30.25 34.70 17.13 27.89
things: (1) there are no changes in the crosslinking efficiencies in the region of in-
terest on all samples in the absence of LZD73, and (2) there are no localized peaks
in the crosslinking efficiencies on samples containing one GCN4 or two GCN4 sites
300 bp apart in the presence of LZD73. However, there is a very small peak in the
crosslinking efficiency plot when the INV2 is either 450 or 900 bp away from CREB.
This peak only shows up in samples containing LZD73. This looks promising in the
sense that LZD73 has been previously shown to stabilize ∼450-bp DNA loops from
cyclization experiments (Gowetski et al., 2013).
Taking into account the results from the attempt to enrich in vitro cross-
linked complexes by affinity chromatography, and the qPCR, we have seen that the
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Figure 4.12: Crosslinking efficiencies among in vitro PCC templates, as a function
of distance from the proximal CREB site. Solid plots are from data normalized
to template yield, while dashed plots are from data normalized to the amount of
intermolecular ligation.
His-tagged LZD proteins do not seem to form DNA crosslinks with formaldehyde.
One key feature in formaldehyde-mediated protein-DNA crosslinks is to have nucle-
ophilic residues from both the protein and the DNA that are close enough for the
crosslinker to react with. Lu et al. (2010) elucidated structures of formaldehyde-
induced crosslinks of four amino acids with three nucleotides, in which the Lys-dG
crosslink gave the highest yield. A closer inspection of the LZD protein sequences
(see Appendix 2.4) showed that our protein have a lot of lysines, but none are in
the vicinity of the DNA binding region that makes crucial contacts with the DNA.
We believe that the lack of nucleophilic amino acid residues in the DNA binding
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domain is the main cause of the failure of our PCC experiments.
4.5 Conclusions
Results from both in vivo and in vitro PCC experiments showed that we
have optimized crosslinking conditions that would give decent restriction enzyme
and ligase activities. Given our current protocol, it seems that trace amounts of
formaldehyde in our templates have considerably lowered the efficiency of digestion
and religation, which affects the specific ligation product yields. Therefore, the
crosslinking and template harvest methods have to be modified further to improve
final product yields.
An important requirement for a successful 3C assay lies in the ability of the
protein being studied to form specific crosslinks with its DNA binding site. However,
the LZD protein sequences showed two lysine residues in the DNA binding domains,
but neither of them are close enough to make crucial contacts with the DNA. In
order to move the project forward, we need to generate DNA-crosslinkable LZD
proteins. We have addressed this challenge by identifying four amino acids in the
DNA binding domains, and mutating them into lysines. This will be discussed in
more detail in the next chapter.
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Chapter 5: Improving protein design
5.1 Objectives
Our initial reporter gene assay results indicate that 4har and lzee are fairly
good repressors, but not efficient looping proteins on operators spaced 85.5 base
pairs apart. Increasing the distance to 300-1150 failed to show that these proteins
can loop DNA. There is a possibility that the C-terminal four helix bundle region
does not form stably upon tetramerization, which would explain the non-formation
of DNA loops with these proteins. Thus, the first part of this chapter discusses the
initial attempt to improve the design to the LZT proteins, by designing a protein
library and screening for mutants that can form more stable C-terminal four helix
bundles and repress the reporter protein expression in our specialized E. coli strains.
The failure of the PCC mainly stems from the initial requirement that the
protein being studied should be able to make crosslinks to DNA. Unfortunately, all
our proteins don’t have lysine residues located in the vicinity of their DNA binding
sites that can make the crosslinks with DNA contacts. In the second part of this
chapter, we discuss the lengths we went through in generating lysine mutants and
selecting for better DNA crosslinkers, with the main goal of generating a version
of the LZD proteins that can crosslink each end of the protein to its respective
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GCN4 binding site. We hope that these crosslinkable proteins would work better in
capturing in vitro and in vivo DNA loops by PCC.
5.2 Rationale
De novo protein design relies on the premise that the resulting protein folds
into a structure that buries hydrophobic residues into the core of the protein and
exposes the hydrophilic residues to the polar solvent. Moreover, there is a network
of secondary structures usually stabilized by hydrogen bonds that keeps the protein
folded. With these in mind, one can design a particular secondary structure by
choosing alternating polar and nonpolar amino acid sequences with a periodicity
that matches the desired secondary structure (Kamtekar, Schiffer, Xiong, Babik,
& Hecht, 1993). In the case of an alpha-helical protein, the pattern of polar and
nonpolar amino acids should be close to the 3.6-residue repeat. Given this pattern,
a coiled-coil motif can be generated if the first and fourth amino acids in the heptad
repeat would either be a nonpolar amino acid (usually valine or leucine), and the
rest are polar residues.
The LZT protein design incorporates both parallel coiled-coil and the antipar-
allel four helix bundle motifs. In order to transition from one fold into another while
maintaining alpha helical registry, linker sequences are designed to allow the parallel
alpha helices to open up a little bit to allow the kitty positioning of the antiparallel
alpha helices. Thus, we designed the LZT library by optimizing sequence patterns













N-terminal tag DBD LZIP LacI
V   E   E   L   L   S   K   V
GTT GAG GAG CTG CTG TCC AAA GTA
n   p   p   n   x   p   x   n
GTN VAN VAN NTN NNN VAN NNN NTN
lzee linker sequence
lzee library linker sequence
Figure 5.1: Strategy for designing the LZT protein library, based on the binary pat-
terning of amino acid sequences (Kamtekar et al., 1993). We used lzee as the protein
template to build the library on. To allow seamless transition into the antiparallel
coiled-coils, nonspecific amino acids (x) are placed in the e and g positions of the
heptad repeat. protein sequences: n – nonpolar; p – polar; x – any amino acid.
DNA sequences: V – A, G or C; N – A, G, C, or T
The challenge in generating DNA-crosslinkable proteins is to pick residues that
can make formaldehyde adducts with DNA without disrupting the existing network
of bonds between the protein and the its DNA binding site. In order to do this,
we first identified amino acids in the DNA binding domain of the LZD proteins by
picking out residues in the crystal structure of the GCN4 bZip domain (PDB file
1DGC) that are within 2 – 3 Å from the 6-amino group of adenine or 2-amino group
of guanine.
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Figure 5.2: Two views of the LZD87 mutants, highlighting the locations of the amino
acids mutated into lysine residues. red spheres: T6K, blue spheres: A8K, orange
spheres: A9K, yellow spheres: R13K. The images were generated using PyMOL,
using PDB file 2DGC as template.
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Each of the these amino acids are then mutated into lysine, with the idea that
lysine would be in close proximity to these bases to be crosslinked with formalde-
hyde. The same amino acids in the C-terminal DNA binding domain are mutated,
which would generate our first set of LZD single mutants. Then, each of the single
mutants would be tested for its crosslinking ability; once we have identified better
crosslinkers from each end of the protein, then we can generate a double mutant
that can crosslink DNA from both ends of the protein.
5.3 Materials and Methods
Oligonucleotides used for cloning were purchased from IDT, while molecular
biology reagents and enzymes were purchased from NEB. All other reagents were
purchased from Fisher Scientific, Sigma, and USB Corporation. PCR was done on
either Eppendorf Mastercycler or MJ Research PTC-200 thermal cycler. Protein
purifications were done on the ÅKTA FPLC instrument (Amersham Biosciences),
attached with a 1-mL prepacked HisTrap HP (GE Healthcare) column previously
charged with 0.2 M cobalt acetate.
5.3.1 Generating the LZT protein library
The parent plasmid for cloning in the LZT library was prepared as follows:
Mutagenesis PCRs were done on lacUV5-lzee/pGEX6P1 plasmid using the primer
pairs that (1) introduced an upstream SpeI site in the linker region, and (2) that










The first reaction generated a 203 bp product, while the second reaction gave
a 121 bp product. Each PCR product was purified using the PCR Purification Kit
(Thermo Scientific), and then mixed together for mutually primed synthesis of the
complete lzee gene insert that contains both SpeI and MfeI sites in the linker region
(274 bp). The resulting product was digested with BamHI and EcoRI and cloned
into the BamHI – EcoRI digest of lacUV5-pGEX6P1 plasmid. The recombinant
plasmid was then transformed into XL1-Blue cells and plated onto LB amp selection
plates. Correct transformants were identified by SpeI or MfeI digestion and DNA
sequencing. This plasmid was then identified as lacUV5-lzeeV2/pGEX6P1.
To generate the LZT library, the following overlapping oligonucleotides were






The resulting Klenow product was digested with SpeI and MfeI, and the 50-bp
digestion product was isolated by native PAGE and worked up by phenol/chloroform
extraction and ethanol precipitation. The library was then cloned into the SpeI
– MfeI digest of lacUV5-lzeeV2/pGEX6P1. The ligation product is purified and
worked up by phenol/chloroform extraction and ethanol precipitation.
As a positive control for library insertion, the following oligonucleotide was
substituted for LZEElib-SpeI-v2 in the first step: LZEElibctrl-SpeI 5’-CTGAAAAA
ACTAGTTGAGGAGCTCCTGTCCAAGCTTCGTGCTCTGGCT-3’. Successful
insertion of this sequence into the plasmid is verified by SacI or HindIII digestion.
5.3.2 Generating the LZD87 lysine mutants
The single mutants on the N-terminal DNA binding domains were generated
by site-directed mutagenesis PCR using LZD87/pRSETA as the plasmid template
and the following phosphorylated primers:












On the other hand, the single mutants on the C-terminal DNA binding do-
mains were made similarly using the following phosphorylated primers:











The ends of the resulting linear mutated plasmid products were blunt ligated
together and cloned into XL1-Blue cells for plasmid propagation. Correct transfor-
mants were identified by DNA sequencing.
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5.3.3 In vivo crosslinking assays on LZD87 single mutants
In vivo crosslinking for the LZD87 mutants was done similarly to the crosslink-
ing method for PCC, with a few modifications. BL21-AI cells were transformed with
plasmids containing the GCN4 binding sites (IC-450) and the expression plasmid for
the LZD87 single mutants. The resulting transformants were plated on LB selection
plates containing amp, kan and cam. Surviving colonies were then grown in liquid
cultures and the LZD proteins were induced with 0.2 % arabinose for 15 hours at
37 ◦C with agitation. The cells were harvested and resuspended in 1x PBS buffer
± 1 % formaldehyde. The crosslinking step was done at 37 ◦C for 10 minutes, after
which, the reactions were quenched with 350 mM glycine. The crosslinked cells
were washed once with 1x PBS to remove residual formaldehyde, and then lysed
with BugBuster R© reagent in Native Binding Buffer (10 mM MES pH 6, 500 mM
NaCl, 20 mM imidazole) at ambient temperature for 20 minutes. The crosslinked
His-tagged proteins were isolated from the lysate using batch purification with Ni
Sepharose FF beads (GE Healthcare). The crosslinks were removed from the su-
pernatant after mixing with the affinity beads and the initial eluate by incubating
the samples at 70 ◦C for at least 8 hours. prior to DNA workup using the PCR
purification kit. Finally, the worked up samples were analyzed for IC-450 yields
using PCR.
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5.4 Results and Discussion
5.4.1 Screening the LZT library for better repressors
We used the in vivo repression assay coupled with a colorimetric screen in
Chapter 3 to look for better repressors in the LZT library. First, the ligation mixture
generated in Section 5.3.1 was transformed into FW102/CW-237.5, a reporter strain
containing a distal CREB and a proximal wild-type GCN4 site 237.5 bp apart.
The transformants are then plated onto tetrazolium-glucose and tetrazolium-lactose
plates containing amp, kan, and strep. Pink colonies from both colorimetric plates
were then selected for the repression assays.
Repression assay results on selected library transformants showed that no
transformant stood out in terms of its ability to significantly repress the reporter
protein (see Figure 5.3). The result for transformant MP73-33 (top plot) was even-
tually ruled out as an outlier when the assay was repeated (middle plot). Moreover,
sequencing results for MP73-33 showed a truncated sequence that only included the
bZip sequence. From the transformants that were analyzed, we verified the gene
insert sequences for eight of them. Three of them showed the complete sequence
that matches the intended amino acid pattern (MP113-1, MP113-5, MP113-7), two
transformants did not clone in the library insert but got translated up to the four-
helix bundle sequence (MP95-15, MP95-25), two had truncated sequences (MP73-33
and MP73-49), and one had a doubly-inserted library sequence (MP113-10).
There are two possible outcomes for the transformants growing on tetra-lac
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Figure 5.3: Screening the LZT library for better repressors. Transformants MP113-
9 and MP113-10 were selected from tetrazolium lactose plates, while the rest were
selected from tetrazolium glucose. None of the transformants analyzed showed sig-
nificant repression of the reporter protein.
131
plates. If the mutant is a very efficient repressor as lzee, it will not grow in tetra-lac
media. Otherwise, it will either be white or pink. Given the proposed recombination
events discussed in Chapter 3.4.8 (page 80), it looks that what we are actually
analyzing in the repression assays are the weak repressors.
5.4.2 In vivo crosslinking results
Next, we tested four of the LZD87 single mutants in their ability to crosslink
DNA in vivo. Figure 5.4 shows that all of the LZD87 single mutants but T6K-
LZD87 analyzed seem to have good expression amounts. PCR results from both the
supernatants post-mixing with the affinity beads and the eluates showed comparable
yields of IC-450 plasmid (see Figures 5.5 and 5.6). This could mean two things: (1)
the template concentrations have not been optimized to linear amounts, and (2) the
LZD87 mutant may not have crosslinked successfully to the DNA.
At this point, we could have proceeded to quantifying the plasmid yields by
qPCR, but we decided to do the crosslinking in vitro and see if we could get clearer
results.
5.4.3 In vitro crosslinking results
In the previous chapter, we have observed that formaldehyde had significantly
affected the restriction enzyme and ligation activities in our PCC experiments.
Thus, we first tested several methods of quenching and removing residual formalde-















































































































































Figure 5.4: Protein expression on LZD87 single mutants. SDS-PAGE of crude
lysates of BL21-AI transformed with LZD87/pRSETA plasmids, 15 hours post-
induction 0.2 % arabinose. Results showed good expression levels on all LZD87
single mutants.
excess formaldehyde in our in vitro PCC samples. Figure 5.7 showed that removing
formaldehyde by isopropanol precipitation was indeed more efficient than simple
quenching of the excess formaldehyde with glycine, Tris or the restriction enzyme
buffer.
Then, we adapted a ChIP-like method to demonstrate a quick and simple
way for the LZD87 mutants to crosslink DNA in vitro. Crosslinking the protein to
the plasmid DNA coupled with a purification step to isolate the His-tagged protein
allows us to concentrate the amount of DNA that is actually bound to the protein.
This way, we are certain that subsequent enzymatic treatments (i.e. digestion and
religation for PCC) are done on samples that may be forming DNA loops.
A binding reaction containing 5 nM IC-450 plasmid and 25 nM purified LZD87
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Figure 5.5: Plasmid yields from batch purification of crosslinked protein-DNA com-
plexes. Agarose gel electrophoresis of PCR products from reverse-crosslinked and
worked up initial supernatants from batch purification of His-tagged LZD87 in BL21-
AI, using primers that amplify the GCN4 sites in IC-450 (799 bp PCR product) and
the gene inserts in the recombinant pRSET plasmids (554 bp PCR product).
mutant was prepared in H/L buffer (20 mM HEPES pH 7.7, 2 mM Na2(ATP), 0.2
% glycerol, 0.01 % IGEPAL, 4 mM MgCl2, 10 mM DTT, 100 µg/mL BSA) and
incubate at ambient temperature for 30 minutes. Then, the solution was crosslinked
with 0.1 % formaldehyde at 37 ◦C for 10 minutes. The complexes were isolated by
isopropanol precipitation, and resuspended in restriction enzyme buffer containing
the restriction enzyme. We used ApoI as the restriction buffer (IC-450 plasmid has 9
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Figure 5.6: Plasmid yields from batch purification of crosslinked protein-DNA com-
plexes. Agarose gel electrophoresis of PCR products from reverse-crosslinked and
worked up initial eluates from batch purification of His-tagged LZD87 in BL21-AI,
using primers that amplify the GCN4 sites in IC-450 (799 PCR product) and the
gene inserts in the recombinant pRSET plasmids (554 bp PCR product).
ApoI cut sites, with a 272-bp fragment containing CREB site, and a 732-bp fragment
containing the INV2 site). The mixture was digested for 1 hour, and the digestion
products were subsequently labeled with α32P ATP. The labeled samples were then
diluted in Native Binding Buffer and passed through His SpinTrap columns to isolate
His-tagged proteins, which may or may not be attached to the DNA. Radioactivities

















Figure 5.7: Comparing various methods of removing formaldehyde in crosslinked
DNA. Native PAGE of ApoI digestion products of IC-450 ± CH2O. 2.5 nM IC-450
plasmid was incubated in H/L buffer ± 0.1 % formaldehyde at 37 ◦C for 10 minutes.
Crosslinked samples were quenched in the stop solutions at 37 ◦C for 1 hour before
digesting with ApoI (0.1 U/µL). Mock – IC-450 was only added after the quenching
step.
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and the samples were analysed by SDS-PAGE.
SDS-PAGE analysis showed most of the ApoI digestion products ended up
in the initial flowthrough, which indicated that most of the DNA was not bound
and/or crosslinked to the protein (see Figure 5.8). However, no bands were detected
in the initial eluates (gel picture not shown), which showed that none of the LZD
mutants tested so far can crosslink to its DNA binding site. It is possible that the
formaldehyde may not be an efficient crosslinker in our system.
Finally, we repeated the experiment on the LZD87 double mutants with UV
crosslinking using a 254 nm UV light with a 120000 µJ/cm2 energy output. SDS-
PAGE analysis of all batch purification samples showed similar results as that of
the formaldehyde crosslinking experiment.
5.5 Conclusion
Based on the results presented, we have not identified a better LZT repressor
(or possibly a better looping protein), nor we have seen clear evidence of DNA
crosslinking in any of the LZD87 mutants that we have tested.
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Figure 5.8: Phosphorimage of ApoI digestion products of formaldehyde-crosslinked
IC-450 ± LZD87 mutants after batch purification, initial supernatants. Bands were
visualized in 10 % (40:1) polyacrylamide gel in Tris-glycine-SDS buffer.
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Figure 5.9: Phosphorimage of ApoI digestion products of UV-crosslinked IC-450
± LZD87 mutants after batch purification. Bands were visualized in 10 % (40:1)
polyacrylamide gel in Tris-glycine-SDS buffer.
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Chapter 6: Conclusions and Future Directions
In Chapter 2, we have demonstrated that none of the tetrameric DNA binding
proteins can form a protein-DNA sandwich complex, which is a necessary precursor
to illustrate DNA looping. In Chapter 3, we have seen relatively weak coopera-
tive repression in reporter strains containing high-affinity GCN4 operators >300
bp apart upon dose-dependent expression of lzee and LZD87, although there is no
clear evidence whether the repression is due to DNA looping. Moreover, we have
also seen host either cell toxicity or significantly low expression of reporter protein
upon induction of lzee and LZD87. In Chapter 4, we have seen a weak interaction
between DNA loci containing GCN4 sites spaced 450 bp, and possibly 900 bp, apart
in the presence of LZD73. Finally, in Chapter 5, we were not successful in selecting
a better LZT repressor, or have showed that one of the LZD87 mutants can make
crosslinks to the DNA.
What have we learned from all these experiments? One thing stands out –
it is more difficult than initially thought to make DNA loops in vivo using very
small and relatively rigid DNA looping proteins. On one hand, it is possible that in
forming small loops, the energy cost in bending the intervening DNA to conform to
the relatively inflexible looping protein is too great such that it is energetically more
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favorable for the host cell to inactivate either the protein, by introducing mutations
to the expression plasmid, or the reporter gene. On the other hand, in large loop
formation, partially unwinding the supercoiled DNA, or to bending the looping
protein in order to wedge itself within the supercoiled DNA, so as to accommodate
binding to two operators with the correct spatial orientation may also be too large.
The results presented here support the thermodynamic model that DNA flexibility
plays a more passive role in in vivo DNA loop formation.
6.1 Characterization experiments on the LZD proteins
We can still evaluate the in vivo looping efficiency of the LZD proteins us-
ing our repression assay, given the following modifications. First, using the pGEX
plasmids as the expression plasmids for our repression assay was rife with problems.
Using expression plasmids designed for protein overexpression are not suitable for
looping assays where the desired response should be sensitive to increased local con-
centration of the protein at the primary operator via cooperativity at a distance,
and not by protein saturation at the primary site. At the same time, having too
many homologous sequences between the expression plasmid and the F’ episome,
which would most likely result to different recombination events, would complicate
our analysis. Thus, we suggest to clone the LZD genes into the expression plasmid
Whipple developed to complement the reporter strains in his genetic assay.
Second, we can further optimize the combination of weak proximal and strong
distal operators in our looping strains, specifically for characterizing the LZD pro-
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teins. By design, the N-terminal end of the protein binds with high affinity to
CREB, while the C-terminal end binds very well to INV2. However, we could not
tell for sure which end of the protein actually binds to which operator during the
repression assay. Alternatively, we can optimize amino acid sequences in the DNA
binding domains of LZD proteins to engineer ends with low or high binding affinities
to the operators.
Third, we can introduce a single flexible hinge in the extended LZIP region
in the LZD proteins by introducing prolines or glycines. These amino acid residues
are known to break protein secondary structures due to steric hindrance of the side
chain or high conformational flexibility, respectively. This would allow some degree
of protein flexibility, which may be able to stabilize smaller DNA loops in vivo. If the
new proteins can stabilize smaller loops than those of the LZD proteins, this would
further support the thermodynamic model that looping protein flexibility drives in
vivo DNA looping.
6.2 Modifications on the LZT protein library
From a design standpoint, switching from a parallel coiled-coil to an antipar-
allel four helix bundle requires opening up the C-terminal end of the coiled-coil to
accommodate the alpha helices from the other coiled-coil. A simple adjustment to
the protein library sequence is to introduce one or two glycine residues in the hep-
tad linker sequence. This would introduce breaks in the parallel coiled-coils, which
would aid in the correct folding of the four helix bundle at the C-terminal ends.
142
However, this might introduce some degree of flexibility to the whole protein, which
may contribute to the overall stability of DNA loops.
The protein library can then be probed using the repression assay as currently
designed, to select for better looping proteins. The selected mutants can then be
expressed in large-scale quantities and characterized further by ultracentrifugation
techniques to verify if they can form tetramers in solution.
6.3 Conclusions
We have utilized and optimized several molecular tools in characterizing the
in vitro and in vivo looping abilities of artificially designed DNA binding proteins.
The failure of the LZD proteins to stabilize in vivo DNA loops further supports the
idea that inherent protein flexibility is a necessary requirement in the formation of
DNA loops. The inability of the putatively tetrameric lzee protein to form in vitro
sandwich complexes with DNA, yet functions as a highly effective repressor protein
that triggers host cell toxicity or permanent repression, can be utilized in designing
other genetic assays that detect recombination, which could be a consequence of
DNA looping. This work embodies an additional step in developing an arsenal of
tools, not just in understanding the thermodynamics of DNA loop formation, but
also provide us tools to be used to modulate in vivo gene expression at will.
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Appendix 1: Growth Media and Selection Plates for Microbiology Work
1.1 General Directions
• Use autoclaved glasswares or sterile containers for storing solutions and media.
• Filter all solutions through a 0.2-micron filter, or autoclave at 121 ◦C for at
least 20 minutes. Cool autoclaved growth media to ∼55 ◦C before mixing in
the antibiotics.
• Store solutions at room temperature, growth media and agar plates at 4 ◦C.
1.2 Solutions
• 1 M MgCl2, 50 mL (store in 10-mL aliquots)
• 1 M MgSO4, 50 mL (store in 10-mL aliquots)
• 2 M glucose, 50 mL (store in 10-mL aliquots)
• glycerol, 50 mL (autoclave for 20 minutes)
1.3 Growth Media
1. Luria-Bertani (LB): 1% tryptone, 0.5% yeast extract, 1% NaCl
Dissolve 10 g tryptone, 5 g yeast extract, and 10 g NaCl in deionized water to
make 1 L solution.
(a) LBAG (for preparing glycerol stock solutions, and working cultures of
pGEX-transformed BL21 cells): LB + 100 µg/mL amp, 20 mM glucose
Add 1 mL 100 mg/mL ampicillin and 10 mL 2 M glucose per 1 L auto-
claved LB media.
(b) LB amp tet (for preparing plasmid midipreps, minipreps or glycerol stock
solutions of XL1-Blue cells transformed with pGEX or pRSET): LB +
100 µg/mL amp, 30 µg/mL tet
Add 1 mL each of 100 mg/mL ampicillin and 30 mg/mL tetracycline per
1 L autoclaved LB media
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(c) LB kan cam tet (for preparing plasmid midipreps, minipreps or glycerol
stock solutions of XL1-Blue cells transformed with promoter-operator
constructs): LB + 50 µg/mL kan, 50 µg/mL cam, 30 µg/mL tet
Add 1 mL each 50 mg/mL kanamycin, 50 mg/mL chloramphenicol and
30 mg/mL tetracycline per 1 L autoclaved LB media
(d) LB kan strep (for preparing working cultures of reporter strains contain-
ing intact lacZYA in the F’ episome): LB + 50 µg/mL kan, 100 µg/ml
strep
Add 1 mL each 50 mg/mL kanamycin, and 100 mg/mL streptomycin per
1 L autoclaved LB media
(e) LB amp kan strep (for preparing working cultures of reporter strains
containing pGEX (or pBAD)): LB + 100 µg/mL amp, 50 µg/mL kan,
100 µg/ml strep
Add 1 mL each 100 mg/mL ampicillin, 50 mg/mL kanamycin, and 100
mg/mL streptomycin per 1 L autoclaved LB media
2. SOB: 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2, 10 mM MgSO4
Dissolve 20 g tryptone, 5 g yeast extract, g NaCl, g KCl in deionized water
to make 1 L solution. Add 10 mL each of 1 M MgCl2 and MgSO4 per 1 L
autoclaved media just before using.
3. SOC (for cell transformations, should be freshly prepared): SOB + 20 mM
glucose
Add 10 mL 2 M glucose per 1 L autoclaved SOB media
4. 2X YTA: 1.6% tryptone, 1% yeast extract, 0.5% NaCl, 100 µg/mL amp
Dissolve 16 g tryptone, 10 g yeast extract, and 5 g NaCl in deionized water to
make 1 L solution. Add 1 mL 100 mg/mL ampicillin to autoclaved media.
1.4 Agar Plates
• Add 15 g agar per 1 L growth media before autoclaving.
• Keep the working area clean and sterile by working near a bunsen burner.
• Cool down media to 55 ◦C before mixing in the antibiotics. Pipet 20 mL per
sterile Petri dish. Let the solution set at room temperature before storing the
plates upside down, wrapped in aluminum foil.
1. LBAG – for selecting BL21 cells containing intact pGEX after cell transfor-
mation
2. LB amp tet – for selecting XL1-Blue cells containing either intact pGEX,
pRSET, or pBAD after cell transformation
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3. LB kan cam tet X-gal (or Bluo-Gal) ± IPTG (or arabinose) – for select-
ing XL1-Blue cells containing intact promoter-operator constructs after cell
transformation
4. LB kan strep X-gal (or Bluo-gal) ± IPTG (or arabinose) – for selecting reporter
strains containing intact lacZYA in the F’ episome
5. LB amp kan strep X-gal (or Bluo-gal) ± IPTG (or arabinose) – for selecting
reporter strains containing pGEX (or pBAD) after cell transformation
6. MacConkey: 1.7% pancreatic digest of gelatin, 0.3% peptones (meat and ca-
sein), 1% lactose, 0.15% bile salts #3, 0.5% NaCl, 1.35% agar, 0.003% neutral
red, 0.0001% crystal violet
Dissolve 50 g MacConkey powder mix in deionized water to make 1 L solution.
Boil for 1 minute to completely dissolve the powder before autoclaving. Mix in
the required antibiotics after the solution has been autoclaved and cooled to
55 ◦C before pouring into Petri dishes.
7. Tetrazolium: Antibiotic Medium 2 (0.15% beef extract, 0.3% yeast extract,
0.6% peptone, 1.5% agar), 0.005% tetrazolium chloride
Dissolve 25.5 g Antibiotic Medium 2 powder mix and 50 mg 2,3,5-triphenyl-
2H-tetrazolium chloride in deionized water to make 1 L solution. Boil for 1
minute to completely dissolve the mixture before autoclaving. Mix in 50 mL
20% glucose, 50 mL 20% lactose, or 10 mL 20% arabinose, and the required
antibiotics after the solution has been autoclaved and cooled to 55 ◦C before
pouring into Petri dishes.
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Appendix 2: Relevant DNA and Protein Sequences
2.1 Expression plasmids
• [pRSETA - 2897 bp] pRSETA complete sequence
highlighted in green: BamHI and EcoRI sites
1 GATCTCGATC CCGCGAAATT AATACGACTC ACTATAGGGA GACCACAACG
51 GTTTCCCTCT AGAAATAATT TTGTTTAACT TTAAGAAGGA GATATACATA
101 TGCGGGGTTC TCATCATCAT CATCATCATG GTATGGCTAG CATGACTGGT
151 GGACAGCAAA TGGGTCGGGA TCTGTACGAC GATGACGATA AGGATCGATG
201 GGGATCCGAG CTCGAGATCT GCAGCTGGTA CCATGGAATT CGAAGCTTGA
251 TCCGGCTGCT AACAAAGCCC GAAAGGAAGC TGAGTTGGCT GCTGCCACCG
301 CTGAGCAATA ACTAGCATAA CCCCTTGGGG CCTCTAAACG GGTCTTGAGG
351 GGTTTTTTGC TGAAAGGAGG AACTATATCC GGATCTGGCG TAATAGCGAA
401 GAGGCCCGCA CCGATCGCCC TTCCCAACAG TTGCGCAGCC TGAATGGCGA
451 ATGGGACGCG CCCTGTAGCG GCGCATTAAG CGCGGCGGGT GTGGTGGTTA
501 CGCGCAGCGT GACCGCTACA CTTGCCAGCG CCCTAGCGCC CGCTCCTTTC
551 GCTTTCTTCC CTTCCTTTCT CGCCACGTTC GCCGGCTTTC CCCGTCAAGC
601 TCTAAATCGG GGGCTCCCTT TAGGGTTCCG ATTTAGTGCT TTACGGCACC
651 TCGACCCCAA AAAACTTGAT TAGGGTGATG GTTCACGTAG TGGGCCATCG
701 CCCTGATAGA CGGTTTTTCG CCCTTTGACG TTGGAGTCCA CGTTCTTTAA
751 TAGTGGACTC TTGTTCCAAA CTGGAACAAC ACTCAACCCT ATCTCGGTCT
801 ATTCTTTTGA TTTATAAGGG ATTTTGCCGA TTTCGGCCTA TTGGTTAAAA
851 AATGAGCTGA TTTAACAAAA ATTTAACGCG AATTTTAACA AAATATTAAC
901 GCTTACAATT TAGGTGGCAC TTTTCGGGGA AATGTGCGCG GAACCCCTAT
951 TTGTTTATTT TTCTAAATAC ATTCAAATAT GTATCCGCTC ATGAGACAAT
1001 AACCCTGATA AATGCTTCAA TAATATTGAA AAAGGAAGAG TATGAGTATT
1051 CAACATTTCC GTGTCGCCCT TATTCCCTTT TTTGCGGCAT TTTGCCTTCC
1101 TGTTTTTGCT CACCCAGAAA CGCTGGTGAA AGTAAAAGAT GCTGAAGATC
1151 AGTTGGGTGC ACGAGTGGGT TACATCGAAC TGGATCTCAA CAGCGGTAAG
1201 ATCCTTGAGA GTTTTCGCCC CGAAGAACGT TTTCCAATGA TGAGCACTTT
1251 TAAAGTTCTG CTATGTGGCG CGGTATTATC CCGTATTGAC GCCGGGCAAG
1301 AGCAACTCGG TCGCCGCATA CACTATTCTC AGAATGACTT GGTTGAGTAC
1351 TCACCAGTCA CAGAAAAGCA TCTTACGGAT GGCATGACAG TAAGAGAATT
1401 ATGCAGTGCT GCCATAACCA TGAGTGATAA CACTGCGGCC AACTTACTTC
1451 TGACAACGAT CGGAGGACCG AAGGAGCTAA CCGCTTTTTT GCACAACATG
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1501 GGGGATCATG TAACTCGCCT TGATCGTTGG GAACCGGAGC TGAATGAAGC
1551 CATACCAAAC GACGAGCGTG ACACCACGAT GCCTGTAGCA ATGGCAACAA
1601 CGTTGCGCAA ACTATTAACT GGCGAACTAC TTACTCTAGC TTCCCGGCAA
1651 CAATTAATAG ACTGGATGGA GGCGGATAAA GTTGCAGGAC CACTTCTGCG
1701 CTCGGCCCTT CCGGCTGGCT GGTTTATTGC TGATAAATCT GGAGCCGGTG
1751 AGCGTGGGTC TCGCGGTATC ATTGCAGCAC TGGGGCCAGA TGGTAAGCCC
1801 TCCCGTATCG TAGTTATCTA CACGACGGGG AGTCAGGCAA CTATGGATGA
1851 ACGAAATAGA CAGATCGCTG AGATAGGTGC CTCACTGATT AAGCATTGGT
1901 AACTGTCAGA CCAAGTTTAC TCATATATAC TTTAGATTGA TTTAAAACTT
1951 CATTTTTAAT TTAAAAGGAT CTAGGTGAAG ATCCTTTTTG ATAATCTCAT
2001 GACCAAAATC CCTTAACGTG AGTTTTCGTT CCACTGAGCG TCAGACCCCG
2051 TAGAAAAGAT CAAAGGATCT TCTTGAGATC CTTTTTTTCT GCGCGTAATC
2101 TGCTGCTTGC AAACAAAAAA ACCACCGCTA CCAGCGGTGG TTTGTTTGCC
2151 GGATCAAGAG CTACCAACTC TTTTTCCGAA GGTAACTGGC TTCAGCAGAG
2201 CGCAGATACC AAATACTGTT CTTCTAGTGT AGCCGTAGTT AGGCCACCAC
2251 TTCAAGAACT CTGTAGCACC GCCTACATAC CTCGCTCTGC TAATCCTGTT
2301 ACCAGTGGCT GCTGCCAGTG GCGATAAGTC GTGTCTTACC GGGTTGGACT
2351 CAAGACGATA GTTACCGGAT AAGGCGCAGC GGTCGGGCTG AACGGGGGGT
2401 TCGTGCACAC AGCCCAGCTT GGAGCGAACG ACCTACACCG AACTGAGATA
2451 CCTACAGCGT GAGCTATGAG AAAGCGCCAC GCTTCCCGAA GGGAGAAAGG
2501 CGGACAGGTA TCCGGTAAGC GGCAGGGTCG GAACAGGAGA GCGCACGAGG
2551 GAGCTTCCAG GGGGAAACGC CTGGTATCTT TATAGTCCTG TCGGGTTTCG
2601 CCACCTCTGA CTTGAGCGTC GATTTTTGTG ATGCTCGTCA GGGGGGCGGA
2651 GCCTATGGAA AAACGCCAGC AACGCGGCCT TTTTACGGTT CCTGGCCTTT
2701 TGCTGGCCTT TTGCTCACAT GTTCTTTCCT GCGTTATCCC CTGATTCTGT
2751 GGATAACCGT ATTACCGCCT TTGAGTGAGC TGATACCGCT CGCCGCAGCC
2801 GAACGACCGA GCGCAGCGAG TCAGTGAGCG AGGAAGCGGA AGAGCGCCCA
2851 ATACGCAAAC CGCCTCTCCC CGCGCGTTGG CCGATTCATT AATGCAG
• [pFastBac1 - 4776 bp] pFastBac1 complete sequence
highlighted in green: SacI and HindIII sites
1 GACGCGCCCT GTAGCGGCGC ATTAAGCGCG GCGGGTGTGG TGGTTACGCG
51 CAGCGTGACC GCTACACTTG CCAGCGCCCT AGCGCCCGCT CCTTTCGCTT
101 TCTTCCCTTC CTTTCTCGCC ACGTTCGCCG GCTTTCCCCG TCAAGCTCTA
151 AATCGGGGGC TCCCTTTAGG GTTCCGATTT AGTGCTTTAC GGCACCTCGA
201 CCCCAAAAAA CTTGATTAGG GTGATGGTTC ACGTAGTGGG CCATCGCCCT
251 GATAGACGGT TTTTCGCCCT TTGACGTTGG AGTCCACGTT CTTTAATAGT
301 GGACTCTTGT TCCAAACTGG AACAACACTC AACCCTATCT CGGTCTATTC
351 TTTTGATTTA TAAGGGATTT TGCCGATTTC GGCCTATTGG TTAAAAAATG
401 AGCTGATTTA ACAAAAATTT AACGCGAATT TTAACAAAAT ATTAACGTTT
451 ACAATTTCAG GTGGCACTTT TCGGGGAAAT GTGCGCGGAA CCCCTATTTG
501 TTTATTTTTC TAAATACATT CAAATATGTA TCCGCTCATG AGACAATAAC
551 CCTGATAAAT GCTTCAATAA TATTGAAAAA GGAAGAGTAT GAGTATTCAA
601 CATTTCCGTG TCGCCCTTAT TCCCTTTTTT GCGGCATTTT GCCTTCCTGT
651 TTTTGCTCAC CCAGAAACGC TGGTGAAAGT AAAAGATGCT GAAGATCAGT
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701 TGGGTGCACG AGTGGGTTAC ATCGAACTGG ATCTCAACAG CGGTAAGATC
751 CTTGAGAGTT TTCGCCCCGA AGAACGTTTT CCAATGATGA GCACTTTTAA
801 AGTTCTGCTA TGTGGCGCGG TATTATCCCG TATTGACGCC GGGCAAGAGC
851 AACTCGGTCG CCGCATACAC TATTCTCAGA ATGACTTGGT TGAGTACTCA
901 CCAGTCACAG AAAAGCATCT TACGGATGGC ATGACAGTAA GAGAATTATG
951 CAGTGCTGCC ATAACCATGA GTGATAACAC TGCGGCCAAC TTACTTCTGA
1001 CAACGATCGG AGGACCGAAG GAGCTAACCG CTTTTTTGCA CAACATGGGG
1051 GATCATGTAA CTCGCCTTGA TCGTTGGGAA CCGGAGCTGA ATGAAGCCAT
1101 ACCAAACGAC GAGCGTGACA CCACGATGCC TGTAGCAATG GCAACAACGT
1151 TGCGCAAACT ATTAACTGGC GAACTACTTA CTCTAGCTTC CCGGCAACAA
1201 TTAATAGACT GGATGGAGGC GGATAAAGTT GCAGGACCAC TTCTGCGCTC
1251 GGCCCTTCCG GCTGGCTGGT TTATTGCTGA TAAATCTGGA GCCGGTGAGC
1301 GTGGGTCTCG CGGTATCATT GCAGCACTGG GGCCAGATGG TAAGCCCTCC
1351 CGTATCGTAG TTATCTACAC GACGGGGAGT CAGGCAACTA TGGATGAACG
1401 AAATAGACAG ATCGCTGAGA TAGGTGCCTC ACTGATTAAG CATTGGTAAC
1451 TGTCAGACCA AGTTTACTCA TATATACTTT AGATTGATTT AAAACTTCAT
1501 TTTTAATTTA AAAGGATCTA GGTGAAGATC CTTTTTGATA ATCTCATGAC
1551 CAAAATCCCT TAACGTGAGT TTTCGTTCCA CTGAGCGTCA GACCCCGTAG
1601 AAAAGATCAA AGGATCTTCT TGAGATCCTT TTTTTCTGCG CGTAATCTGC
1651 TGCTTGCAAA CAAAAAAACC ACCGCTACCA GCGGTGGTTT GTTTGCCGGA
1701 TCAAGAGCTA CCAACTCTTT TTCCGAAGGT AACTGGCTTC AGCAGAGCGC
1751 AGATACCAAA TACTGTCCTT CTAGTGTAGC CGTAGTTAGG CCACCACTTC
1801 AAGAACTCTG TAGCACCGCC TACATACCTC GCTCTGCTAA TCCTGTTACC
1851 AGTGGCTGCT GCCAGTGGCG ATAAGTCGTG TCTTACCGGG TTGGACTCAA
1901 GACGATAGTT ACCGGATAAG GCGCAGCGGT CGGGCTGAAC GGGGGGTTCG
1951 TGCACACAGC CCAGCTTGGA GCGAACGACC TACACCGAAC TGAGATACCT
2001 ACAGCGTGAG CATTGAGAAA GCGCCACGCT TCCCGAAGGG AGAAAGGCGG
2051 ACAGGTATCC GGTAAGCGGC AGGGTCGGAA CAGGAGAGCG CACGAGGGAG
2101 CTTCCAGGGG GAAACGCCTG GTATCTTTAT AGTCCTGTCG GGTTTCGCCA
2151 CCTCTGACTT GAGCGTCGAT TTTTGTGATG CTCGTCAGGG GGGCGGAGCC
2201 TATGGAAAAA CGCCAGCAAC GCGGCCTTTT TACGGTTCCT GGCCTTTTGC
2251 TGGCCTTTTG CTCACATGTT CTTTCCTGCG TTATCCCCTG ATTCTGTGGA
2301 TAACCGTATT ACCGCCTTTG AGTGAGCTGA TACCGCTCGC CGCAGCCGAA
2351 CGACCGAGCG CAGCGAGTCA GTGAGCGAGG AAGCGGAAGA GCGCCTGATG
2401 CGGTATTTTC TCCTTACGCA TCTGTGCGGT ATTTCACACC GCAGACCAGC
2451 CGCGTAACCT GGCAAAATCG GTTACGGTTG AGTAATAAAT GGATGCCCTG
2501 CGTAAGCGGG TGTGGGCGGA CAATAAAGTC TTAAACTGAA CAAAATAGAT
2551 CTAAACTATG ACAATAAAGT CTTAAACTAG ACAGAATAGT TGTAAACTGA
2601 AATCAGTCCA GTTATGCTGT GAAAAAGCAT ACTGGACTTT TGTTATGGCT
2651 AAAGCAAACT CTTCATTTTC TGAAGTGCAA ATTGCCCGTC GTATTAAAGA
2701 GGGGCGTGGC CAAGGGCATG GTAAAGACTA TATTCGCGGC GTTGTGACAA
2751 TTTACCGAAC AACTCCGCGG CCGGGAAGCC GATCTCGGCT TGAACGAATT
2801 GTTAGGTGGC GGTACTTGGG TCGATATCAA AGTGCATCAC TTCTTCCCGT
2851 ATGCCCAACT TTGTATAGAG AGCCACTGCG GGATCGTCAC CGTAATCTGC
2901 TTGCACGTAG ATCACATAAG CACCAAGCGC GTTGGCCTCA TGCTTGAGGA
149
2951 GATTGATGAG CGCGGTGGCA ATGCCCTGCC TCCGGTGCTC GCCGGAGACT
3001 GCGAGATCAT AGATATAGAT CTCACTACGC GGCTGCTCAA ACCTGGGCAG
3051 AACGTAAGCC GCGAGAGCGC CAACAACCGC TTCTTGGTCG AAGGCAGCAA
3101 GCGCGATGAA TGTCTTACTA CGGAGCAAGT TCCCGAGGTA ATCGGAGTCC
3151 GGCTGATGTT GGGAGTAGGT GGCTACGTCT CCGAACTCAC GACCGAAAAG
3201 ATCAAGAGCA GCCCGCATGG ATTTGACTTG GTCAGGGCCG AGCCTACATG
3251 TGCGAATGAT GCCCATACTT GAGCCACCTA ACTTTGTTTT AGGGCGACTG
3301 CCCTGCTGCG TAACATCGTT GCTGCTGCGT AACATCGTTG CTGCTCCATA
3351 ACATCAAACA TCGACCCACG GCGTAACGCG CTTGCTGCTT GGATGCCCGA
3401 GGCATAGACT GTACAAAAAA ACAGTCATAA CAAGCCATGA AAACCGCCAC
3451 TGCGCCGTTA CCACCGCTGC GTTCGGTCAA GGTTCTGGAC CAGTTGCGTG
3501 AGCGCATACG CTACTTGCAT TACAGTTTAC GAACCGAACA GGCTTATGTC
3551 AACTGGGTTC GTGCCTTCAT CCGTTTCCAC GGTGTGCGTC ACCCGGCAAC
3601 CTTGGGCAGC AGCGAAGTCG AGGCATTTCT GTCCTGGCTG GCGAACGAGC
3651 GCAAGGTTTC GGTCTCCACG CATCGTCAGG CATTGGCGGC CTTGCTGTTC
3701 TTCTACGGCA AGGTGCTGTG CACGGATCTG CCCTGGCTTC AGGAGATCGG
3751 AAGACCTCGG CCGTCGCGGC GCTTGCCGGT GGTGCTGACC CCGGATGAAG
3801 TGGTTCGCAT CCTCGGTTTT CTGGAAGGCG AGCATCGTTT GTTCGCCCAG
3851 GACTCTAGCT ATAGTTCTAG TGGTTGGCTA CGTATACTCC GGAATATTAA
3901 TAGATCATGG AGATAATTAA AATGATAACC ATCTCGCAAA TAAATAAGTA
3951 TTTTACTGTT TTCGTAACAG TTTTGTAATA AAAAAACCTA TAAATATTCC
4001 GGATTATTCA TACCGTCCCA CCATCGGGCG CGGATCCCGG TCCGAAGCGC
4051 GCGGAATTCA AAGGCCTACG TCGACGAGCT CACTAGTCGC GGCCGCTTTC
4101 GAATCTAGAG CCTGCAGTCT CGAGGCATGC GGTACCAAGC TTGTCGAGAA
4151 GTACTAGAGG ATCATAATCA GCCATACCAC ATTTGTAGAG GTTTTACTTG
4201 CTTTAAAAAA CCTCCCACAC CTCCCCCTGA ACCTGAAACA TAAAATGAAT
4251 GCAATTGTTG TTGTTAACTT GTTTATTGCA GCTTATAATG GTTACAAATA
4301 AAGCAATAGC ATCACAAATT TCACAAATAA AGCATTTTTT TCACTGCATT
4351 CTAGTTGTGG TTTGTCCAAA CTCATCAATG TATCTTATCA TGTCTGGATC
4401 TGATCACTGC TTGAGCCTAG GAGATCCGAA CCAGATAAGT GAAATCTAGT
4451 TCCAAACTAT TTTGTCATTT TTAATTTTCG TATTAGCTTA CGACGCTACA
4501 CCCAGTTCCC ATCTATTTTG TCACTCTTCC CTAAATAATC CTTAAAAACT
4551 CCATTTCCAC CCCTCCCAGT TCCCAACTAT TTTGTCCGCC CACAGCGGGG
4601 CATTTTTCTT CCTGTTATGT TTTTAATCAA ACATCCTGCC AACTCCATGT
4651 GACAAACCGT CATCTTCGGC TACTTTTTCT CTGTCACAGA ATGAAAATTT
4701 TTCTGTCATC TCTTCGTTAT TAATGTTTGT AATTGACTGA ATATCAACGC
4751 TTATTTGCAG CCTGAATGGC GAATGG
SacI-HindIII gene inserts for recombinant pFastBac1
– His-tagged 4har gene
4076 gagctcacaa cggtttccct ctagaaataa ttttgtttaa ctttaagaag
4126 gagatataca tatgcggggt tctCATCATC ATCATCATCA Tggtatggct
4176 agcatgactg gtggacagca aatgggtcgg gatctgtacg acgatgacga
4226 taaggatcga tggGGATCCG ACCCAGCGGC ACTGAAACGT GCACGCAACA
4276 CCGAAGCTGC ACGTCGTTCC CGTGCTCGTA AACTGCAGCG TATGAAACAA
150
4326 CTGGAAGACA AAGTTGAAGA GCTGCTGTCC AAGAACTACC ACCTGGAAAA
4376 CGAAGTTGCT CGTCTGAAAA AACTGGTTGC GCGCCTGGCG CGTCAAGTAC
4426 GTGCTCTGGC TGATTCTCTG ATGCAGCTGG CTCGCCAGGT TTCCCGTCTG
4476 GCAGACTCCC TGTAGTAGAA TTCGAAGCTT
– His-tagged 4hee gene
4076 GAGCTCACAA CGGTTTCCct ctagaaataa ttttgtttaa ctttaagaag
4126 gagatataca tatgcggggt tctCATCATC ATCATCATCA Tggtatggct
4176 agcatgactg gtggacagca aatgggtcgg gatctgtacg acgatgacga
4226 taaggatcga tggGGATCCG ACCCAGCGGC ACTGAAACGT GCACGCAACA
4276 CCGAAGCTGC ACGTCGTTCC CGTGCTCGTA AACTGCAGCG TATGAAACAA
4326 CTGGAAGACA AAGTTGAAGA GCTGCTGTCC AAGAACTACC ACCTGGAAAA
4376 CGAAGTTGCT CGTCTGAAAA AACTGGTTGA GGAGCTGGCG CGTCAAGTAC
4426 GTGCTCTGGC TGATTCTCTG ATGCAGCTGG CTCGCCAGGT TTCCCGTCTG
4476 GCAGACTCCC TGTAGTAGaa ttcgaAGCTT
– His-tagged lzar gene
4076 GAGCTCACAA CGGTTTCCct ctagaaataa ttttgtttaa ctttaagaag
4126 gagatataca tatgcggggt tctcatcatc atcatcatca tggtatggct
4176 agcatgactg gtggacagca aatgggtcgg gatctgtacg acgatgacga
4226 taaggatcga tggGGATCCG ACCCAGCGGC ACTGAAACGT GCACGCAACA
4276 CCGAAGCTGC ACGTCGTTCC CGTGCTCGTA AACTGCAGCG TATGAAACAA
4326 CTGGAAGACA AAGTTGAAGA GCTGCTGTCC AAGAACTACC ACCTGGAAAA
4376 CGAAGTTGCT CGTCTGAAAA AACTGGTTGC GCGCCTGAAG AAGCTGGTAC
4426 GTGCTCTGGC TGATTCTCTG ATGCAGCTGG CTCGCCAGGT TTCCCGTCTG
4476 GAATCCGGTC AGTAGTAGaa ttcgaagctt
– His-tagged lzee gene
4076 GAGCTCACAA CGGTTTCCct ctagaaataa ttttgtttaa ctttaagaag
4126 gagatataca tatgcggggt tctcatcatc atcatcatca tggtatggct
4176 agcatgactg gtggacagca aatgggtcgg gatctgtacg acgatgacga
4226 taaggatcga tggGGATCCG ACCCAGCGGC ACTGAAACGT GCACGCAACA
4276 CCGAAGCTGC ACGTCGTTCC CGTGCTCGTA AACTGCAGCG TATGAAACAA
4326 CTGGAAGACA AAGTTGAAGA GCTGCTGTCC AAGAACTACC ACCTGGAAAA
4376 CGAAGTTGCT CGTCTGAAAA AACTGGTTGA GGAGCTGCTG TCCAAAGTAC
4426 GTGCTCTGGC TGATTCTCTG ATGCAGCTGG CTCGCCAGGT TTCCCGTCTG
4476 GAATCCGGTC AGTAGTAGaa ttcgaAGCTT
• [pGEX6P1 - 4984 bp] pGEX6P1 complete sequence
uppercase: Ptac (-35 and -10), GST affinity tag, multiple cloning site, lacI,
Pwt-lac (-35 and -10), lacZα
highlighted in green: EcoNI, EcoRI and BamHI sites
*sequence in cyan was changed to lacUV5 and wild-type lac promoters
*sequence in yellow was deleted in lacUV5-pGEX6P1b plasmids
1 acgttatcga ctgcacggtg caccaatgct tctggcgtca ggcagccatc
51 ggaagctgtg gtatggctgt gcaggtcgta aatcactgca taattcgtgt
101 cgctcaaggc gcactcccgt tctggataat gttttttgcg ccgacatcat
151
151 aacggttctg gcaaatattc tgaaatgagc tgTTGACAat taatcatcgg
201 ctcgTATAAT gtgtggaatt gtgagcggat aacaatttca cacaggaaac
251 agtattcATG TCCCCTATAC TAGGTTATTG GAAAATTAAG GGCCTTGTGC
301 AACCCACTCG ACTTCTTTTG GAATATCTTG AAGAAAAATA TGAAGAGCAT
351 TTGTATGAGC GCGATGAAGG TGATAAATGG CGAAACAAAA AGTTTGAATT
401 GGGTTTGGAG TTTCCCAATC TTCCTTATTA TATTGATGGT GATGTTAAAT
451 TAACACAGTC TATGGCCATC ATACGTTATA TAGCTGACAA GCACAACATG
501 TTGGGTGGTT GTCCAAAAGA GCGTGCAGAG ATTTCAATGC TTGAAGGAGC
551 GGTTTTGGAT ATTAGATACG GTGTTTCGAG AATTGCATAT AGTAAAGACT
601 TTGAAACTCT CAAAGTTGAT TTTCTTAGCA AGCTACCTGA AATGCTGAAA
651 ATGTTCGAAG ATCGTTTATG TCATAAAACA TATTTAAATG GTGATCATGT
701 AACCCATCCT GACTTCATGT TGTATGACGC TCTTGATGTT GTTTTATACA
751 TGGACCCAAT GTGCCTGGAT GCGTTCCCAA AATTAGTTTG TTTTAAAAAA
801 CGTATTGAAG CTATCCCACA AATTGATAAG TACTTGAAAT CCAGCAAGTA
851 TATAGCATGG CCTTTGCAGG GCTGGCAAGC CACGTTTGGT GGTGGCGACC
901 ATCCTCCAAA ATCGGATctg gaagttctgt tccaggggcc cctgGGATCC
951 CCGGAATTCC CGGGTCGACT CGAGCGGCCG Catcgtgact gactgacgat
1001 ctgcctcgcg cgtttcggtg atgacggtga aaacctctga cacatgcagc
1051 tcccggagac ggtcacagct tgtctgtaag cggatgccgg gagcagacaa
1101 gcccgtcagg gcgcgtcagc gggtgttggc gggtgtcggg gcgcagccat
1151 gacccagtca cgtagcgata gcggagtgta taattcttga agacgaaagg
1201 gcctcgtgat acgcctattt ttataggtta atgtcatgat aataatggtt
1251 tcttagacgt caggtggcac ttttcgggga aatgtgcgcg gaacccctat
1301 ttgtttattt ttctaaatac attcaaatat gtatccgctc atgagacaat
1351 aaccctgata aatgcttcaa taatattgaa aaaggaagag tatgagtatt
1401 caacatttcc gtgtcgccct tattcccttt tttgcggcat tttgccttcc
1451 tgtttttgct cacccagaaa cgctggtgaa agtaaaagat gctgaagatc
1501 agttgggtgc acgagtgggt tacatcgaac tggatctcaa cagcggtaag
1551 atccttgaga gttttcgccc cgaagaacgt tttccaatga tgagcacttt
1601 taaagttctg ctatgtggcg cggtattatc ccgtgttgac gccgggcaag
1651 agcaactcgg tcgccgcata cactattctc agaatgactt ggttgagtac
1701 tcaccagtca cagaaaagca tcttacggat ggcatgacag taagagaatt
1751 atgcagtgct gccataacca tgagtgataa cactgcggcc aacttacttc
1801 tgacaacgat cggaggaccg aaggagctaa ccgctttttt gcacaacatg
1851 ggggatcatg taactcgcct tgatcgttgg gaaccggagc tgaatgaagc
1901 cataccaaac gacgagcgtg acaccacgat gcctgcagca atggcaacaa
1951 cgttgcgcaa actattaact ggcgaactac ttactctagc ttcccggcaa
2001 caattaatag actggatgga ggcggataaa gttgcaggac cacttctgcg
2051 ctcggccctt ccggctggct ggtttattgc tgataaatct ggagccggtg
2101 agcgtgggtc tcgcggtatc attgcagcac tggggccaga tggtaagccc
2151 tcccgtatcg tagttatcta cacgacgggg agtcaggcaa ctatggatga
2201 acgaaataga cagatcgctg agataggtgc ctcactgatt aagcattggt
2251 aactgtcaga ccaagtttac tcatatatac tttagattga tttaaaactt
2301 catttttaat ttaaaaggat ctaggtgaag atcctttttg ataatctcat
2351 gaccaaaatc ccttaacgtg agttttcgtt ccactgagcg tcagaccccg
152
2401 tagaaaagat caaaggatct tcttgagatc ctttttttct gcgcgtaatc
2451 tgctgcttgc aaacaaaaaa accaccgcta ccagcggtgg tttgtttgcc
2501 ggatcaagag ctaccaactc tttttccgaa ggtaactggc ttcagcagag
2551 cgcagatacc aaatactgtc cttctagtgt agccgtagtt aggccaccac
2601 ttcaagaact ctgtagcacc gcctacatac ctcgctctgc taatcctgtt
2651 accagtggct gctgccagtg gcgataagtc gtgtcttacc gggttggact
2701 caagacgata gttaccggat aaggcgcagc ggtcgggctg aacggggggt
2751 tcgtgcacac agcccagctt ggagcgaacg acctacaccg aactgagata
2801 cctacagcgt gagctatgag aaagcgccac gcttcccgaa gggagaaagg
2851 cggacaggta tccggtaagc ggcagggtcg gaacaggaga gcgcacgagg
2901 gagcttccag ggggaaacgc ctggtatctt tatagtcctg tcgggtttcg
2951 ccacctctga cttgagcgtc gatttttgtg atgctcgtca ggggggcgga
3001 gcctatggaa aaacgccagc aacgcggcct ttttacggtt cctggccttt
3051 tgctggcctt ttgctcacat gttctttcct gcgttatccc ctgattctgt
3101 ggataaccgt attaccgcct ttgagtgagc tgataccgct cgccgcagcc
3151 gaacgaccga gcgcagcgag tcagtgagcg aggaagcgga agagcgcctg
3201 atgcggtatt ttctccttac gcatctgtgc ggtatttcac accgcataaa
3251 ttccgacacc atcgaatggt gcaaaacctt tcgcggtatg gcatgatagc
3301 gcccggaaga gagtcaattc agggtggtga atGTGAAACC AGTAACGTTA
3351 TACGATGTCG CAGAGTATGC CGGTGTCTCT TATCAGACCG TTTCCCGCGT
3401 GGTGAACCAG GCCAGCCACG TTTCTGCGAA AACGCGGGAA AAAGTGGAAG
3451 CGGCGATGGC GGAGCTGAAT TACATTCCCA ACCGCGTGGC ACAACAACTG
3501 GCGGGCAAAC AGTCGTTGCT GATTGGCGTT GCCACCTCCA GTCTGGCCCT
3551 GCACGCGCCG TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC
3601 TGGGTGCCAG CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC
3651 TGTAAAGCGG CGGTGCACAA TCTTCTCGCG CAACGCGTCA GTGGGCTGAT
3701 CATTAACTAT CCGCTGGATG ACCAGGATGC CATTGCTGTG GAAGCTGCCT
3751 GCACTAATGT TCCGGCGTTA TTTCTTGATG TCTCTGACCA GACACCCATC
3801 AACAGTATTA TTTTCTCCCA TGAAGACGGT ACGCGACTGG GCGTGGAGCA
3851 TCTGGTCGCA TTGGGTCACC AGCAAATCGC GCTGTTAGCG GGCCCATTAA
3901 GTTCTGTCTC GGCGCGTCTG CGTCTGGCTG GCTGGCATAA ATATCTCACT
3951 CGCAATCAAA TTCAGCCGAT AGCGGAACGG GAAGGCGACT GGAGTGCCAT
4001 GTCCGGTTTT CAACAAACCA TGCAAATGCT GAATGAGGGC ATCGTTCCCA
4051 CTGCGATGCT GGTTGCCAAC GATCAGATGG CGCTGGGCGC AATGCGCGCC
4101 ATTACCGAGT CCGGGCTGCG CGTTGGTGCG GATATCTCGG TAGTGGGATA
4151 CGACGATACC GAAGACAGCT CATGTTATAT CCCGCCGTCA ACCACCATCA
4201 AACAGGATTT TCGCCTGCTG GGGCAAACCA GCGTGGACCG CTTGCTGCAA
4251 CTCTCTCAGG GCCAGGCGGT GAAGGGCAAT CAGCTGTTGC CCGTCTCACT
4301 GGTGAAAAGA AAAACCACCC TGGCGCCCAA TACGCAAACC GCCTCTCCCC
4351 GCGCGTTGGC CGATTCATTA ATGCAGCTGG CACGACAGGT TTCCCGACTG
4401 GAAAGCGGGC AGTGAgcgca acgcaattaa tgtgagttag ctcactcatt
4451 aggcacccca ggcTTTACAc tttatgcttc cggctcgTAT GTTgtgtgga
4501 attgtgagcg gataacaatt tcacacagga aacagctATG ACCATGATTA
4551 CGGATTCACT GGCCGTCGTT TTACAACGTC GTGACTGGGA AAACCCTGGC
4601 GTTACCCAAC TTAATCGCCT TGCAGCACAT CCCCCTTTCG CCAGCTGGCG
153
4651 TAATAGCGAA GAGGCCCGCA CCGATCGCCC TTCCCAACAG TTGCGCAGCC
4701 TGAATGGCGA ATGGCGCTTT GCCTGGTTTC CGGCACCAGA AGCGGTGCCG
4751 GAAAGCTGGC TGGAGTGCGA TCTTCCTGAG GCCGATACTG TCGTCGTCCC
4801 CTCAAACTGG CAGATGCACG GTTACGATGC GCCCATCTAC ACCAACGTAA
4851 CCTATCCCAT TACGGTCAAT CCGCCGTTTG TTCCCACGGA GAATCCGACG
4901 GGTTGTTACT CGCTCACATT TAATGTTGAT GAAAGCTGGC TACAGGAAGG
4951 CCAGACGCGA ATTATTTTTG ATGGCGTTgg TAATGTTGAT GAAAGCTGGC
5001 TACAGGAAGG CCAGACGCGA ATTATTTTTG ATGGCGTTgg aatt
Modifications on the promoter sequence
uppercase sequences: -35 and -10
– [lacUV5-pGEX6P1 - 4986 bp] lacUV5 promoter sequence
183 TTTACActtt atgcttccgg ctcgTATAAT
– [lacWT-pGEX6P1 - 4986 bp] wild-type lac promoter sequence
183 TTTACActtt atgcttccgg ctcgTATGTT
BamHI-EcoRI gene inserts for recombinant pRSETA, pGEX6P1 and pGEX6P1b
plasmids
– 4har gene (in pRSETA and pGEX6P1)
1 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
51 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
101 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
151 CTGAAAAAAC TGGTTGCGCG CCTGGCGCGT CAAGTACGTG CTCTGGCTGA
201 TTCTCTGATG CAGCTGGCTC GCCAGGTTTC CCGTCTGGCA GACTCCCTGT
251 AGTAGAATTC
– 4hee gene (in pRSETA)
1 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
51 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
101 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
151 CTGAAAAAAC TGGTTGAGGA GCTGGCGCGT CAAGTACGTG CTCTGGCTGA
201 TTCTCTGATG CAGCTGGCTC GCCAGGTTTC CCGTCTGGCA GACTCCCTGT
251 AGTAGAATTC
– lzar gene (in pRSETA)
1 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
51 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
101 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
151 CTGAAAAAAC TGGTTGCGCG CCTGAAGAAG CTGGTACGTG CTCTGGCTGA
201 TTCTCTGATG CAGCTGGCTC GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT
251 AGTAGAATTC
– lzee gene (in pRSETA)
highlighted in yellow: base in original sequence design
202 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
252 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
154
302 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
352 CTGAAAAAAC TGGTTGAGGA GCTGCTGTCC AAAGTACGTG CTCTGGCTGA
402 TTCTCTGATG CAGCTGGCTC GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT
452 AGTAGAATTC
– lzee gene (in pGEX6P1)
highlighted in yellow: point mutation resulting to Ser instead of Arg
945 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
995 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
1045 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
1095 CTGAAAAAAC TGGTTGAGGA GCTGCTGTCC AAAGTAAGTG CTCTGGCTGA
1145 TTCTCTGATG CAGCTGGCTC GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT
1195 AGTAGAATTC
– [lacUV5-lzee.v2/pGEX6P1 - 5231 bp] lzee gene with added restriction
enzyme sites
highlighted in green: SpeI and MfeI sites
highlighted in yellow: base in original sequence design
947 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
997 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
1047 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
1097 CTGAAAAAAC TAGTTGAGGA GCTGCTGTCC AAAGTACGTG CTCTGGCTGA
1147 TTCTCTGATG CAATTGGCTC GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT
1197 AGTAGAATTC
– [lacUV5-lzee.v2 libctrl/pGEX6P1 - 5231 bp] lzee.v2 library control gene
highlighted in green: SpeI, SacI, HindIII and MfeI sites
947 GGATCCGACC CAGCGGCACT GAAACGTGCA CGCAACACCG AAGCTGCACG
997 TCGTTCCCGT GCTCGTAAAC TGCAGCGTAT GAAACAACTG GAAGACAAAG
1047 TTGAAGAGCT GCTGTCCAAG AACTACCACC TGGAAAACGA AGTTGCTCGT
1097 CTGAAAAAAC TAGTTGAGGA GCTCCTGTCC AAGCTTCGTG CTCTGGCTGA
1147 TTCTCTGATG CAATTGGCTC GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT
1197 AGTAGAATTC
– LZD73 gene
1 GGATCCGATC CAGCTGCTCT GAAGCGAGCT CGGAACACTG AAGCTGCTCG
51 ACGGAGCCGA GCTCGGAAGC TGCAACGAAT GAAGCAGCTG GAAGACAAGG
101 TGGAGGAACT GCTGAGCAAG AACTACCACC TGGAGAACGA AGTTGCGCGC
151 CTGAAGAAGC TGGTGGGTGA ACTGCAGAAG TTACAGCGGG TGAAGCGAGC
201 TCGGAACACT GAAGCTGCTC GACGGAGCCG AGCTCGAAAG GCTGCTCTGA
251 AGGGATAGTA AGAATTC
– LZD80 gene
1 GGATCCGATC CAGCTGCTCT GAAGCGAGCT CGGAACACTG AAGCTGCTCG
51 ACGGAGCCGA GCTCGGAAGC TGCAACGAAT GAAGCAGCTG GAAGACAAGG
101 TGGAGGAACT GCTGAGCAAG AACTACCACC TGGAGAACGA AGTTGCGCGC
151 CTGAAAAAGC TGGTGGAAGA ACTGCTGAGC AAAGTGGGCG AACTGCAGAA
201 GTTACAGCGG GTGAAGCGAG CTCGGAACAC TGAAGCTGCT CGACGGAGCC
155
251 GAGCTCGAAA GGCTGCTCTG AAGGGATAGT AAGAATTC
– LZD87 gene
1 GGATCCGATC CAGCTGCTCT GAAGCGAGCT CGGAACACTG AAGCTGCTCG
51 ACGGAGCCGA GCTCGGAAGC TGCAACGAAT GAAGCAGCTG GAAGACAAGG
101 TGGAGGAACT GCTGAGCAAG AACTACCACC TGGAGAACGA AGTTGCGCGC
151 CTGAAAAAGC TGGTGGAAGA ACTGCTGAGC AAAGTGCGTG CGCTGGCGGA
201 TTCTCTGGGC GAACTGCAGA AGTTACAGCG GGTGAAGCGA GCTCGGAACA
251 CTGAAGCTGC TCGACGGAGC CGAGCTCGAA AGGCTGCTCT GAAGGGATAG
301 TAAGAATTC
• [pBAD/Myc-HisA - 4094 bp] pBAD/Myc-HisA complete sequence
highlighted in green: KpnI and EcoRI sites
1 AAGAAACCAA TTGTCCATAT TGCATCAGAC ATTGCCGTCA CTGCGTCTTT
51 TACTGGCTCT TCTCGCTAAC CAAACCGGTA ACCCCGCTTA TTAAAAGCAT
101 TCTGTAACAA AGCGGGACCA AAGCCATGAC AAAAACGCGT AACAAAAGTG
151 TCTATAATCA CGGCAGAAAA GTCCACATTG ATTATTTGCA CGGCGTCACA
201 CTTTGCTATG CCATAGCATT TTTATCCATA AGATTAGCGG ATCCTACCTG
251 ACGCTTTTTA TCGCAACTCT CTACTGTTTC TCCATACCCG TTTTTTGGGC
301 TAACAGGAGG AATTAACCAT GGATCCGAGC TCGAGATCTG CAGCTggtac
351 catatgggaa ttcGAAGCTT GGGCCCGAAC AAAAACTCAT CTCAGAAGAG
401 GATCTGAATA GCGCCGTCGA CCATCATCAT CATCATCATT GAGTTTAAAC
451 GGTCTCCAGC TTGGCTGTTT TGGCGGATGA GAGAAGATTT TCAGCCTGAT
501 ACAGATTAAA TCAGAACGCA GAAGCGGTCT GATAAAACAG AATTTGCCTG
551 GCGGCAGTAG CGCGGTGGTC CCACCTGACC CCATGCCGAA CTCAGAAGTG
601 AAACGCCGTA GCGCCGATGG TAGTGTGGGG TCTCCCCATG CGAGAGTAGG
651 GAACTGCCAG GCATCAAATA AAACGAAAGG CTCAGTCGAA AGACTGGGCC
701 TTTCGTTTTA TCTGTTGTTT GTCGGTGAAC GCTCTCCTGA GTAGGACAAA
751 TCCGCCGGGA GCGGATTTGA ACGTTGCGAA GCAACGGCCC GGAGGGTGGC
801 GGGCAGGACG CCCGCCATAA ACTGCCAGGC ATCAAATTAA GCAGAAGGCC
851 ATCCTGACGG ATGGCCTTTT TGCGTTTCTA CAAACTCTTT TGTTTATTTT
901 TCTAAATACA TTCAAATATG TATCCGCTCA TGAGACAATA ACCCTGATAA
951 ATGCTTCAAT AATATTGAAA AAGGAAGAGT ATGAGTATTC AACATTTCCG
1001 TGTCGCCCTT ATTCCCTTTT TTGCGGCATT TTGCCTTCCT GTTTTTGCTC
1051 ACCCAGAAAC GCTGGTGAAA GTAAAAGATG CTGAAGATCA GTTGGGTGCA
1101 CGAGTGGGTT ACATCGAACT GGATCTCAAC AGCGGTAAGA TCCTTGAGAG
1151 TTTTCGCCCC GAAGAACGTT TTCCAATGAT GAGCACTTTT AAAGTTCTGC
1201 TATGTGGCGC GGTATTATCC CGTGTTGACG CCGGGCAAGA GCAACTCGGT
1251 CGCCGCATAC ACTATTCTCA GAATGACTTG GTTGAGTACT CACCAGTCAC
1301 AGAAAAGCAT CTTACGGATG GCATGACAGT AAGAGAATTA TGCAGTGCTG
1351 CCATAACCAT GAGTGATAAC ACTGCGGCCA ACTTACTTCT GACAACGATC
1401 GGAGGACCGA AGGAGCTAAC CGCTTTTTTG CACAACATGG GGGATCATGT
1451 AACTCGCCTT GATCGTTGGG AACCGGAGCT GAATGAAGCC ATACCAAACG
1501 ACGAGCGTGA CACCACGATG CCTGTAGCAA TGGCAACAAC GTTGCGCAAA
1551 CTATTAACTG GCGAACTACT TACTCTAGCT TCCCGGCAAC AATTAATAGA
1601 CTGGATGGAG GCGGATAAAG TTGCAGGACC ACTTCTGCGC TCGGCCCTTC
156
1651 CGGCTGGCTG GTTTATTGCT GATAAATCTG GAGCCGGTGA GCGTGGGTCT
1701 CGCGGTATCA TTGCAGCACT GGGGCCAGAT GGTAAGCCCT CCCGTATCGT
1751 AGTTATCTAC ACGACGGGGA GTCAGGCAAC TATGGATGAA CGAAATAGAC
1801 AGATCGCTGA GATAGGTGCC TCACTGATTA AGCATTGGTA ACTGTCAGAC
1851 CAAGTTTACT CATATATACT TTAGATTGAT TTAAAACTTC ATTTTTAATT
1901 TAAAAGGATC TAGGTGAAGA TCCTTTTTGA TAATCTCATG ACCAAAATCC
1951 CTTAACGTGA GTTTTCGTTC CACTGAGCGT CAGACCCCGT AGAAAAGATC
2001 AAAGGATCTT CTTGAGATCC TTTTTTTCTG CGCGTAATCT GCTGCTTGCA
2051 AACAAAAAAA CCACCGCTAC CAGCGGTGGT TTGTTTGCCG GATCAAGAGC
2101 TACCAACTCT TTTTCCGAAG GTAACTGGCT TCAGCAGAGC GCAGATACCA
2151 AATACTGTCC TTCTAGTGTA GCCGTAGTTA GGCCACCACT TCAAGAACTC
2201 TGTAGCACCG CCTACATACC TCGCTCTGCT AATCCTGTTA CCAGTGGCTG
2251 CTGCCAGTGG CGATAAGTCG TGTCTTACCG GGTTGGACTC AAGACGATAG
2301 TTACCGGATA AGGCGCAGCG GTCGGGCTGA ACGGGGGGTT CGTGCACACA
2351 GCCCAGCTTG GAGCGAACGA CCTACACCGA ACTGAGATAC CTACAGCGTG
2401 AGCTATGAGA AAGCGCCACG CTTCCCGAAG GGAGAAAGGC GGACAGGTAT
2451 CCGGTAAGCG GCAGGGTCGG AACAGGAGAG CGCACGAGGG AGCTTCCAGG
2501 GGGAAACGCC TGGTATCTTT ATAGTCCTGT CGGGTTTCGC CACCTCTGAC
2551 TTGAGCGTCG ATTTTTGTGA TGCTCGTCAG GGGGGCGGAG CCTATGGAAA
2601 AACGCCAGCA ACGCGGCCTT TTTACGGTTC CTGGCCTTTT GCTGGCCTTT
2651 TGCTCACATG TTCTTTCCTG CGTTATCCCC TGATTCTGTG GATAACCGTA
2701 TTACCGCCTT TGAGTGAGCT GATACCGCTC GCCGCAGCCG AACGACCGAG
2751 CGCAGCGAGT CAGTGAGCGA GGAAGCGGAA GAGCGCCTGA TGCGGTATTT
2801 TCTCCTTACG CATCTGTGCG GTATTTCACA CCGCATATGG TGCACTCTCA
2851 GTACAATCTG CTCTGATGCC GCATAGTTAA GCCAGTATAC ACTCCGCTAT
2901 CGCTACGTGA CTGGGTCATG GCTGCGCCCC GACACCCGCC AACACCCGCT
2951 GACGCGCCCT GACGGGCTTG TCTGCTCCCG GCATCCGCTT ACAGACAAGC
3001 TGTGACCGTC TCCGGGAGCT GCATGTGTCA GAGGTTTTCA CCGTCATCAC
3051 CGAAACGCGC GAGGCAGCAG ATCAATTCGC GCGCGAAGGC GAAGCGGCAT
3101 GCATAATGTG CCTGTCAAAT GGACGAAGCA GGGATTCTGC AAACCCTATG
3151 CTACTCCGTC AAGCCGTCAA TTGTCTGATT CGTTACCAAT TATGACAACT
3201 TGACGGCTAC ATCATTCACT TTTTCTTCAC AACCGGCACG GAACTCGCTC
3251 GGGCTGGCCC CGGTGCATTT TTTAAATACC CGCGAGAAAT AGAGTTGATC
3301 GTCAAAACCA ACATTGCGAC CGACGGTGGC GATAGGCATC CGGGTGGTGC
3351 TCAAAAGCAG CTTCGCCTGG CTGATACGTT GGTCCTCGCG CCAGCTTAAG
3401 ACGCTAATCC CTAACTGCTG GCGGAAAAGA TGTGACAGAC GCGACGGCGA
3451 CAAGCAAACA TGCTGTGCGA CGCTGGCGAT ATCAAAATTG CTGTCTGCCA
3501 GGTGATCGCT GATGTACTGA CAAGCCTCGC GTACCCGATT ATCCATCGGT
3551 GGATGGAGCG ACTCGTTAAT CGCTTCCATG CGCCGCAGTA ACAATTGCTC
3601 AAGCAGATTT ATCGCCAGCA GCTCCGAATA GCGCCCTTCC CCTTGCCCGG
3651 CGTTAATGAT TTGCCCAAAC AGGTCGCTGA AATGCGGCTG GTGCGCTTCA
3701 TCCGGGCGAA AGAACCCCGT ATTGGCAAAT ATTGACGGCC AGTTAAGCCA
3751 TTCATGCCAG TAGGCGCGCG GACGAAAGTA AACCCACTGG TGATACCATT
3801 CGCGAGCCTC CGGATGACGA CCGTAGTGAT GAATCTCTCC TGGCGGGAAC
3851 AGCAAAATAT CACCCGGTCG GCAAACAAAT TCTCGTCCCT GATTTTTCAC
157
3901 CACCCCCTGA CCGCGAATGG TGAGATTGAG AATATAACCT TTCATTCCCA
3951 GCGGTCGGTC GATAAAAAAA TCGAGATAAC CGTTGGCCTC AATCGGCGTT
4001 AAACCCGCCA CCAGATGGGC ATTAAACGAG TATCCCGGCA GCAGGGGATC
4051 ATTTTGCGCT TCAGCCATAC TTTTCATACT CCCGCCATTC AGAG
KpnI-EcoRI gene inserts for recombinant pBAD/Myc-HisA plasmids
– untagged lzee gene
346 GGTACCGAAG TTCTGTTCCA GGGGCCCCTG GGATCCGACC CAGCGGCACT
396 GAAACGTGCA CGCAACACCG AAGCTGCACG TCGTTCCCGT GCTCGTAAAC
446 TGCAGCGTAT GAAACAACTG GAAGACAAAG TTGAAGAGCT GCTGTCCAAG
496 AACTACCACC TGGAAAACGA AGTTGCTCGT CTGAAAAAAC TGGTTGAGGA
546 GCTGCTGTCC AAAGTACGTG CTCTGGCTGA TTCTCTGATG CAGCTGGCTC
596 GCCAGGTTTC CCGTCTGGAA TCCGGTCAGT AGTAGAATTC
– untagged LZD73 gene
346 GGTACCGAAG TTCTGTTCCA GGGGCCCCTG GGATCCGATC CAGCTGCTCT
396 GAAGCGAGCT CGGAACACTG AAGCTGCTCG ACGGAGCCGA GCTCGGAAGC
446 TGCAACGAAT GAAGCAGCTG GAAGACAAGG TGGAGGAACT GCTGAGCAAG
496 AACTACCACC TGGAGAACGA AGTTGCGCGC CTGAAGAAGC TGGTGGGTGA
546 ACTGCAGAAG TTACAGCGGG TGAAGCGAGC TCGGAACACT GAAGCTGCTC
596 GACGGAGCCG AGCTCGAAAG GCTGCTCTGA AGGGATAGTA AGAATTC
– untagged LZD80 gene
346 GGTACCGAAG TTCTGTTCCA GGGGCCCCTG GGATCCGATC CAGCTGCTCT
396 GAAGCGAGCT CGGAACACTG AAGCTGCTCG ACGGAGCCGA GCTCGGAAGC
446 TGCAACGAAT GAAGCAGCTG GAAGACAAGG TGGAGGAACT GCTGAGCAAG
496 AACTACCACC TGGAGAACGA AGTTGCGCGC CTGAAAAAGC TGGTGGAAGA
546 ACTGCTGAGC AAAGTGGGCG AACTGCAGAA GTTACAGCGG GTGAAGCGAG
596 CTCGGAACAC TGAAGCTGCT CGACGGAGCC GAGCTCGAAA GGCTGCTCTG
646 AAGGGATAGT AAGAATTC
– untagged LZD87 gene
346 GGTACCGAAG TTCTGTTCCA GGGGCCCCTG GGATCCGATC CAGCTGCTCT
396 GAAGCGAGCT CGGAACACTG AAGCTGCTCG ACGGAGCCGA GCTCGGAAGC
446 TGCAACGAAT GAAGCAGCTG GAAGACAAGG TGGAGGAACT GCTGAGCAAG
496 AACTACCACC TGGAGAACGA AGTTGCGCGC CTGAAAAAGC TGGTGGAAGA
546 ACTGCTGAGC AAAGTGCGTG CGCTGGCGGA TTCTCTGGGC GAACTGCAGA
596 AGTTACAGCG GGTGAAGCGA GCTCGGAACA CTGAAGCTGC TCGACGGAGC
646 CGAGCTCGAA AGGCTGCTCT GAAGGGATAG TAAGAATTC
2.2 Mutagenesis primer sequences for generating 300- to 1150-bp loop-
ing constructs with distal INV2 site
• [lambdaFP-EcoRI]
1 ccattcagct GAATTCcaga cgtaacagca ccac
158
• [lambdaRP-SacI]
1 tttctgttcg GAGCTCccat taccacctta accg
• [mutFP-INV2-300]
1 actagtATgt catatgacGA tgtacaCTGC GGGAAGTGCG GTATCAGCAT
51 CGCAGAGC
• [mutRP-INV2-300]
1 GACGCACTCC CCGCCGCCGC TGTTTTTGCG
• [mutFP-INV2-450]
1 GTGCactagt TGgtcatatg acGGtgtaca CGGCAGAAAA TTCTGCCAGG
51 GCGG
• [mutRP-INV2-450]
1 TTGATGATGC GTTCGTTTCT GATGATTTTG CTGCCTCTTT TGAGGCCACC
51 GCATCTCGTG
• [mutFP-INV2-650]
1 actagtTCgt catatgacGC tgtacaCAGT GCCGGTGCGG CGAAAACGTC
51 AG
• [mutRP-INV2-650]
1 TGCGGCTGCG GCACTTTTTT CCGCTTCAGT GGCCTTTG
• [mutFP-INV2-900]
1 actagtGGgt catatgacGG tgtacaACGC GTCCGTGGTG GCACAGAGTA
51 CG
• [mutRP-INV2-900]
1 TCAAGACGAC GCAGCACCTC CGGCCGG
• [mutFP3-BsrGI]
1 tgtacaGTGG TGGTGAACAC GGTGGGCTCA G
• [mutRP-INV2-1150]
1 GCgtcatatg acGgaattcT TGAAGACGAA AGGGCCTCGT
2.3 Promoter-operator constructs
• [pJ1653 - 5618 bp] pJ1653 complete sequence
highlighted in green: EcoRI, SacI, BamHI, SalI and NotI sites
highlighted in cyan: -35 and -10 regions of lacUV5 promoter
1 GAACTCCGGA TGAGCATTCA TCAGGCGGGC AAGAATGTGA ATAAAGGCCG
51 GATAAAACTT GTGCTTATTT TTCTTTACGG TCTTTAAAAA GGCCGTAATA
101 TCCAGCTGAA CGGTCTGGTT ATAGGTACAT TGAGCAACTG ACTGAAATGC
151 CTCAAAATGT TCTTTACGAT GCCATTGGGA TATATCAACG GTGGTATATC
201 CAGTGATTTT TTTCTCCATT TTAGCTTCCT TAGCTCCTGA AAATCTCGAT
159
251 AACTCAAAAA ATACGCCCGG TAGTGATCTT ATTTCATTAT GGTGAAAGTT
301 GGAACCTCTT ACGTGCCGAT CAACGTCTCA TTTTCGCCAA AAGTTGGCCC
351 AGGGCTTCCC GGTATCAACA GGGACACCAG GATTTATTTA TTCTGCGAAG
401 TGATCTTCCG TCACAGGTAT TTATTCGGCG CAAAGTGCGT CGGGTGATGC
451 TGCCAACTTA CTGATTTAGT GTATGATGGT GTTTTTGAGG TGCTCCAGTG
501 GCTTCTGTTT CTATCAGCTG TCCCTCCTGT TCAGCTACTG ACGGGGTGGT
551 GCGTAACGGC AAAAGCACCG CCGGACATCA GCGCTAGCGG AGTGTATACT
601 GGCTTACTAT GTTGGCACTG ATGAGGGTGT CAGTGAAGTG CTTCATGTGG
651 CAGGAGAAAA AAGGCTGCAC CGGTGCGTCA GCAGAATATG TGATACAGGA
701 TATATTCCGC TTCCTCGCTC ACTGACTCGC TACGCTCGGT CGTTCGACTG
751 CGGCGAGCGG AAATGGCTTA CGAACGGGGC GGAGATTTCC TGGAAGATGC
801 CAGGAAGATA CTTAACAGGG AAGTGAGAGG GCCGCGGCAA AGCCGTTTTT
851 CCATAGGCTC CGCCCCCCTG ACAAGCATCA CGAAATCTGA CGCTCAAATC
901 AGTGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCTG
951 GCGGCTCCCT CGTGCGCTCT CCTGTTCCTG CCTTTCGGTT TACCGGTGTC
1001 ATTCCGCTGT TATGGCCGCG TTTGTCTCAT TCCACGCCTG ACACTCAGTT
1051 CCGGGTAGGC AGTTCGCTCC AAGCTGGACT GTATGCACGA ACCCCCCGTT
1101 CAGTCCGACC GCTGCGCCTT ATCCGGTAAC TATCGTCTTG AGTCCAACCC
1151 GGAAAGACAT GCAAAAGCAC CACTGGCAGC AGCCACTGGT AATTGATTTA
1201 GAGGAGTTAG TCTTGAAGTC ATGCGCCGGT TAAGGCTAAA CTGAAAGGAC
1251 AAGTTTTGGT GACTGCGCTC CTCCAAGCCA GTTACCTCGG TTCAAAGAGT
1301 TGGTAGCTCA GAGAACCTTC GAAAAACCGC CCTGCAAGGC GGTTTTTTCG
1351 TTTTCAGAGC AAGAGATTAC GCGCAGACCA AAACGATCTC AAGAAGATCA
1401 TCTTATTAAT CAGATAAAAT ATTTCTAGAT TTCAGTGCAA TTTATCTCTT
1451 CAAATGTAGC ACCTGAAGTC AGCCCCATAC GATATAAGTT GTAATTCTCA
1501 TGTTTGACAG CTTATCATCG ATAAGCTAGC TTTAATGCGG TAGTTTATCA
1551 CAGTTAAATT GCTAACGCAG TCAGGCACCG TGTATGAAAT CTAACAATGC
1601 GCTCATCGTC ATCCTCGGCA CCGTCACCCT GGATGCTGTA GGCATAGGCT
1651 TGGTTATGCC GGTTGCACAA TCTTCTCGCG CAACGCGTCA GTGGGCTGAT
1701 CATTAACTAT CCGCTGGATG ACCAGGATGC CATTGCTGTG GAAGCTGCCT
1751 GCACTAATGT TCCGGCGTTA TTTCTTGATG TCTCTGACCA GACACCCATC
1801 AACAGTATTA TTTTCTCCCA TGAAGACGGT ACGCGACTGG GCGTGGAGCA
1851 TCTGGTCGCA TTGGGTCACC AGCAAATCGC GCTGTTAGCG GGCCCATTAA
1901 GTTCTGTCTC GGCGCGTCTG CGTCTGGCTG GCTGGCATAA ATATCTCACT
1951 CGCAATCAAA TTCAGCCGAT AGCGGAACGG GAAGGCGACT GGAGTGCCAT
2001 GTCCGGTTTT CAACAAACCA TGCAAATGCT GAATGAGGGC ATCGTTCCCA
2051 CTGCGATGCT GGTTGCCAAC GATCAGATGG CGCTGGGCGC AATGCGCGCC
2101 ATTACCGAGT CCGGGCTGCG CGTTGGTGCG GATATCTCGG TAGTGGGATA
2151 CGACGATACC GAAGACAGCT CATGTTATAT CCCGCCGTTA ACCACCATCA
2201 AACAGGATTT TCGCCTGCTG GGGCAAACCA GCGTGGACCG CTTGCTGCAA
2251 CTCTCTCAGG GCCAGGCGGT GAAGGGCAAT CAGCTGTTGC CCGTCTCACT
2301 GGTGAAAAGA AAAACCACCC TGGCGCCCAA TACGCAAACC GCCTCTCCCC
2351 GCGCGTTGGC CGATTCATTA ATGCAGCTGG CACGACAGGT TTCCCGACTG
2401 GAAAGCGGGC AGTGAGCGCA ACGCAATTAA TGTAAGTTAG CGCGAATTAT
2451 CGTCCATTCC GACAGCATCG CCAGTCACTA TGGCGTGCTG CTAGCGCTAT
160
2501 ATGCGTTGAT GCAATTTCTA TGCGCACCCG TTCTCGGAGC ACTGTCCGAC
2551 CGCTTTGGCC GCCGCCCAGT CCTGCTCGCT TCGCTACTTG GAGCCACTAT
2601 CGACTACGCG ATCATGGCGA CCACACCCGT CCTGTGGGAT CAGATCTCGC
2651 AATTGCCGTT GATTTGGGGA TCTTTGTTGT AGGTGGACCA GTTGGTGATT
2701 TTGAACTTTT GCTTTGCCAC GGAACGGTCT GCGTTGTCGG GAAGATGCGT
2751 GATCTGATCC TTCAACTCAG CAAAAGTTCG ATTTATTCAA CAAAGCCGCC
2801 GTCCCGTCAA GTCAGCGTAA TGCTCTGCCA GTGTTACAAC CAATTAACCA
2851 ATTCTGATTA GAAAAACTCA TCGAGCATCA AATGAAACTG CAATTTATTC
2901 ATATCAGGAT TATCAATACC ATATTTTTGA AAAAGCCGTT TCTGTAATGA
2951 AGGAGAAAAC TCACCGAGGC AGTTCCATAG GATGGCAAGA TCCTGGTATC
3001 GGTCTGCGAT TCCGACTCGT CCAACATCAA TACAACCTAT TAATTTCCCC
3051 TCGTCAAAAA TAAGGTTATC AAGTGAGAAA TCACCATGAG TGACGACTGA
3101 ATCCGGTGAG AATGGCAAGA GCTTATGCAT TTCTTTCCAG ACTTGTTCAA
3151 CAGGCCAGCC ATTACGCTCG TCATCAAAAT CACTCGCATC AACCAAACCG
3201 TTATTCATTC GTGATTGCGC CTGAGCGAGA CGAAATACGC GATCGCTGTT
3251 AAAAGGACAA TTACAAACAG GAATCGAATG CAACCGGCGC AGGAACACTG
3301 CCAGCGCATC AACAATATTT TCACCTGAAT CAGGATATTC TTCTAATACC
3351 TGGAATGCTG TTTTCCCGGG GATCGCAGTG GTGAGTAACC ATGCATCATC
3401 AGGAGTACGG ATAAAATGCT TGATGGTCGG AAGAGGCATA AATTCCGTCA
3451 GCCAGTTTAG TCTGACCATC TCATCTGTAA CATCATTGGC AACGCTACCT
3501 TTGCCATGTT TCAGAAACAA CTCTGGCGCA TCGGGCTTCC CATACAATCG
3551 ATAGATTGTC GCACCTGATT GCCCGACATT ATCGCGAGCC CATTTATACC
3601 CATATAAATC AGCATCCATG TTGGAATTTA ATCGCGGCCT CGAGCAAGAC
3651 GTTTCCCGTT GAATATGGCT CATAACACCC CTTGTATTAC TGTTTATGTA
3701 AGCAGACAGT TTTATTGTTC ATGATGATAT ATTTTTATCT TGTGCAATGT
3751 AACATCAGAG ATTTTGAGAC ACAACGTGGC TTTGTTGAAT AAATCGAACT
3801 TTTGCTGAGT TGAAGGATCA GATCACGCAT CTTCCCGACA ACGCAGACCG
3851 TTCCGTGGCA AAGCAAAAGT TCAAAATCAC CAACTGGTCC CACCTGACCC
3901 CATGCCGAAC TCAGAAGTGA AACGCCGTAG CGCCGATGGT AGTGTGGGGT
3951 CTCCCCATGC GAGAGTAGGG AACTGCCAGG CATCAAATAA AACGAAAGGC
4001 TCAGTCGAAA GACTGGGCCT TTCGTTTTAT CTGTTGTTTG TCGGTGAACG
4051 CTCTCCTGAG TAGGACAAAT CCGCCGGGAG CGGATTTGAA CGTTGCGAAG
4101 CAACGGCCCG GAGGGTGGCG GGCAGGACGC CCGCCATAAA CTGCCAGGCA
4151 TCAAATTAAG CAGAAGGCCA TCCTGACGGA TGGCCTTTTT GCGTTTCTAC
4201 AAACTCTTTT GTTTATTTTT CTAAATACAT TCAAATATGT ATCCGCTCAT
4251 GACATTAACC TATAAAAATA GGCGTATCAC GAGGCCCTTT CGTCTTCAAg
4301 aattcGAAAG TTAATGAATA GCACCGCCGg agctcggtac cCGGggatcc
4351 GCTTTACACT TTATGCTTCC GGCTCGTATA ATGTgtcgac CGAAAGTTAA
4401 TGAATAGCAC CCCgcggccg cACACAGGAA ACAGCTATGA CCATGATTAC
4451 GAATTTCGAC ctgcagCCaa gcttGGCACT GGCCGTCGTT TTACAACGTC
4501 GTGACTGGGA AAACCCTGGC GTTACCCAAC TTAATCGCCT TGCAGCACAT
4551 CCCCCTTTCG CCAGCTGGCG TAATAGCGAA GAGGCCCGCA CCGATCGCCC
4601 TTCCCAACAG TTGCGCAGCC TGAATGGCGA ATGGCGCTTT GCCTGGTTTC
4651 CGGCACCAGA AGCGGTGCCG GAAGCTGGCT GGAGTGCGAT CTTCCTGAGG
4701 CCGATACTGT CGTCGTCCCC TCAAACTGGC AGATGCACGG TTACGATGCG
161
4751 CCCATCTACA CCAACGTAAC CTATCCCATT ACGGTCAATC CGCCGTTTGT
4801 TCCCAcggag aatccgacgg ggtgctattc attaactttc aatgttgatg
4851 AAAGCTGGCT ACAGGAAGGC CAGACGCGAA TTATTTTTGA TGGCGTTAAC
4901 TCGGCGTTTC ATCTGTGGTG CAACGGGCGC TGGGTCGGTT ACGGCCAGGA
4951 CAGTCGTTTG CCGTCTGAAT TTGACCTGAG CGCATTTTTA CGCGCCGGAG
5001 AAAACCGCCT CGCGGTGATG GTGCTGCGTT GGAGTGACGG CAGTTATCTG
5051 GAAGATCAGG ATATGTGGCG GATGAGCGGC ATTTTCCGTG ACGAATTTCT
5101 GCCATTCATC CGCTTATTAT CACTTATTCA GGCGTAGCAC CAGGCGTTTA
5151 AGGGCACCAA TAACTGCCTT AAAAAAATTA CGCCCCGCCC TGCCACTCAT
5201 CGCAGTACTG TTGTAATTCA TTAAGCATTC TGCCGACATG GAAGCCATCA
5251 CAGACGGCAT GATGAACCTG AATCGCCAGC GGCATCAGCA CCTTGTCGCC
5301 TTGCGTATAA TATTTGCCCA TGGTGAAAAC GGGGGCGAAG AAGTTGTCCA
5351 TATTGGCCAC GTTTAAATCA AAACTGGTGA AACTCACCCA GGGATTGGCT
5401 GAGACGAAAA ACATATTCTC AATAAACCCT TTAGGGAAAT AGGCCAGGTT
5451 TTCACCGTAA CACGCCACAT CTTGCGAATA TATGTGTAGA AACTGCCGGA
5501 AATCGTCGTG GTATTCACTC CAGAGCGATG AAAACGTTTC AGTTTGCTCA
5551 TGGAAAACGG TGTAACAAGG GTGAACACTA TCCCATATCA CCAGCTCACC
5601 GTCTTTCATT GCCATACG
• [proxWT-1] SalI – NotI sequence insert in pJ1653
4385 gtcgacCAAa tgactcttTC CCACAACCgc ggccgc
• [proxCREB-1] SalI – NotI sequence insert in pJ1653
4385 gtcgacCAat gacgtcatTC CCACAACCgc ggccgc
• [distWT] EcoRI – SacI gene insert in pJ1653
4300 gaattcAAat gactcttGTA CAAATTGCCG gagctc
• [distCREB] EcoRI – SacI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctc
• [CC-85] EcoRI – NotI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctcggta ccCGGggatc
4350 cGCTTTACAC TTTATGCTTC CGGCTCGTAT AATGTgtcga cCAatgacgt
4400 catTCCCACA ACCgcggccg c
• [CW-85.5] EcoRI – NotI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctcggta ccCGGggatc
4350 cGCTTTACAC TTTATGCTTC CGGCTCGTAT AATGTgtcga cCAAatgact
4400 cttTCCCACA ACCgcggccg c
• [CW-138.5] EcoRI – NotI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctcGCTG CTAACAAAGC
4350 CCGAAAGGAA GCTGAGTTGG CTGCTGCCAC CGCTGAGCAA TAACTAGCgg
4400 atccGCTTTA CACTTTATGC TTCCGGCTCG TATAATGTgt cgacCAAatg
4450 actcttTCCC ACAACCgcgg ccgc
162
• [CW-187.5] EcoRI – NotI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctcGCTG CTAACAAAGC
4350 CCGAAAGGAA GCTGAGTTGG CTGCTGCCAC CGCTGAGCAA TAACTAGCAT
4400 AACCCCTTGG GGCCTCTAAA CGGGTCTTGA GGGGTTTTTT GCTGAAAgga
4450 tccGCTTTAC ACTTTATGCT TCCGGCTCGT ATAATGTgtc gacCAAatga
4500 ctcttTCCCA CAACCgcggc cgc
• [CW-237.5] EcoRI – NotI gene insert in pJ1653
4300 gaattcAAat gacgtcatGT ACAATTGCCG gagctcGCTG CTAACAAAGC
4350 CCGAAAGGAA GCTGAGTTGG CTGCTGCCAC CGCTGAGCAA TAACTAGCAT
4400 AACCCCTTGG GGCCTCTAAA CGGGTCTTGA GGGGTTTTTT GCTGAAAGGA
4450 GGAACTATAT CCGGATCTGG CGTAATAGCG AAGAGGCCCG CACCGATgga
4500 tccGCTTTAC ACTTTATGCT TCCGGCTCGT ATAATGTgtc gacCAAatga
4550 ctcttTCCCA CAACCgcggc cgc
• [proxCREB-2 and proxWT-2] EcoRI – SacI linker sequence in proxCREB-1
and proxWT-1
4300 gaattcCAGA CGTAACAGCA CCACGGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAA
4550 CTGATGGTGG AAGAGGTGGC GCGTAACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAG
4800 AGTCCTCAAA AAACGCGGCG GCCACCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCC
5000 GGTCGTGCAG CTTCCTCGGC AACGGCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCA
5150 ACGGCATCCA CGAAGGCGAC AGAGGCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
• [IC-300 and IW-300.5] EcoRI – SacI gene insert in proxCREB-2 and proxWT-
2
4300 gaattcCAGA CGTAACAGCA CCACGGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
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4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAA
4550 CTGATGGTGG AAGAGGTGGC GCGTAACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAG
4800 AGTCCTCAAA AAACGCGGCG GCCACCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCC
5000 GGTCGTGCAG CTTCCTCGGC AACGGCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCa
5150 ctagtATgtc atatgacGAt gtacaCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
• [IC-450 and IW-450.5] EcoRI – SacI gene insert in proxCREB-2 and proxWT-
2
4300 gaattcCAGA CGTAACAGCA CCACGGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAA
4550 CTGATGGTGG AAGAGGTGGC GCGTAACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAG
4800 AGTCCTCAAA AAACGCGGCG GCCACCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCa
5000 ctagtTGgtc atatgacGGt gtacaCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCA
5150 ACGGCATCCA CGAAGGCGAC AGAGGCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
• [IC-650 and IW-650.5] EcoRI – SacI gene insert in proxCREB-2 and proxWT-
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4300 gaattcCAGA CGTAACAGCA CCACGGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAA
4550 CTGATGGTGG AAGAGGTGGC GCGTAACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAa
4800 ctagtTCgtc atatgacGCt gtacaCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCC
5000 GGTCGTGCAG CTTCCTCGGC AACGGCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCA
5150 ACGGCATCCA CGAAGGCGAC AGAGGCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
• [IC-900 and IW-900.5] EcoRI – SacI gene insert in proxCREB-2 and proxWT-
2
4300 gaattcCAGA CGTAACAGCA CCACGGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAa
4550 ctagtGGgtc atatgacGGt gtacaACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAG
4800 AGTCCTCAAA AAACGCGGCG GCCACCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCC
5000 GGTCGTGCAG CTTCCTCGGC AACGGCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCA
5150 ACGGCATCCA CGAAGGCGAC AGAGGCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
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5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
• [IC-1150 and IW-1150.5] EcoRI – SacI gene insert in proxCREB-2 and proxWT-
2
4300 gaattcCgtc atatgacGCt gtacaGTGGT GGTGAACACG GTGGGCTCAG
4350 AGAATCCGGA TGAAGCCGGG CGTTACAGCA TGGATGTGGA GTACGGTCAG
4400 TACAGTGTCA TCCTGCAGGT TGACGGTTTT CCACCATCGC ACGCCGGGAC
4450 CATCACCGTG TATGAAGATT CACAACCGGG GACGCTGAAT GATTTTCTCT
4500 GTGCCATGAC GGAGGATGAT GCCCGGCCGG AGGTGCTGCG TCGTCTTGAA
4550 CTGATGGTGG AAGAGGTGGC GCGTAACGCG TCCGTGGTGG CACAGAGTAC
4600 GGCAGACGCG AAGAAATCAG CCGGCGATGC CAGTGCATCA GCTGCTCAGG
4650 TCGCGGCCCT TGTGACTGAT GCAACTGACT CAGCACGCGC CGCCAGCACG
4700 TCCGCCGGAC AGGCTGCATC GTCAGCTCAG GAAGCGTCCT CCGGCGCAGA
4750 AGCGGCATCA GCAAAGGCCA CTGAAGCGGA AAAAAGTGCC GCAGCCGCAG
4800 AGTCCTCAAA AAACGCGGCG GCCACCAGTG CCGGTGCGGC GAAAACGTCA
4850 GAAACGAATG CTGCAGCGTC ACAACAATCA GCCGCCACGT CTGCCTCCAC
4900 CGCGGCCACG AAAGCGTCAG AGGCCGCCAC TTCAGCACGA GATGCGGTGG
4950 CCTCAAAAGA GGCAGCAAAA TCATCAGAAA CGAACGCATC ATCAAGTGCC
5000 GGTCGTGCAG CTTCCTCGGC AACGGCGGCA GAAAATTCTG CCAGGGCGGC
5050 AAAAACGTCC GAGACGAATG CCAGGTCATC TGAAACAGCA GCGGAACGGA
5100 GCGCCTCTGC CGCGGCAGAC GCAAAAACAG CGGCGGCGGG GAGTGCGTCA
5150 ACGGCATCCA CGAAGGCGAC AGAGGCTGCG GGAAGTGCGG TATCAGCATC
5200 GCAGAGCAAA AGTGCGGCAG AAGCGGCGGC AATACGTGCA AAAAATTCGG
5250 CAAAACGTGC AGAAGATATA GCTTCAGCTG TCGCGCTTGA GGATGCGGAC
5300 ACAACGAGAA AGGGGATAGT GCAGCTCAGC AGTGCAACCA ACAGCACGTC
5350 TGAAACGCTT GCTGCAACGC CAAAGGCGGT TAAGGTGGTA ATGGgagctc
2.4 Translated protein sequences
His-tagged recombinant proteins in pRSETA and pFastBac1
• [empty pRSETA - 71 aa]
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDRWGSELEICSWYH
GIRSLIRLLTKPERKLSWLLPPLSNN





























GST-tagged recombinant proteins in pGEX6P1 and pGEX6P1b

































































Untagged recombinant proteins in pBAD/Myc-HisA
• [empty pBAD-Myc-HisA - 30 aa]
MDPSSRSAAGTIWEFEAWARTKTHLRRGSE
















2.5 PCC qPCR primers
• FPnorm2-PCC (FPnorm)
1 CAGGCGTTTA AGGGCACCAA TA
• RPnorm2-PCC (RPnorm)
1 GCTGGCGATT CAGGTTCATC AT
• qFPctrl1-HinP1I-428 (FPctrl1)
1 CATTTTCGCC AAAAGTTGGC CCAGGG
• qFPctrl2-HinP1I-581 (FPctrl2)
1 CTATCAGCTG TCCCTCCTGT TCAGC
• qRPctrl1-HinP1I-428 (RPctrl1)
1 GAAACAGAAG CCACTGGAGC ACCTC
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• qRPctrl2-HinP1I-581 (RPctrl2)
1 CTTCACTGAC ACCCTCATCA GTGCC
• qFP-HinP1I-5676 (A1)
1 AAAACCCTGG CGTTACCCAA CTTAATCG
• qRP-HinP1I-5282 (A2)
1 CCATTACCAC CTTAACCGCC TTTGG
• qFP-HinP1I-5282 (B1)
1 GGTATCAGCA TCGCAGAGCA AAAGTG
• qRP-HinP1I-5100 (B2)
1 CACTTTTGCT CTGCGATGCT GATACC
• qFP-HinP1I-5100 (C1)
1 GCAGCAAAAT CATCAGAAAC GAACGCATC
• qRP-HinP1I-4743 (C2)
1 AGCATTCGTT TCTGACGTTT TCGCC
• qFP-HinP1I-4686 (D1)
1 AGTACGGCAG ACGCGAAGAA ATCAG
• qRP-HinP1I-3930 (D2, old)
1 CCGACAAACA ACAGATAAAA CGAAAGGCC
• qRP-HinP1I-3930 (D2, new)
1 CCTACTCAGG AGAGCGTTCA CCG
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Oehler, S., Eismann, E. R., Krämer, H., & Müller-Hill, B. (1990). The three
operators of the lac operon cooperate in repression. The EMBO journal ,
9 (4), 973–979.
Parker, M. W., Lo Bello, M., & Federici, G. (1990). Crystallization of glutathione
S-transferase from human placenta. Journal of molecular biology , 213 (2),
221–222.
Peters, J. P., Becker, N. A., Rueter, E. M., Bajzer, Z., Kahn, J. D., & Maher, L. J.
(2011). Quantitative methods for measuring DNA flexibility in vitro and in
vivo. Methods in enzymology , 488 , 287–335.
Rutkauskas, D., Zhan, H., Matthews, K. S., Pavone, F. S., & Vanzi, F. (2009).
Tetramer opening in LacI-mediated DNA looping. Proceedings of the National
174
Academy of Sciences of the United States of America, 106 (39), 16627–16632.
Sasse-Dwight, S., & Gralla, J. D. (1988). Probing the Escherichia coli glnALG
upstream activation mechanism in vivo. Proceedings of the National Academy
of Sciences of the United States of America, 85 , 8934–8938.
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